Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,A1BG,Alpha-1B-glycoprotein,20117,60,2.71 [0.60-12.21],0.1930552605021364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AAMDC,Mth938 domain-containing protein,19543,57,1.20 [0.74-1.93],0.460563122658043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AARSD1,Alanyl-tRNA editing protein Aarsd1,23054,68,1.14 [0.79-1.67],0.4845848135100794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,19410,56,1.86 [1.01-3.42],0.0453780241208408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,22892,70,1.45 [1.01-2.08],0.0465412480912662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABL1,Tyrosine-protein kinase ABL1,23054,68,1.20 [0.89-1.62],0.2349523417762034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABO,Histo-blood group ABO system transferase,20118,60,0.95 [0.80-1.13],0.5660468179247171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABRAXAS2,BRISC complex subunit Abraxas 2,19410,56,1.18 [0.80-1.73],0.4054205274994363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22619,68,1.13 [0.87-1.46],0.3684491537623905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19747,59,0.80 [0.51-1.26],0.3386079905083204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20092,59,1.15 [0.88-1.50],0.3184075439162538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAN,Aggrecan core protein,22926,69,0.89 [0.41-1.95],0.7804438252444563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,20118,60,1.68 [0.70-4.04],0.2462685144972621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,22746,68,1.18 [0.80-1.74],0.3930617707968061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACHE,Acetylcholinesterase,19647,60,1.40 [0.70-2.80],0.3410096040069157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOT13,Acyl-coenzyme A thioesterase 13,20029,58,1.03 [0.83-1.28],0.7954616678431282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,23166,69,0.98 [0.64-1.50],0.9132914186769344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19503,59,0.93 [0.53-1.63],0.8015129545347763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP5,Tartrate-resistant acid phosphatase type 5,23266,69,1.59 [0.84-2.99],0.1513260961189954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,23340,71,0.77 [0.59-1.01],0.0566013270858776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRBP,Acrosin-binding protein,20022,60,1.12 [0.62-2.03],0.709768931029745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRV1,Acrosomal protein SP-10,19503,59,1.23 [0.99-1.53],0.0582076490903693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19410,56,1.09 [0.54-2.20],0.8102225633646016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",22746,68,1.58 [1.10-2.28],0.0138417309823157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN2,Alpha-actinin-2,19410,56,0.97 [0.64-1.47],0.8802764289333745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN4,Alpha-actinin-4,22757,70,0.96 [0.48-1.90],0.905289013578231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACVRL1,Serine/threonine-protein kinase receptor R3,22923,70,1.50 [0.68-3.33],0.3166184421591622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,23166,69,1.35 [0.97-1.87],0.0752501671135783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19410,56,1.07 [0.68-1.67],0.7783947476538173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACYP1,Acylphosphatase-1,19579,60,1.22 [0.84-1.76],0.288301584493306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,23437,70,1.64 [1.01-2.67],0.047475258486529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,23048,70,1.99 [1.28-3.11],0.0022837944020295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19503,59,0.95 [0.44-2.05],0.898614018239024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22746,68,1.44 [0.72-2.86],0.2998807128693091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22963,70,0.98 [0.55-1.74],0.9412262456033668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23437,70,1.05 [0.57-1.91],0.8796027113348389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23338,71,0.94 [0.46-1.89],0.855144660766745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20029,58,1.71 [0.79-3.68],0.1718756539556727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19503,59,1.49 [0.78-2.86],0.2300455040589739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23457,69,0.54 [0.23-1.28],0.1624932819214401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23054,68,1.48 [0.87-2.51],0.1488077215515076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22746,68,0.85 [0.41-1.78],0.6725237506327095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19503,59,1.42 [0.75-2.69],0.2861278978038613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23228,70,1.41 [0.88-2.25],0.1562732265364798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,20102,59,2.20 [1.18-4.13],0.0134540602733691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL4,ADAMTS-like protein 4,19543,57,0.67 [0.23-1.94],0.4656045812430359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL5,ADAMTS-like protein 5,20092,59,0.94 [0.50-1.74],0.8330914499506481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22619,68,1.43 [1.03-2.00],0.0347237591287547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADD1,Alpha-adducin,19647,60,1.00 [0.70-1.43],0.9971771145326704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRB3,Adhesion G protein-coupled receptor B3,22923,70,0.97 [0.52-1.83],0.9347623036397266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRD1,Adhesion G-protein coupled receptor D1,19647,60,1.50 [0.85-2.65],0.1588641210000692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,20029,58,1.29 [0.84-2.00],0.2447737943071845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE2,Adhesion G protein-coupled receptor E2,23248,71,1.17 [0.57-2.42],0.6682088308342591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE5,Adhesion G protein-coupled receptor E5,23346,69,1.01 [0.51-2.01],0.979972426098692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,20092,59,3.07 [1.26-7.44],0.0133472143933793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG1,Adhesion G-protein coupled receptor G1,23054,68,1.17 [0.92-1.48],0.1912521427007668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG2,Adhesion G-protein coupled receptor G2,23166,69,0.64 [0.32-1.26],0.1949345951581551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRV1,Adhesion G-protein coupled receptor V1,19446,57,1.07 [0.76-1.52],0.7006640894136122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,19647,60,1.47 [1.09-1.97],0.0104870667168555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22746,68,1.33 [1.03-1.72],0.0306898353606616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADIPOQ,Adiponectin,20117,60,0.73 [0.51-1.04],0.0769801981684799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADM,Pro-adrenomedullin,23366,71,1.28 [0.58-2.83],0.535479288244693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,19410,56,0.59 [0.34-1.02],0.0587538325228347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFAP1,Actin filament-associated protein 1,19647,60,1.09 [0.81-1.47],0.5517724596346003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFM,Afamin,20117,60,1.89 [0.56-6.36],0.3012719487612999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFP,Alpha-fetoprotein,22880,70,1.09 [0.79-1.51],0.5881213836831825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGBL2,Cytosolic carboxypeptidase 2,19446,57,1.02 [0.77-1.35],0.8866231138658813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGER,Advanced glycosylation end product-specific receptor,23096,71,0.67 [0.41-1.12],0.1271571862636505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR2,Anterior gradient protein 2 homolog,22489,70,1.10 [0.89-1.36],0.3839006387504642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR3,Anterior gradient protein 3,22582,68,1.13 [0.80-1.59],0.4960062342770024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRN,Agrin,23248,71,1.65 [0.97-2.82],0.0657874149340916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRP,Agouti-related protein,23437,70,1.17 [0.78-1.74],0.4510376731871144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGT,Angiotensinogen,20118,60,1.02 [0.32-3.22],0.9758137178673508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,23166,69,1.33 [1.02-1.72],0.0331695811721209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHCY,Adenosylhomocysteinase,23166,69,1.01 [0.74-1.39],0.9288229897549568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK,Neuroblast differentiation-associated protein AHNAK,19543,57,1.02 [0.47-2.22],0.9674303827641968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK2,Protein AHNAK2,19543,57,0.67 [0.27-1.63],0.3775824433780169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20022,60,1.00 [0.69-1.46],0.98628127049163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSG,Alpha-2-HS-glycoprotein,20118,60,1.06 [0.43-2.65],0.8972012536584695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSP,Alpha-hemoglobin-stabilizing protein,23137,69,1.04 [0.81-1.34],0.7396437958260038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIDA,"Axin interactor, dorsalization-associated protein",19557,56,0.67 [0.43-1.02],0.0634521059496736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1,Allograft inflammatory factor 1,22619,68,0.86 [0.57-1.30],0.4800706088198213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1L,Allograft inflammatory factor 1-like,19543,57,0.97 [0.60-1.57],0.9126369602272328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23021,68,1.22 [1.01-1.48],0.0415716952360327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK1,Adenylate kinase isoenzyme 1,23166,69,1.22 [0.88-1.68],0.2293148583701934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK2,"Adenylate kinase 2, mitochondrial",20044,58,0.97 [0.77-1.23],0.8316638476550418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKAP12,A-kinase anchor protein 12,19647,60,1.41 [0.46-4.37],0.5509986567194269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B1,Aldo-keto reductase family 1 member B1,22619,68,1.02 [0.76-1.36],0.914357784371544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B10,Aldo-keto reductase family 1 member B10,19557,56,0.87 [0.56-1.36],0.5450647288399002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1C4,Aldo-keto reductase family 1 member C4,22746,68,1.16 [0.80-1.67],0.4327564006802201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19503,59,1.21 [0.86-1.70],0.2725891759477853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT1S1,Proline-rich AKT1 substrate 1,22655,70,1.29 [0.93-1.79],0.1215456600122586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT2,RAC-beta serine/threonine-protein kinase,20053,58,1.06 [0.87-1.29],0.5865957631495189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT3,RAC-gamma serine/threonine-protein kinase,22513,68,1.19 [0.82-1.71],0.3597578366991422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALCAM,CD166 antigen,23457,69,1.29 [0.43-3.82],0.6477906316632814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,23180,69,1.30 [0.90-1.88],0.162363476981815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH2,"Aldehyde dehydrogenase, mitochondrial",20022,60,1.04 [0.65-1.66],0.8827809162643078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",23098,70,1.26 [0.97-1.64],0.0844136215547748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20053,58,1.19 [0.71-1.99],0.5165048072636158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALMS1,Alstrom syndrome protein 1,19747,59,0.56 [0.28-1.13],0.1059468887817654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPI,Intestinal-type alkaline phosphatase,19503,59,0.97 [0.79-1.19],0.7603178640841973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",23054,68,1.23 [1.02-1.50],0.0325873856362965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBN,Ameloblastin,22757,70,0.44 [0.18-1.12],0.0842578520310601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBP,Protein AMBP,23330,70,1.23 [0.44-3.44],0.6996351202899493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20102,59,0.73 [0.28-1.85],0.5032602595318807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMFR,E3 ubiquitin-protein ligase AMFR,22655,70,1.12 [0.81-1.53],0.4958309520769084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO1,Amphoterin-induced protein 1,19557,56,1.06 [0.65-1.73],0.8139019204138344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,23054,68,1.35 [0.54-3.35],0.5215815008894491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMN,Protein amnionless,22757,70,1.03 [0.66-1.61],0.8995892404381866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOT,Angiomotin,19647,60,1.27 [0.66-2.42],0.4759788362260864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOTL2,Angiomotin-like protein 2,19939,60,0.69 [0.36-1.30],0.2483841422229845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMPD3,AMP deaminase 3,20044,58,0.82 [0.57-1.16],0.2593110567449178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18871,58,1.15 [0.73-1.80],0.5469380270654276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2A,Pancreatic alpha-amylase,22306,65,1.14 [0.72-1.78],0.5821475826631547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2B,Alpha-amylase 2B,21605,63,1.20 [0.76-1.87],0.4343705100252799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,23127,70,2.24 [1.32-3.82],0.0028793963998307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT1,Angiopoietin-1,23074,69,1.19 [0.92-1.54],0.1812596022778831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,23366,71,1.22 [0.71-2.12],0.4706187824128105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,22801,67,1.64 [0.78-3.41],0.1906674825846386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,23170,71,1.41 [0.84-2.37],0.197610222580239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL3,Angiopoietin-related protein 3,23203,70,0.85 [0.46-1.55],0.5908713201208967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,23212,71,1.41 [0.89-2.22],0.1427337817781071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL7,Angiopoietin-related protein 7,23366,71,1.51 [0.86-2.65],0.1541592545483162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANK2,Ankyrin-2,19410,56,0.75 [0.47-1.18],0.2156060260699368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19503,59,0.98 [0.72-1.34],0.8979233675673852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRA2,Ankyrin repeat family A protein 2,19396,57,1.04 [0.65-1.65],0.8685257382534868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,22619,68,1.36 [1.02-1.83],0.0379798934149895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19543,57,0.61 [0.25-1.49],0.2794379485123482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,23240,70,1.09 [0.49-2.38],0.8374758643872943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA1,Annexin A1,19547,59,1.25 [0.78-2.00],0.3636759068639964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,22655,70,1.32 [1.07-1.64],0.0107118489994676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA11,Annexin A11,23098,69,1.23 [0.88-1.73],0.2315931286029997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA2,Annexin A2,19252,56,1.26 [0.91-1.73],0.1593134654584133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA3,Annexin A3,23338,71,1.16 [0.86-1.55],0.3306546393046021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA4,Annexin A4,23065,69,1.08 [0.81-1.44],0.5845581459926363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA5,Annexin A5,22573,70,0.70 [0.34-1.46],0.3450133009408418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22757,70,0.79 [0.50-1.25],0.3140714525916624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC3,Membrane primary amine oxidase,23274,70,1.17 [0.57-2.40],0.6637060098383935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP1G2,AP-1 complex subunit gamma-like 2,20022,60,1.07 [0.79-1.45],0.6804414781302034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP2B1,AP-2 complex subunit beta,19557,56,0.90 [0.52-1.56],0.7025756179503516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3B1,AP-3 complex subunit beta-1,20029,58,1.02 [0.74-1.42],0.8964543374203842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3S2,AP-3 complex subunit sigma-2,20044,58,0.94 [0.55-1.60],0.8280657640779125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23054,68,1.21 [0.79-1.84],0.3819411452638477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APCS,Serum amyloid P-component,19937,60,0.85 [0.40-1.82],0.6724662080091557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23303,71,1.19 [0.85-1.67],0.2986204843618817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APLP1,Amyloid-like protein 1,23166,69,0.78 [0.51-1.18],0.240341754394949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA1,Apolipoprotein A-I,20117,60,0.75 [0.28-2.00],0.5666394871155676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA2,Apolipoprotein A-II,20118,60,1.37 [0.84-2.23],0.2074738028848839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA4,Apolipoprotein A-IV,20117,60,1.11 [0.56-2.20],0.7748680283722797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOB,Apolipoprotein B-100,20118,60,1.17 [0.39-3.54],0.7787714703459772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOBR,Apolipoprotein B receptor,19543,57,0.91 [0.50-1.65],0.7609933287920003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOC1,Apolipoprotein C-I,20085,60,1.01 [0.53-1.90],0.9839854446280816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOD,Apolipoprotein D,19238,58,1.32 [0.81-2.14],0.2666572444385954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOE,Apolipoprotein E,20117,60,1.26 [0.98-1.61],0.0719342966811963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,20118,60,0.36 [0.20-0.65],0.000652080207819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOH,Beta-2-glycoprotein 1,23180,69,1.06 [0.60-1.88],0.8373867315306428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOL1,Apolipoprotein L1,20118,60,1.16 [0.78-1.73],0.4648729826941311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOM,Apolipoprotein M,23240,70,0.72 [0.35-1.49],0.3769596582392935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,23143,69,1.40 [1.02-1.91],0.035601874893508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APPL2,DCC-interacting protein 13-beta,19647,60,1.08 [0.86-1.35],0.4997161781474494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APRT,Adenine phosphoribosyltransferase,22919,70,1.03 [0.66-1.60],0.9058885209339425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARAF,Serine/threonine-protein kinase A-Raf,19747,59,0.96 [0.66-1.40],0.8282078112528323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AREG,Amphiregulin,23054,68,1.26 [0.75-2.13],0.3838994591362152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARF6,ADP-ribosylation factor 6,20029,58,1.07 [0.85-1.36],0.5601071168691834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARFIP1,Arfaptin-1,20053,58,1.14 [0.79-1.63],0.4893503688375203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG1,Arginase-1,23006,71,1.03 [0.69-1.54],0.8782117054594228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",20022,60,1.23 [0.72-2.10],0.4436789777258367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP1,Rho GTPase-activating protein 1,22619,68,1.33 [0.84-2.11],0.2255037944547849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP25,Rho GTPase-activating protein 25,22619,68,1.30 [0.96-1.77],0.094155376595568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP30,Rho GTPase-activating protein 30,19747,59,0.56 [0.23-1.38],0.2094431799716568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP45,Rho GTPase-activating protein 45,19647,60,1.14 [0.85-1.54],0.3830800600223771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP5,Rho GTPase-activating protein 5,19396,57,0.89 [0.62-1.29],0.5433374783819336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF1,Rho guanine nucleotide exchange factor 1,20044,58,1.11 [0.83-1.47],0.4813095791573885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF10,Rho guanine nucleotide exchange factor 10,20053,58,0.96 [0.74-1.26],0.7799885552102797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF12,Rho guanine nucleotide exchange factor 12,23141,70,1.21 [0.99-1.49],0.066124816558945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,19446,57,1.34 [1.01-1.77],0.0447933335838022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID3A,AT-rich interactive domain-containing protein 3A,19446,57,0.85 [0.43-1.65],0.6224555808587002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID4B,AT-rich interactive domain-containing protein 4B,22655,70,0.96 [0.57-1.62],0.8854328918864451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL13B,ADP-ribosylation factor-like protein 13B,19410,56,0.96 [0.65-1.40],0.8161419886297836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19410,56,0.79 [0.41-1.53],0.4896537313037284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARMCX2,Armadillo repeat-containing X-linked protein 2,19446,57,0.66 [0.37-1.18],0.158032337075354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,22757,70,0.46 [0.23-0.91],0.0260266813410808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19410,56,1.03 [0.62-1.69],0.9164202284366736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,23180,69,1.32 [0.86-2.04],0.2076569971182192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSB,Arylsulfatase B,23054,68,1.07 [0.74-1.57],0.7137109181559516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART3,Ecto-ADP-ribosyltransferase 3,23274,70,1.38 [0.78-2.43],0.2710893383926538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART5,Ecto-ADP-ribosyltransferase 5,19446,57,1.17 [0.84-1.64],0.3600927127108232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARTN,Artemin,22757,70,0.84 [0.48-1.44],0.5188562040914205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH1,Acid ceramidase,19920,59,1.36 [0.87-2.14],0.1791941780429872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH2,Neutral ceramidase,22963,70,1.41 [0.91-2.19],0.118658250234369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR1,Asialoglycoprotein receptor 1,22963,70,1.26 [0.64-2.48],0.4961988340313731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR2,Asialoglycoprotein receptor 2,20118,60,1.06 [0.43-2.64],0.9028169972711928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPN,Asporin,20092,59,1.04 [0.43-2.52],0.9321128617023814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPSCR1,Tether containing UBX domain for GLUT4,20053,58,0.90 [0.62-1.32],0.5906482806492651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19543,57,1.02 [0.79-1.31],0.9037785985540608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASS1,Argininosuccinate synthase,19410,56,1.12 [0.80-1.56],0.5057986561734723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22655,70,1.00 [0.73-1.37],0.9875140426205148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19396,57,1.63 [0.88-3.01],0.1219245101842812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG16L1,Autophagy-related protein 16-1,20029,58,1.06 [0.79-1.42],0.7024275231253267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG4A,Cysteine protease ATG4A,22619,68,1.08 [0.76-1.55],0.6527064079802365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,23228,70,1.46 [1.08-1.98],0.0149344731768191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19410,56,0.86 [0.46-1.59],0.6215463648539963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19410,56,1.10 [0.50-2.42],0.8086347583652201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19410,56,0.59 [0.26-1.32],0.1983851461833558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,19396,57,1.32 [0.78-2.26],0.3022969824368455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19410,56,0.79 [0.47-1.33],0.374601564889827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19410,56,0.76 [0.41-1.41],0.3871743284148222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5IF1,"ATPase inhibitor, mitochondrial",23248,71,1.09 [0.90-1.33],0.3555335169871699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5PO,"ATP synthase subunit O, mitochondrial",22655,70,0.73 [0.43-1.27],0.269450730219224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6AP2,Renin receptor,22619,68,0.87 [0.48-1.55],0.6312827596507771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1D,V-type proton ATPase subunit D,23054,68,0.85 [0.36-2.04],0.7243047905047812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1F,V-type proton ATPase subunit F,22622,70,0.83 [0.60-1.16],0.2829144463792364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G1,V-type proton ATPase subunit G 1,19543,57,0.86 [0.60-1.23],0.4050790944137784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G2,V-type proton ATPase subunit G 2,19410,56,0.85 [0.63-1.13],0.2619751206557673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,20029,58,1.06 [0.49-2.29],0.8802091886352715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",20117,60,3.02 [0.85-10.77],0.0879560963705616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN10,Ataxin-10,22655,70,1.18 [0.88-1.59],0.2672239714043202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,19446,57,1.01 [0.79-1.29],0.9278856465454596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2L,Ataxin-2-like protein,20053,58,1.12 [0.67-1.86],0.6721910032441409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN3,Ataxin-3,20044,58,0.94 [0.63-1.41],0.7555174224712118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXIN1,Axin-1,23141,70,1.16 [0.93-1.45],0.185861617972335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXL,Tyrosine-protein kinase receptor UFO,23274,70,1.03 [0.48-2.22],0.9430268398780896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZI2,5-azacytidine-induced protein 2,20053,58,1.06 [0.68-1.66],0.7964675133071022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZU1,Azurocidin,22516,69,0.82 [0.60-1.12],0.2156528309677119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,20117,60,1.40 [0.87-2.26],0.1634473878068134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19410,56,0.84 [0.23-3.06],0.7946840419258872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19543,57,1.19 [0.60-2.37],0.6231313086812817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GALT1,"Beta-1,4-galactosyltransferase 1",23248,71,0.98 [0.46-2.09],0.9578026795910832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GAT1,"Beta-1,4-glucuronyltransferase 1",23180,69,0.82 [0.34-1.95],0.6490362264351931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BABAM1,BRISC and BRCA1-A complex member 1,19503,59,0.99 [0.41-2.42],0.9851497372801292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BACH1,Transcription regulator protein BACH1,23141,70,1.30 [0.99-1.72],0.0573180842809435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG3,BAG family molecular chaperone regulator 3,22923,70,0.91 [0.55-1.52],0.7312975484233797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG4,BAG family molecular chaperone regulator 4,19503,59,1.12 [0.69-1.81],0.6502516051290241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG6,Large proline-rich protein BAG6,22746,68,1.25 [0.70-2.24],0.4441845785389168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22619,68,1.29 [0.94-1.77],0.1105786729747889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAMBI,BMP and activin membrane-bound inhibitor homolog,22619,68,1.53 [0.77-3.02],0.2203936870627418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BANK1,B-cell scaffold protein with ankyrin repeats,23141,70,1.18 [0.96-1.45],0.1256486385677821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAP18,Chromatin complexes subunit BAP18,20044,58,1.03 [0.73-1.46],0.8456176532874218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,19557,56,1.16 [0.90-1.50],0.2539118924736072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAX,Apoptosis regulator BAX,22613,70,1.10 [0.87-1.38],0.4366665239497355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,23180,69,1.28 [0.55-3.00],0.5695387490103996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAN,Brevican core protein,22963,70,0.73 [0.40-1.34],0.3116194677820842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20092,59,1.44 [0.68-3.01],0.3377386347910228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19446,57,0.94 [0.56-1.56],0.7998359727479519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCHE,Cholinesterase,19744,58,1.52 [0.59-3.95],0.3887097465442102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2,Apoptosis regulator Bcl-2,20029,58,1.39 [0.99-1.93],0.0540818730770222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L1,Bcl-2-like protein 1,20044,58,1.06 [0.82-1.37],0.6548578490376584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",23141,70,1.61 [0.92-2.82],0.0974386665668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L15,Bcl-2-like protein 15,19503,59,0.81 [0.51-1.31],0.3948135013154583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19396,57,1.28 [0.94-1.76],0.1224781904326944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7B,B-cell CLL/lymphoma 7 protein family member B,20022,60,0.83 [0.45-1.53],0.555032765518281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,23141,70,1.26 [1.00-1.58],0.0486334578630853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BDNF,Brain-derived neurotrophic factor,20102,59,1.27 [0.93-1.73],0.1319229114520767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BECN1,Beclin-1,19543,57,1.03 [0.67-1.58],0.9100731310073596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BEX3,Protein BEX3,19396,57,1.45 [0.99-2.13],0.0569472511953865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGLAP,Osteocalcin,20102,59,1.09 [0.83-1.43],0.5339488770112898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGN,Biglycan,22583,67,0.84 [0.69-1.02],0.0807585019958112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHLHE40,Class E basic helix-loop-helix protein 40,19446,57,0.84 [0.58-1.22],0.3682678924556045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19410,56,0.80 [0.29-2.15],0.6515205770271282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BID,BH3-interacting domain death agonist,23141,70,1.08 [0.80-1.46],0.624028226720079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIN2,Bridging integrator 2,23180,69,1.01 [0.80-1.28],0.928168551925891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIRC2,Baculoviral IAP repeat-containing protein 2,22619,68,0.98 [0.70-1.39],0.9262443628813298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLMH,Bleomycin hydrolase,23457,69,0.97 [0.49-1.92],0.9238481328766156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLNK,B-cell linker protein,19503,59,1.06 [0.59-1.90],0.8561339445874848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19446,57,0.97 [0.68-1.38],0.8760209941730874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20044,58,0.82 [0.43-1.56],0.5448244145334944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLVRB,Flavin reductase,23180,69,0.98 [0.71-1.35],0.90323647112056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP10,Bone morphogenetic protein 10,19647,60,1.36 [0.56-3.32],0.5011145893757063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP4,Bone morphogenetic protein 4,22923,70,0.75 [0.46-1.22],0.2471063542261532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP6,Bone morphogenetic protein 6,22712,68,1.18 [0.69-2.03],0.5452992251563558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,19647,60,2.27 [0.83-6.23],0.1119442871336515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20092,59,1.13 [0.55-2.32],0.7404035042394218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19503,59,1.22 [0.72-2.06],0.4571268117083533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOC,Brother of CDO,22746,68,0.46 [0.18-1.16],0.0992762328299558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA1,BolA-like protein 1,19446,57,1.25 [0.83-1.89],0.2822660109143906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA2_BOLA2B,BolA-like protein 2,19543,57,0.89 [0.55-1.44],0.6304978263635354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFA2,BPI fold-containing family A member 2,18887,57,0.97 [0.77-1.22],0.7693148978704492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB1,BPI fold-containing family B member 1,23130,69,0.91 [0.65-1.27],0.5852759604277826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB2,BPI fold-containing family B member 2,20055,59,1.19 [0.82-1.74],0.3614355499270129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRAP,BRCA1-associated protein,19830,57,1.08 [0.85-1.37],0.5196421928435118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD1,Bromodomain-containing protein 1,19747,59,0.78 [0.31-1.95],0.6008739921154517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD2,Bromodomain-containing protein 2,19446,57,1.33 [0.71-2.50],0.3744572237518758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD3,Bromodomain-containing protein 3,19410,56,0.86 [0.47-1.57],0.6199551143867539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRDT,Bromodomain testis-specific protein,19410,56,1.03 [0.51-2.05],0.9402799724129928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRK1,Protein BRICK1,22655,70,1.02 [0.64-1.62],0.9500492728842876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRME1,Break repair meiotic recombinase recruitment factor 1,19446,57,1.39 [0.87-2.24],0.1717084045981075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRSK2,Serine/threonine-protein kinase BRSK2,20053,58,1.54 [0.84-2.81],0.1652512266534484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSG,Basigin,23399,69,2.14 [0.79-5.79],0.1325902749171555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSND,Barttin,19396,57,1.42 [0.82-2.44],0.2068990059852444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23375,71,0.88 [0.58-1.32],0.5374556116087083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,23375,71,1.48 [1.06-2.06],0.0203994678575547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTC,Probetacellulin,22619,68,1.04 [0.78-1.38],0.807060546920094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTD,Biotinidase,20117,60,1.39 [0.41-4.78],0.5975303790874342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTLA,B- and T-lymphocyte attenuator,19396,57,0.93 [0.67-1.29],0.6487652209622057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN1A1,Butyrophilin subfamily 1 member A1,19984,60,0.93 [0.46-1.85],0.8285857665771938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN2A1,Butyrophilin subfamily 2 member A1,23248,71,1.27 [0.59-2.72],0.5381339891488187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,23141,70,1.77 [1.12-2.79],0.0141944704454775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTNL10,Butyrophilin-like protein 10,19396,57,1.00 [0.55-1.84],0.9883845734933976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C19orf12,Protein C19orf12,22655,70,1.14 [0.84-1.54],0.3883415338066922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1GALT1C1,C1GALT1-specific chaperone 1,19410,56,1.20 [0.58-2.52],0.6215452265433719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,23329,69,1.73 [0.69-4.33],0.2423822884622335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20053,58,0.99 [0.68-1.44],0.9578677511244174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QL2,Complement C1q-like protein 2,19503,59,1.21 [0.70-2.07],0.4990603125659831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23274,70,1.52 [0.96-2.40],0.0710416616766132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19647,60,1.77 [0.91-3.46],0.0932840503594598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20053,58,0.90 [0.39-2.06],0.8008262450799928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19616,60,0.80 [0.50-1.27],0.3442395914148358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1R,Complement C1r subcomponent,20117,60,0.69 [0.16-3.06],0.6282444012880937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1RL,Complement C1r subcomponent-like protein,20078,60,1.53 [0.43-5.50],0.5140572943724029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1S,Complement C1s subcomponent,20117,60,0.49 [0.16-1.54],0.223543749497877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2,Complement C2,23240,70,1.27 [0.46-3.50],0.637839282829542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2CD2L,Phospholipid transfer protein C2CD2L,22622,70,1.36 [0.87-2.12],0.1771267251040559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2orf69,UPF0565 protein C2orf69,19557,56,1.05 [0.69-1.60],0.8185528033218021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C3,Complement C3,19097,59,1.02 [0.59-1.78],0.940312324280786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C4BPB,C4b-binding protein beta chain,23228,70,1.46 [0.86-2.47],0.1621680350322806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C5,Complement C5,20117,60,2.82 [0.71-11.14],0.1394030960321219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7,Complement component C7,19631,58,1.15 [0.52-2.55],0.7330319549437752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7orf50,Uncharacterized protein C7orf50,20044,58,0.64 [0.17-2.37],0.5072112327875498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C8B,Complement component C8 beta chain,20117,60,0.96 [0.43-2.14],0.9200854766613406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9,Complement component C9,20118,60,0.97 [0.63-1.49],0.881582102036177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9orf40,Uncharacterized protein C9orf40,20029,58,0.89 [0.65-1.21],0.4563779117380118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA1,Carbonic anhydrase 1,22687,69,0.99 [0.68-1.43],0.9489292357498148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA11,Carbonic anhydrase-related protein 11,22619,68,0.52 [0.20-1.33],0.1717755196459778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA12,Carbonic anhydrase 12,23054,68,1.17 [0.61-2.22],0.6401876791436956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA13,Carbonic anhydrase 13,22899,69,1.15 [0.93-1.42],0.1874707640531269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA14,Carbonic anhydrase 14,23366,71,0.95 [0.53-1.68],0.8531072920758154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA2,Carbonic anhydrase 2,23102,69,1.06 [0.78-1.44],0.6887014180328237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA3,Carbonic anhydrase 3,23424,69,1.05 [0.74-1.49],0.7790531949009042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA4,Carbonic anhydrase 4,23457,69,1.10 [0.47-2.62],0.8218199228413381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA5A,"Carbonic anhydrase 5A, mitochondrial",22746,68,1.14 [0.91-1.44],0.2587770934182598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA6,Carbonic anhydrase 6,23108,69,0.77 [0.55-1.07],0.1169348698940819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA7,Carbonic anhydrase 7,19747,59,1.12 [0.56-2.25],0.7519668963626341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA8,Carbonic anhydrase-related protein,19503,59,0.69 [0.37-1.30],0.251932889615808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,23366,71,1.36 [0.91-2.05],0.137018704113141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CABP2,Calcium-binding protein 2,19557,56,0.98 [0.65-1.48],0.9160918646029274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19446,57,1.16 [0.55-2.42],0.6974069134920116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19410,56,0.81 [0.46-1.41],0.4522975795057125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19446,57,0.96 [0.61-1.50],0.8522900118848593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20053,58,1.11 [0.83-1.49],0.4926813460019713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACYBP,Calcyclin-binding protein,19615,60,1.12 [0.88-1.43],0.3618023470637345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CADPS,Calcium-dependent secretion activator 1,19557,56,0.81 [0.39-1.67],0.5685380781301141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB1,Calbindin,23054,68,1.17 [0.73-1.86],0.520608967093863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB2,Calretinin,22655,70,1.10 [0.59-2.05],0.7557258361486272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCA,Calcitonin,22930,70,1.21 [0.91-1.61],0.1954680930875067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCB,Calcitonin gene-related peptide 2,20044,58,1.16 [0.65-2.08],0.6140976655021002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23298,71,1.14 [0.93-1.40],0.2048112837092168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19543,57,0.99 [0.70-1.39],0.94147513252206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALY,Neuron-specific vesicular protein calcyon,19410,56,1.02 [0.52-2.02],0.950898670118984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22619,68,1.10 [0.69-1.76],0.6914366571700519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19557,56,0.78 [0.46-1.34],0.3655750180572393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20053,58,0.94 [0.74-1.19],0.6128821641745928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,23090,69,2.71 [0.98-7.53],0.0548925929062629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPG,Macrophage-capping protein,22998,70,0.86 [0.60-1.23],0.4215363473263361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPN3,Calpain-3,20022,60,0.54 [0.25-1.18],0.1241062272762845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPS,Calcyphosin,20044,58,0.90 [0.66-1.23],0.5177708528350703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CARHSP1,Calcium-regulated heat-stable protein 1,22655,70,0.94 [0.62-1.42],0.7613534855098651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASC3,Protein CASC3,19557,56,0.82 [0.44-1.55],0.5401092394383189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP1,Caspase-1,22655,70,0.92 [0.67-1.26],0.6028303712613112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP10,Caspase-10,22655,70,1.13 [0.84-1.51],0.4314171711157356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP2,Caspase-2,23141,70,1.13 [0.83-1.53],0.433122488159377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP3,Caspase-3,23457,69,1.06 [0.83-1.35],0.6408337283361666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP4,Caspase-4,19747,59,0.91 [0.77-1.07],0.2557520183725875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP7,Caspase-7,20044,58,1.19 [0.88-1.60],0.2479938245667373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP8,Caspase-8,23304,70,1.10 [0.79-1.53],0.579497714033084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP9,Caspase-9,19503,59,1.01 [0.67-1.52],0.9508456651896072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASQ2,Calsequestrin-2,19410,56,1.05 [0.62-1.78],0.8562324532700543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAT,Catalase,19832,60,0.99 [0.63-1.55],0.9554580014733554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLIF,Cobalamin binding intrinsic factor,23136,69,0.93 [0.71-1.22],0.5996500786203566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,19446,57,1.20 [0.98-1.46],0.0776960781523388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN4,Cerebellin-4,23366,71,0.93 [0.49-1.78],0.8350307297379603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBS,Cystathionine beta-synthase,19543,57,1.06 [0.65-1.73],0.800048739424678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBX2,Chromobox protein homolog 2,19410,56,0.54 [0.21-1.37],0.1931285969761095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22963,70,1.13 [0.85-1.50],0.3870503427715036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCAR2,Cell cycle and apoptosis regulator protein 2,20044,58,1.08 [0.70-1.66],0.7315133415796984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC134,Coiled-coil domain-containing protein 134,20022,60,0.93 [0.55-1.57],0.7965231872614815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC28A,Coiled-coil domain-containing protein 28A,19557,56,1.89 [0.85-4.19],0.1185346540869386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC50,Coiled-coil domain-containing protein 50,20053,58,0.91 [0.64-1.29],0.5978517421372089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC80,Coiled-coil domain-containing protein 80,23166,69,1.15 [0.64-2.05],0.6471445052837781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19543,57,1.05 [0.70-1.57],0.8114573631637428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL11,Eotaxin,23437,70,1.63 [0.93-2.85],0.0855313882870454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL13,C-C motif chemokine 13,23403,70,1.24 [0.92-1.67],0.1575237821503449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,23127,70,1.68 [1.13-2.51],0.0104027992173553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL15,C-C motif chemokine 15,23457,69,1.16 [0.73-1.85],0.522052736915497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL16,C-C motif chemokine 16,23457,69,1.18 [0.79-1.77],0.4193755420928281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL17,C-C motif chemokine 17,23090,71,1.16 [0.93-1.45],0.1843930041676104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL18,C-C motif chemokine 18,22875,70,1.16 [0.89-1.51],0.2764281728765235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL19,C-C motif chemokine 19,23375,71,0.86 [0.69-1.06],0.1604690475652092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL2,C-C motif chemokine 2,22923,70,1.15 [0.78-1.71],0.4829513559565001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL20,C-C motif chemokine 20,23437,70,1.10 [0.88-1.37],0.4196882152772029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL21,C-C motif chemokine 21,23248,71,0.91 [0.52-1.58],0.7401426676953567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL22,C-C motif chemokine 22,22901,71,1.24 [0.84-1.81],0.2771024449078059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL23,C-C motif chemokine 23,23248,71,1.28 [0.79-2.07],0.3136306980668245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL24,C-C motif chemokine 24,23212,71,0.95 [0.73-1.23],0.6822571256155536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL25,C-C motif chemokine 25,23437,70,1.31 [0.86-2.00],0.2027857673765674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL26,C-C motif chemokine 26,23141,70,1.00 [0.81-1.25],0.969855879773932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL27,C-C motif chemokine 27,23166,69,1.12 [0.79-1.57],0.5333349699667458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL28,C-C motif chemokine 28,23062,70,1.26 [0.92-1.74],0.1520720938936878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL3,C-C motif chemokine 3,23141,70,1.03 [0.77-1.37],0.8580346043054542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL4,C-C motif chemokine 4,23173,71,1.04 [0.76-1.43],0.799540501628592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL5,C-C motif chemokine 5,23274,70,1.06 [0.87-1.30],0.560361490329228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL7,C-C motif chemokine 7,23141,70,1.26 [0.92-1.73],0.1502263782917012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL8,C-C motif chemokine 8,23330,70,1.33 [0.94-1.87],0.1091177911337776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN1,CCN family member 1,23018,67,1.13 [0.84-1.52],0.4329917923583247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,23133,70,1.55 [1.07-2.24],0.0193583899723942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN3,CCN family member 3,23412,69,1.13 [0.60-2.11],0.7032851573468628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,23366,71,1.97 [1.26-3.09],0.0031609575326817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN5,CCN family member 5,23180,69,1.27 [0.73-2.22],0.3900556390353479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCND2,G1/S-specific cyclin-D2,19747,59,0.83 [0.45-1.53],0.556961497806499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCNE1,G1/S-specific cyclin-E1,19503,59,0.65 [0.38-1.12],0.1177256975250611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCS,Copper chaperone for superoxide dismutase,22963,70,1.00 [0.64-1.57],0.9942629527532374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCT5,T-complex protein 1 subunit epsilon,22619,68,1.02 [0.63-1.65],0.9401027959434208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD101,Immunoglobulin superfamily member 2,20029,58,1.03 [0.57-1.88],0.9156658736736027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD109,CD109 antigen,23180,69,0.66 [0.37-1.20],0.1726575823250013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,22736,69,1.54 [0.93-2.54],0.0917240559771884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD160,CD160 antigen,23437,70,1.09 [0.71-1.67],0.6822024071541366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23274,70,1.51 [0.95-2.39],0.0828990373346828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164,Sialomucin core protein 24,23180,69,1.42 [0.76-2.66],0.2757225672922422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164L2,CD164 sialomucin-like 2 protein,19557,56,1.29 [0.65-2.55],0.4679845551111035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD177,CD177 antigen,23139,69,1.08 [0.90-1.29],0.401177117259919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD1C,T-cell surface glycoprotein CD1c,23228,70,1.67 [0.71-3.93],0.2393971886019049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,19410,56,1.57 [1.04-2.36],0.0310695617951548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200,OX-2 membrane glycoprotein,23141,70,0.68 [0.30-1.52],0.3458009406109614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200R1,Cell surface glycoprotein CD200 receptor 1,23061,70,0.81 [0.45-1.48],0.4962470501176943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD207,C-type lectin domain family 4 member K,22640,67,1.13 [0.65-1.96],0.6649863064599578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,23235,69,0.68 [0.39-1.17],0.1620871633808541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD22,B-cell receptor CD22,23437,70,1.39 [0.88-2.21],0.1584393508816767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD226,CD226 antigen,19503,59,1.41 [0.79-2.50],0.2482755900190009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,23437,70,1.87 [0.91-3.86],0.0908100408187551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD248,Endosialin,20102,59,0.70 [0.38-1.28],0.2485180085755041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,23228,70,1.59 [1.01-2.51],0.0445206412726105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD274,Programmed cell death 1 ligand 1,22963,70,1.47 [0.83-2.61],0.1851733657460573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD276,CD276 antigen,23129,71,0.90 [0.51-1.61],0.7322059199264385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD28,T-cell-specific surface glycoprotein CD28,22619,68,1.49 [0.92-2.40],0.1013747759862058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,23166,69,1.38 [1.00-1.91],0.0466256056206586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,19647,60,1.73 [0.81-3.72],0.1600322835636576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300C,CMRF35-like molecule 6,23375,71,1.19 [0.68-2.11],0.5418035015363435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300E,CMRF35-like molecule 2,23304,71,1.48 [0.93-2.37],0.1001825629586583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LF,CMRF35-like molecule 1,23366,71,1.16 [0.83-1.63],0.3932190783516945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LG,CMRF35-like molecule 9,23180,69,0.68 [0.38-1.21],0.1869873625720371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,23054,68,1.61 [0.85-3.05],0.1455907534384084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD33,Myeloid cell surface antigen CD33,23228,70,1.18 [0.89-1.56],0.2590682649262389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,23304,71,0.61 [0.36-1.04],0.0686346022370634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD36,Platelet glycoprotein 4,19503,59,1.42 [0.86-2.36],0.1691160499945479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23054,68,1.67 [0.88-3.14],0.1143737772087041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3D,T-cell surface glycoprotein CD3 delta chain,19446,57,1.43 [0.86-2.36],0.1642306399842082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19747,59,1.58 [1.05-2.36],0.0274304272851506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,19503,59,0.64 [0.40-1.02],0.0585044371597413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD4,T-cell surface glycoprotein CD4,23105,70,1.19 [0.59-2.39],0.6251394213167832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40,Tumor necrosis factor receptor superfamily member 5,23137,71,1.20 [0.80-1.80],0.3753909608237661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40LG,CD40 ligand,23437,70,1.30 [0.99-1.69],0.0565202667122782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,23055,70,1.94 [0.99-3.78],0.0517762008874537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD48,CD48 antigen,23212,71,1.50 [0.77-2.92],0.2358145980130198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5,T-cell surface glycoprotein CD5,23330,70,0.98 [0.54-1.78],0.9350063986092284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD55,Complement decay-accelerating factor,22372,69,1.68 [0.81-3.49],0.1666643529373936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD58,Lymphocyte function-associated antigen 3,23084,71,0.58 [0.18-1.88],0.3687517032447603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,22361,67,2.75 [1.40-5.41],0.0034388726142142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,20015,60,1.58 [0.96-2.60],0.0735902768924944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD6,T-cell differentiation antigen CD6,23399,69,0.91 [0.61-1.36],0.6382139349074174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,22923,70,1.65 [1.08-2.54],0.021549317863277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD69,Early activation antigen CD69,23051,69,1.14 [0.89-1.45],0.3018420796036306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD7,T-cell antigen CD7,19472,59,1.04 [0.59-1.84],0.8789482829294454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD70,CD70 antigen,23141,70,1.52 [0.95-2.42],0.0793848773799838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,19647,60,1.83 [1.11-3.03],0.0181730091281314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,23375,71,1.71 [0.98-2.98],0.0605776812675196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD79B,B-cell antigen receptor complex-associated protein beta chain,23437,70,1.36 [0.89-2.09],0.1530821002215035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,20092,59,2.44 [1.36-4.39],0.0028480167731305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD82,CD82 antigen,19747,59,0.65 [0.30-1.42],0.2812782458649805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD83,CD83 antigen,23141,70,1.56 [0.88-2.78],0.1285588407379347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD84,SLAM family member 5,23141,70,1.64 [0.85-3.16],0.1391205721524632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,20029,58,1.87 [0.86-4.09],0.1162040171555629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD8A,T-cell surface glycoprotein CD8 alpha chain,23375,71,0.83 [0.55-1.26],0.3891064033213439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD93,Complement component C1q receptor,22317,69,0.84 [0.42-1.69],0.624941790045224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99,CD99 antigen,23180,69,1.17 [0.40-3.43],0.7692141222578094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99L2,CD99 antigen-like protein 2,23180,69,1.15 [0.49-2.74],0.7460572039828864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,20056,59,1.12 [0.69-1.84],0.6444580252348471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDAN1,Codanin-1,20044,58,0.58 [0.17-1.96],0.3760323274073197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC123,Cell division cycle protein 123 homolog,19396,57,1.15 [0.81-1.64],0.4254003057882609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC25A,M-phase inducer phosphatase 1,19396,57,0.67 [0.32-1.41],0.2888666569252426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC26,Anaphase-promoting complex subunit CDC26,19989,58,1.03 [0.72-1.48],0.8783568569012279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC27,Cell division cycle protein 27 homolog,22619,68,1.10 [0.78-1.54],0.5987597621916223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC37,Hsp90 co-chaperone Cdc37,23228,70,1.09 [0.85-1.40],0.5125234433657968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC42BPB,Serine/threonine-protein kinase MRCK beta,20029,58,1.02 [0.80-1.31],0.8502623063438218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDCP1,CUB domain-containing protein 1,22963,70,1.28 [0.90-1.81],0.1702161094126097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH1,Cadherin-1,22412,68,1.12 [0.67-1.87],0.6661401175191962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH15,Cadherin-15,23342,71,1.02 [0.76-1.37],0.9073191412827808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH17,Cadherin-17,23166,69,1.03 [0.77-1.39],0.8423837853443179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,23166,69,1.43 [0.80-2.54],0.224700890529197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH22,Cadherin-22,19747,59,0.76 [0.29-2.00],0.5790857596662877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH23,Cadherin-23,20044,58,0.72 [0.27-1.96],0.521236821197439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH3,Cadherin-3,23375,71,0.77 [0.43-1.38],0.3778903349027872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH4,Cadherin-4,19446,57,0.79 [0.43-1.45],0.4459330556813262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH5,Cadherin-5,23457,69,0.76 [0.37-1.54],0.4388066724381474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH6,Cadherin-6,23166,69,0.73 [0.42-1.29],0.2800701710948796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR1,Cadherin-related family member 1,22655,70,0.73 [0.42-1.28],0.2721108314611361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR2,Cadherin-related family member 2,23054,68,1.14 [0.82-1.59],0.4227669689424616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR5,Cadherin-related family member 5,23166,69,0.74 [0.44-1.24],0.2522415113519264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK1,Cyclin-dependent kinase 1,19396,57,1.11 [0.55-2.22],0.7684704871883449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20053,58,0.86 [0.54-1.36],0.5267242720605627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKL5,Cyclin-dependent kinase-like 5,19446,57,0.89 [0.52-1.51],0.6579318891072823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN1A,Cyclin-dependent kinase inhibitor 1,23054,68,1.08 [0.89-1.32],0.4472771396080566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,23054,68,1.10 [0.87-1.38],0.4384813253494921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDNF,Cerebral dopamine neurotrophic factor,23054,68,1.43 [0.83-2.44],0.1934758228315899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23165,71,0.64 [0.30-1.38],0.2579613760036881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDSN,Corneodesmosin,23370,70,0.91 [0.56-1.47],0.6901562412994926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23192,70,0.99 [0.45-2.15],0.977751846839455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20029,58,0.87 [0.65-1.18],0.3811840967301891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19747,59,1.02 [0.72-1.44],0.915067779183828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20029,58,0.85 [0.46-1.60],0.621830568992263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19747,59,1.28 [0.79-2.09],0.3143042984629455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23141,70,1.16 [0.92-1.46],0.2115545008183627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22619,68,0.94 [0.59-1.50],0.8066808853445031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22339,68,1.09 [0.77-1.53],0.6330102529005885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20102,59,1.37 [0.83-2.26],0.2210519705153204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22746,68,0.92 [0.60-1.40],0.6927515684273365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPA,CCAAT/enhancer-binding protein alpha,19503,59,0.61 [0.24-1.54],0.292964236722376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPB,CCAAT/enhancer-binding protein beta,22746,68,1.05 [0.61-1.83],0.8513073935868223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA2A,Chymotrypsin-like elastase family member 2A,20102,59,1.14 [0.78-1.66],0.5114983399872326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA3A,Chymotrypsin-like elastase family member 3A,23420,69,1.29 [0.92-1.81],0.1401738039774372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19647,60,1.15 [0.50-2.68],0.7371384242314007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEMIP2,Cell surface hyaluronidase,19503,59,1.41 [0.78-2.56],0.2527408637979692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEND1,Cell cycle exit and neuronal differentiation protein 1,19446,57,0.98 [0.63-1.52],0.9218170819659262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPF,Centromere protein F,19747,59,0.93 [0.59-1.46],0.7479663992812882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPJ,Centromere protein J,19747,59,0.84 [0.57-1.23],0.3649737049365642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP112,Centrosomal protein of 112 kDa,19410,56,1.10 [0.66-1.82],0.7255632841776841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP152,Centrosomal protein of 152 kDa,19396,57,1.37 [0.84-2.23],0.2040149279196244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,22757,70,1.32 [1.06-1.64],0.0135922496210246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP170,Centrosomal protein of 170 kDa,19543,57,0.88 [0.62-1.24],0.4606662152057496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP20,Centrosomal protein 20,22619,68,1.15 [0.87-1.52],0.3161937179717542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,19747,59,0.49 [0.26-0.91],0.0252284075086997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP350,Centrosome-associated protein 350,19396,57,0.86 [0.42-1.76],0.6773988375053449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP43,Centrosomal protein 43,22569,68,1.30 [0.97-1.75],0.0806032440948987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP85,Centrosomal protein of 85 kDa,22619,68,0.98 [0.70-1.37],0.9248954578305034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CERT,Ceramide transfer protein,22655,70,1.38 [0.98-1.95],0.0626965699433647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,23230,69,1.19 [0.93-1.51],0.1601329616745355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES2,Cocaine esterase,23054,68,0.90 [0.61-1.33],0.603861057576174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES3,Carboxylesterase 3,23054,68,0.87 [0.62-1.21],0.3963257696649509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN2,Centrin-2,22655,70,1.12 [0.83-1.52],0.4681870149784388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN3,Centrin-3,20029,58,0.94 [0.68-1.31],0.7286045038624462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFB,Complement factor B,19766,60,1.40 [0.66-2.97],0.3763252097132328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFC1,Cryptic protein,22619,68,0.97 [0.60-1.56],0.8997574105292373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFD,Complement factor D,20117,60,1.14 [0.38-3.36],0.8166407769953056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFH,Complement factor H,18968,58,0.75 [0.25-2.23],0.6072618771711312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR2,Complement factor H-related protein 2,19979,60,1.06 [0.68-1.66],0.7831067289185116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR4,Complement factor H-related protein 4,20075,60,0.97 [0.69-1.36],0.8442336271931229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR5,Complement factor H-related protein 5,19862,58,0.65 [0.38-1.11],0.1177311375968951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFI,Complement factor I,20117,60,1.40 [0.40-4.88],0.6020986206602419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFP,Properdin,20117,60,1.05 [0.35-3.19],0.9271306623509796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGA,Glycoprotein hormones alpha chain,23180,69,1.28 [0.93-1.76],0.1339877844926564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20118,60,1.14 [0.58-2.24],0.7100705795956072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGN,Cingulin,19557,56,1.38 [0.79-2.41],0.2588210437848932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGREF1,Cell growth regulator with EF hand domain protein 1,23166,69,1.05 [0.65-1.71],0.8396179852623733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22619,68,1.30 [0.93-1.81],0.1271296840808243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAD,Chondroadherin,19647,60,0.82 [0.49-1.38],0.464033478968705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20044,58,1.55 [0.95-2.53],0.0794520920901159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD6,MICOS complex subunit MIC25,20022,60,1.55 [0.75-3.21],0.2408767597722892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHEK2,Serine/threonine-protein kinase Chk2,22746,68,0.61 [0.31-1.21],0.1553809216059799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,20102,59,1.11 [0.85-1.45],0.4257692393597297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGB,Secretogranin-1,23311,71,1.09 [0.66-1.80],0.7315189927118079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHI3L1,Chitinase-3-like protein 1,22678,68,1.07 [0.84-1.37],0.5763698420225367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,23273,69,1.14 [0.96-1.35],0.1234869977112501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHL1,Neural cell adhesion molecule L1-like protein,23238,70,0.78 [0.38-1.60],0.4947452511901161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHM,Rab proteins geranylgeranyltransferase component A 1,19557,56,1.06 [0.70-1.61],0.776307177374574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP1A,Charged multivesicular body protein 1a,22963,70,1.22 [0.93-1.61],0.1476308208525461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP6,Charged multivesicular body protein 6,20092,59,1.17 [0.76-1.80],0.4747312008450857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHP1,Calcineurin B homologous protein 1,19446,57,1.09 [0.80-1.50],0.5842065176498615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL1,Chordin-like protein 1,23212,71,0.96 [0.50-1.84],0.896923565643633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL2,Chordin-like protein 2,23166,69,0.98 [0.62-1.57],0.9472358306120364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRM1,Muscarinic acetylcholine receptor M1,19557,56,0.63 [0.27-1.45],0.2751081986081916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIAPIN1,Anamorsin,23228,70,1.32 [0.94-1.85],0.1127126675704588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CILP,Cartilage intermediate layer protein 1,20102,59,0.77 [0.50-1.18],0.2254995233303527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CINP,Cyclin-dependent kinase 2-interacting protein,19747,59,0.93 [0.51-1.69],0.8088126304759269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIRBP,Cold-inducible RNA-binding protein,20029,58,1.04 [0.80-1.35],0.7515156062604872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIT,Citron Rho-interacting kinase,19557,56,0.91 [0.51-1.61],0.7389323237675545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKAP4,Cytoskeleton-associated protein 4,23325,69,1.68 [0.89-3.17],0.106354498809778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKB,Creatine kinase B-type,20102,59,0.81 [0.52-1.26],0.3484606030210859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23056,71,1.13 [0.82-1.57],0.4468344250860944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLASP1,CLIP-associating protein 1,19396,57,0.77 [0.51-1.17],0.2242208057433162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLC,Galectin-10,23130,69,0.98 [0.72-1.34],0.9204792207331024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC10A,C-type lectin domain family 10 member A,22963,70,1.28 [0.72-2.28],0.4062334014680379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC11A,C-type lectin domain family 11 member A,23147,69,1.02 [0.66-1.58],0.9249261896045492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC12A,C-type lectin domain family 12 member A,19503,59,1.05 [0.30-3.73],0.9370719915788952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC14A,C-type lectin domain family 14 member A,23180,69,1.21 [0.63-2.33],0.5660009019112191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1A,C-type lectin domain family 1 member A,22746,68,0.95 [0.50-1.80],0.8629435463803463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1B,C-type lectin domain family 1 member B,23375,71,1.21 [0.98-1.50],0.0837946709769105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC2L,C-type lectin domain family 2 member L,19557,56,0.62 [0.30-1.26],0.1853483787769564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC3B,Tetranectin,19661,60,0.61 [0.18-2.03],0.4232737912272889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,23141,70,0.67 [0.38-1.16],0.1525222831028152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4C,C-type lectin domain family 4 member C,23141,70,0.92 [0.59-1.41],0.6951052211601553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4D,C-type lectin domain family 4 member D,23141,70,1.32 [0.96-1.81],0.0840170942875102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4G,C-type lectin domain family 4 member G,23141,70,0.93 [0.50-1.74],0.8251003304592289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4M,C-type lectin domain family 4 member M,20072,59,0.71 [0.43-1.18],0.185547547960497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC5A,C-type lectin domain family 5 member A,23091,69,1.25 [0.63-2.45],0.526309500871537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,22619,68,1.36 [0.89-2.07],0.15082816709064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,23437,70,1.65 [1.06-2.56],0.0273266095563117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,19557,56,1.70 [1.17-2.47],0.0050738809347821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIC5,Chloride intracellular channel protein 5,19557,56,0.69 [0.28-1.68],0.409375787368989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLINT1,Clathrin interactor 1,19396,57,1.05 [0.62-1.78],0.8610659396016966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIP2,CAP-Gly domain-containing linker protein 2,23141,70,1.07 [0.89-1.29],0.468241156060326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLMP,CXADR-like membrane protein,23366,71,1.00 [0.40-2.50],0.993513746370023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLNS1A,Methylosome subunit pICln,19557,56,1.25 [0.63-2.46],0.5184719543330685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22930,70,1.17 [0.94-1.46],0.1490180267310551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPS,Colipase,23137,69,1.23 [0.92-1.64],0.157678160911622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSPN,Claspin,22622,70,0.53 [0.24-1.17],0.115378597235245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN1,Calsyntenin-1,22655,70,0.79 [0.50-1.24],0.3097404048130892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN2,Calsyntenin-2,23437,70,1.23 [0.74-2.03],0.4282472878249488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN3,Calsyntenin-3,20044,58,1.23 [0.55-2.75],0.617727720878548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,22746,68,1.20 [0.78-1.85],0.4136055088308259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,20117,60,1.83 [1.22-2.74],0.0033853402430105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLUL1,Clusterin-like protein 1,23123,69,1.27 [0.81-2.01],0.2964027770999673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMC1,COX assembly mitochondrial protein homolog,20092,59,1.06 [0.81-1.40],0.656610320803192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMIP,C-Maf-inducing protein,20022,60,1.12 [0.84-1.50],0.4396242349150008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,23274,70,1.65 [1.00-2.71],0.0496350676300302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19446,57,0.94 [0.56-1.56],0.7978949815498496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19509,57,1.04 [0.75-1.44],0.8278378041577803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY2,Protein canopy homolog 2,22746,68,1.08 [0.77-1.50],0.6635091642212407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY4,Protein canopy homolog 4,23054,68,1.20 [0.90-1.59],0.2111217442436746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNST,Consortin,23166,69,1.15 [0.94-1.40],0.1781455154650957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTF,Ciliary neurotrophic factor,19446,57,1.43 [0.71-2.87],0.3130325176917961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,23457,69,0.53 [0.26-1.08],0.0806725419912025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN2,Contactin-2,23366,71,0.99 [0.62-1.60],0.9797291108373614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN3,Contactin-3,23180,69,1.56 [0.75-3.24],0.2366921544352808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN4,Contactin-4,23180,69,0.77 [0.31-1.88],0.5589958247174839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,23226,71,0.63 [0.35-1.12],0.1168676387826965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,23141,70,1.51 [0.96-2.39],0.0758953435836124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP4,Contactin-associated protein-like 4,19557,56,0.95 [0.72-1.25],0.7200768978895324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,20092,59,1.87 [1.19-2.95],0.0068565401629611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL15A1,Collagen alpha-1(XV) chain,20102,59,0.92 [0.37-2.31],0.8593191505764043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,23268,69,3.12 [1.32-7.37],0.0093518968008957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL1A1,Collagen alpha-1(I) chain,23457,69,0.89 [0.36-2.18],0.7991740658239108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL24A1,Collagen alpha-1(XXIV) chain,20029,58,0.78 [0.54-1.14],0.1969855149848033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL28A1,Collagen alpha-1(XXVIII) chain,19557,56,1.02 [0.75-1.39],0.8908039248205225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL2A1,Collagen alpha-1(II) chain,19543,57,1.18 [0.85-1.62],0.3211830751952387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,20102,59,0.67 [0.23-1.95],0.4626060095059637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A1,Collagen alpha-1(IV) chain,23166,69,1.40 [0.82-2.39],0.2131546798755558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A4,Collagen alpha-4(IV) chain,19716,59,0.74 [0.49-1.10],0.1375720243632523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,19647,60,1.35 [0.75-2.44],0.3152800732727523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL6A3,Collagen alpha-3(VI) chain,23457,69,1.54 [0.89-2.67],0.1234653741806745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A1,Collagen alpha-1(IX) chain,23141,70,1.03 [0.64-1.66],0.9128679250995646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A2,Collagen alpha-2(IX) chain,19747,59,0.72 [0.37-1.40],0.3296481202157211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COLEC12,Collectin-12,23129,71,1.44 [0.68-3.05],0.3402745092008423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD1,COMM domain-containing protein 1,19543,57,0.96 [0.63-1.47],0.8569078598604414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD9,COMM domain-containing protein 9,20022,60,0.89 [0.46-1.72],0.7275089245380824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMP,Cartilage oligomeric matrix protein,22939,70,1.13 [0.60-2.15],0.7003103069136923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMT,Catechol O-methyltransferase,22492,68,1.26 [0.97-1.63],0.0823353756102823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPB2,Coatomer subunit beta',19410,56,0.75 [0.40-1.40],0.3710526009710604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPE,Coatomer subunit epsilon,22655,70,0.89 [0.55-1.43],0.6190080883673823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19543,57,1.13 [0.64-2.01],0.6672182479483302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO1A,Coronin-1A,22733,67,0.99 [0.78-1.26],0.943176749099757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO6,Coronin-6,19446,57,0.91 [0.46-1.81],0.7910801841243554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23054,68,1.15 [0.86-1.54],0.354072070488432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX6B1,Cytochrome c oxidase subunit 6B1,20092,59,1.03 [0.48-2.20],0.9465332657717538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA1,Carboxypeptidase A1,23457,69,1.21 [0.88-1.66],0.2319933158647675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA2,Carboxypeptidase A2,23306,70,1.10 [0.81-1.49],0.5547736064960971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA4,Carboxypeptidase A4,19265,59,0.81 [0.46-1.43],0.4644836120866306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB1,Carboxypeptidase B,23457,69,1.28 [0.93-1.75],0.1241566840010771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB2,Carboxypeptidase B2,20085,60,1.07 [0.36-3.17],0.9043807003500994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPE,Carboxypeptidase E,23176,69,0.92 [0.54-1.56],0.7532168943776267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPLX2,Complexin-2,19396,57,0.85 [0.36-1.97],0.6993748992145297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPM,Carboxypeptidase M,23259,71,1.17 [0.65-2.09],0.6024526812133395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19503,59,1.64 [0.94-2.87],0.0803974141060594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPPED1,Serine/threonine-protein phosphatase CPPED1,23375,71,0.96 [0.70-1.33],0.824114125320858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPQ,Carboxypeptidase Q,20069,59,1.60 [0.82-3.12],0.1720466146540654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPTP,Ceramide-1-phosphate transfer protein,19410,56,1.50 [0.90-2.52],0.1225937477791047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,23319,71,1.59 [0.93-2.71],0.091467270309558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM1,Probable carboxypeptidase X1,23228,70,1.22 [0.91-1.64],0.178139753043498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM2,Inactive carboxypeptidase-like protein X2,20092,59,2.04 [0.85-4.89],0.1099007319717008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,20043,60,1.46 [0.74-2.90],0.277899869240535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,23274,70,1.06 [0.68-1.65],0.8109793292777424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22619,68,0.99 [0.77-1.28],0.9483618128286188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRADD,Death domain-containing protein CRADD,22930,70,1.06 [0.80-1.41],0.6761638661218428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,19396,57,1.09 [0.70-1.69],0.7087712847947978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREBZF,CREB/ATF bZIP transcription factor,19396,57,1.80 [0.78-4.17],0.1698943967566756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREG1,Protein CREG1,22860,70,1.08 [0.65-1.78],0.7770348531453541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD1,Protein disulfide isomerase CRELD1,19647,60,1.59 [0.82-3.08],0.1720381029928561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD2,Protein disulfide isomerase CRELD2,23212,71,1.40 [0.96-2.07],0.0841976096434097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,22582,68,0.68 [0.52-0.89],0.0045545333308345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHBP,Corticotropin-releasing factor-binding protein,23129,71,1.03 [0.49-2.18],0.940622514976544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHR1,Corticotropin-releasing factor receptor 1,22746,68,0.89 [0.61-1.31],0.5676424974254779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,23248,71,1.51 [0.54-4.20],0.4296999256788363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,22963,70,1.81 [1.29-2.54],0.0005439683057576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP2,Cysteine-rich secretory protein 2,23366,71,1.48 [0.98-2.24],0.0631079421315403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP3,Cysteine-rich secretory protein 3,19931,59,1.16 [0.47-2.89],0.7432565094781987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRKL,Crk-like protein,23167,71,1.11 [0.91-1.36],0.2939258969685141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRLF1,Cytokine receptor-like factor 1,23248,71,1.12 [0.48-2.59],0.7926231734159184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,22514,70,0.74 [0.55-1.00],0.0528876644589755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAC1,Cartilage acidic protein 1,23457,69,1.11 [0.55-2.22],0.7774297553095679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAM,Cytotoxic and regulatory T-cell molecule,22963,70,1.08 [0.72-1.64],0.6996762212776939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,19557,56,0.58 [0.29-1.17],0.1276591146009603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRX,Cone-rod homeobox protein,22746,68,0.91 [0.73-1.14],0.4286086555966251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB1,Beta-crystallin B1,20092,59,1.04 [0.72-1.52],0.8229067804227868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB2,Beta-crystallin B2,20044,58,1.01 [0.72-1.42],0.945059902277254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYGD,Gamma-crystallin D,20044,58,0.91 [0.70-1.17],0.4634233934069455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYM,Ketimine reductase mu-crystallin,19446,57,1.05 [0.76-1.46],0.7558978203638841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYZL1,Quinone oxidoreductase-like protein 1,19543,57,0.98 [0.74-1.30],0.8917728345099504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSDE1,Cold shock domain-containing protein E1,19410,56,0.77 [0.58-1.02],0.0663318987060464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1,Macrophage colony-stimulating factor 1,23248,71,1.08 [0.49-2.34],0.8547637076052249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,20118,60,1.82 [1.09-3.05],0.022623572369792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2,Granulocyte-macrophage colony-stimulating factor,19410,56,0.58 [0.27-1.25],0.1636210785581827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22963,70,1.09 [0.78-1.53],0.6189922532623549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RB,Cytokine receptor common subunit beta,19503,59,0.80 [0.45-1.43],0.4500332276054406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3,Granulocyte colony-stimulating factor,22757,70,0.76 [0.48-1.18],0.2172506935771913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3R,Granulocyte colony-stimulating factor receptor,19503,59,0.75 [0.32-1.75],0.5040931718016051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,20118,60,2.16 [1.04-4.48],0.0386795022916701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK1D,Casein kinase I isoform delta,19503,59,0.96 [0.64-1.44],0.8365384377364313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK2A1,Casein kinase II subunit alpha,20053,58,0.66 [0.37-1.18],0.1608973636016946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,20102,59,1.36 [0.65-2.84],0.4120465592934287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG5,Chondroitin sulfate proteoglycan 5,19446,57,0.88 [0.51-1.54],0.6652309725391161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSRP3,Cysteine and glycine-rich protein 3,19410,56,0.94 [0.71-1.24],0.665806338393845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST1,Cystatin-SN,17475,56,0.90 [0.69-1.16],0.4038062997948529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,23230,70,2.45 [1.31-4.56],0.0048494501355729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST5,Cystatin-D,22680,68,0.95 [0.65-1.40],0.8006883509319302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST6,Cystatin-M,22567,66,1.18 [0.76-1.83],0.4674118948203657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,23173,71,1.21 [1.02-1.43],0.0315859702201975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSTB,Cystatin-B,22866,69,1.27 [0.79-2.02],0.3221453885295605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTAG1A_CTAG1B,Cancer/testis antigen 1,19712,59,1.25 [0.79-1.99],0.3400893943801508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTBS,Di-N-acetylchitobiase,19830,59,1.69 [0.68-4.21],0.258126515861799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTF1,Cardiotrophin-1,22746,68,1.12 [0.87-1.43],0.3843079079777107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTHRC1,Collagen triple helix repeat-containing protein 1,20102,59,0.56 [0.23-1.37],0.2045448508320787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTLA4,Cytotoxic T-lymphocyte protein 4,20102,59,1.19 [0.55-2.56],0.6540867512409854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTNNA1,Catenin alpha-1,19446,57,1.21 [0.63-2.31],0.5657417769222755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRB1,Chymotrypsinogen B,23180,69,1.07 [0.75-1.53],0.6986776557197234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRC,Chymotrypsin-C,23130,71,0.99 [0.72-1.37],0.969224514453138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRL,Chymotrypsin-like protease CTRL-1,20044,58,1.03 [0.72-1.46],0.8807288191059388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSB,Cathepsin B,23191,69,0.86 [0.57-1.31],0.4863983596040578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSC,Dipeptidyl peptidase 1,23080,70,1.16 [0.73-1.85],0.5216174164328498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSD,Cathepsin D,21693,64,1.48 [0.93-2.35],0.096882824814257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSE,Cathepsin E,19647,60,0.96 [0.61-1.51],0.8530850105185463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,23228,70,0.69 [0.41-1.17],0.1718354792707233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSH,Pro-cathepsin H,22659,68,1.08 [0.81-1.44],0.5880507487343933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,23166,69,2.71 [1.26-5.84],0.0110608266097615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,23437,70,2.03 [1.09-3.78],0.0266548983647006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,18233,54,3.02 [1.05-8.70],0.0401988737512729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSV,Cathepsin L2,23278,71,0.80 [0.48-1.34],0.3975042746071778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,23202,70,1.52 [0.80-2.90],0.2021730449656108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19557,56,1.12 [0.64-1.96],0.6830308311302888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CWC15,Spliceosome-associated protein CWC15 homolog,19917,58,0.92 [0.59-1.43],0.7150623389783073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CX3CL1,Fractalkine,22963,70,1.29 [0.69-2.41],0.4227045531440977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,23141,70,1.19 [0.79-1.81],0.4040526901627291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL1,Growth-regulated alpha protein,23100,71,1.00 [0.80-1.25],0.983631082973194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,23248,71,1.09 [0.80-1.49],0.5678630362744391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL11,C-X-C motif chemokine 11,23375,71,1.07 [0.83-1.37],0.6238292211206442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL12,Stromal cell-derived factor 1,22757,70,1.14 [0.66-1.94],0.6434875860686111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL13,C-X-C motif chemokine 13,23375,71,1.06 [0.77-1.48],0.7107452473986735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL14,C-X-C motif chemokine 14,22757,70,1.13 [0.81-1.58],0.4687131601205089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL16,C-X-C motif chemokine 16,23422,69,1.11 [0.45-2.76],0.8201222895321836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,23437,70,1.29 [0.83-2.00],0.2622573184060438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL3,C-X-C motif chemokine 3,23137,71,1.03 [0.83-1.28],0.7869109474047111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL5,C-X-C motif chemokine 5,23090,68,1.13 [0.94-1.36],0.1848646639454761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL6,C-X-C motif chemokine 6,23437,70,1.24 [0.95-1.63],0.118877359527892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL8,Interleukin-8,23003,71,1.01 [0.75-1.36],0.9475549375042904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL9,C-X-C motif chemokine 9,23248,71,1.15 [0.85-1.55],0.3664232872238135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,19396,57,1.38 [1.09-1.74],0.0066209147323407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5R2,NADH-cytochrome b5 reductase 2,19822,58,0.91 [0.59-1.40],0.6556182173388927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19410,56,0.98 [0.72-1.34],0.8906259522116087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTH3,Cytohesin-3,19396,57,0.95 [0.65-1.37],0.7680490173018604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTL1,Cytokine-like protein 1,20102,59,0.95 [0.36-2.52],0.9201991735555868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAAM1,Disheveled-associated activator of morphogenesis 1,19647,60,1.14 [0.85-1.53],0.3936801688384514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAB2,Disabled homolog 2,23366,71,1.10 [0.91-1.33],0.3214724458164983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAG1,Dystroglycan,23248,71,1.33 [0.86-2.05],0.199189898044486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAND5,DAN domain family member 5,19503,59,0.73 [0.48-1.10],0.1324976623388232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPK2,Death-associated protein kinase 2,19503,59,1.09 [0.72-1.65],0.6851675128335031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,23141,70,1.13 [0.94-1.36],0.1905700127745498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22930,70,1.14 [0.85-1.54],0.3784993440701788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBH,Dopamine beta-hydroxylase,20082,60,1.01 [0.81-1.26],0.9192572544146638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBI,Acyl-CoA-binding protein,23069,69,1.27 [0.98-1.66],0.0739803631969157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBN1,Drebrin,19503,59,0.84 [0.50-1.41],0.499270365088964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBNL,Drebrin-like protein,23248,71,1.11 [0.88-1.39],0.3731975277913977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23228,70,1.59 [0.89-2.84],0.1147214972448899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCC,Netrin receptor DCC,19557,56,0.85 [0.24-2.97],0.7998376942255421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCDC2C,Doublecortin domain-containing protein 2C,19396,57,0.93 [0.60-1.44],0.7379583967895436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCLRE1C,Protein artemis,19396,57,0.72 [0.30-1.73],0.4664533438657199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCN,Decorin,22746,68,0.95 [0.37-2.41],0.9063806333644324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTD,Deoxycytidylate deaminase,19647,60,1.13 [0.87-1.47],0.3750065828899287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN1,Dynactin subunit 1,23366,71,1.19 [0.86-1.64],0.3044605732725495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN2,Dynactin subunit 2,23054,68,0.90 [0.71-1.14],0.3853506139007238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN6,Dynactin subunit 6,22655,70,1.09 [0.83-1.44],0.5379096874292779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,23166,69,1.68 [0.88-3.20],0.1133041232668138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D1,DCN1-like protein 1,19446,57,0.88 [0.59-1.30],0.5273007572677213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D2,DCN1-like protein 2,19396,57,1.19 [0.90-1.58],0.2113990414373875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,23228,70,1.57 [1.09-2.26],0.0160786460312521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDA1,DET1- and DDB1-associated protein 1,19410,56,0.73 [0.34-1.55],0.4093668445811012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",23054,68,1.43 [0.91-2.23],0.1175595905767843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDC,Aromatic-L-amino-acid decarboxylase,23136,69,1.06 [0.68-1.64],0.8102160466684768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDHD2,Phospholipase DDHD2,20053,58,0.97 [0.66-1.43],0.894025239229398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDI2,Protein DDI1 homolog 2,19647,60,0.91 [0.65-1.25],0.5518469181545339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDR1,Epithelial discoidin domain-containing receptor 1,23375,71,0.84 [0.34-2.11],0.7142751593548256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDT,D-dopachrome decarboxylase,20102,59,0.94 [0.52-1.70],0.8410227207375559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX1,ATP-dependent RNA helicase DDX1,20029,58,1.02 [0.61-1.71],0.9420117562768978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX25,ATP-dependent RNA helicase DDX25,19557,56,1.12 [0.56-2.23],0.748863303413024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX39A,ATP-dependent RNA helicase DDX39A,19503,59,1.75 [0.89-3.43],0.1029695952908939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX4,Probable ATP-dependent RNA helicase DDX4,19503,59,0.98 [0.62-1.57],0.9470761077341702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX53,Probable ATP-dependent RNA helicase DDX53,19557,56,0.86 [0.41-1.79],0.682054515099977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX58,Antiviral innate immune response receptor RIG-I,22619,68,1.11 [0.78-1.57],0.5660666514176841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",23141,70,1.12 [0.90-1.40],0.2995564041623877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFA1_DEFA1B,Neutrophil defensin 1,22706,68,0.96 [0.64-1.44],0.8474213454682735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB103A_DEFB103B,Beta-defensin 103,19356,59,1.00 [0.55-1.83],0.99697823517034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB104A_DEFB104B,Beta-defensin 104,19446,57,0.83 [0.50-1.39],0.4790914740208037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB116,Beta-defensin 116,19446,57,1.14 [0.84-1.55],0.4096942274481611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB118,Beta-defensin 118,19446,57,1.01 [0.65-1.57],0.9571176617794228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB4A_DEFB4B,Beta-defensin 4A,22820,68,0.94 [0.81-1.09],0.3930195955347536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENND2B,DENN domain-containing protein 2B,19410,56,0.96 [0.54-1.68],0.8768082496331233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENR,Density-regulated protein,19503,59,1.11 [0.74-1.66],0.6139697611580021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DFFA,DNA fragmentation factor subunit alpha,23437,70,1.21 [0.90-1.64],0.209781892197488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGCR6,Protein DGCR6,19446,57,0.87 [0.44-1.69],0.6749369653105672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKA,Diacylglycerol kinase alpha,19503,59,1.19 [0.76-1.85],0.4533462186558961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKZ,Diacylglycerol kinase zeta,22757,70,1.29 [0.74-2.25],0.3703091967331592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHODH,Dihydroorotate dehydrogenase,19410,56,0.76 [0.40-1.44],0.3987032622394566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHPS,Deoxyhypusine synthase,20022,60,1.26 [0.74-2.17],0.3957442666318145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20044,58,1.19 [0.73-1.94],0.4836103872980762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIABLO,"Diablo homolog, mitochondrial",23091,69,1.08 [0.89-1.31],0.4249062672662911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK1C,Divergent protein kinase domain 1C,19557,56,1.24 [0.71-2.17],0.4569543984730303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK2B,Divergent protein kinase domain 2B,19647,60,1.51 [0.71-3.21],0.2900163339008946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK1,Dickkopf-related protein 1,23375,71,1.22 [0.86-1.73],0.2711002358960472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK3,Dickkopf-related protein 3,23457,69,1.54 [0.77-3.10],0.2214812753987916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,22922,70,1.36 [0.90-2.06],0.1410205362859898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKKL1,Dickkopf-like protein 1,23054,68,1.02 [0.79-1.30],0.8926620621649899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLG4,Disks large homolog 4,20044,58,0.91 [0.63-1.30],0.5967564283595189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLGAP5,Disks large-associated protein 5,20053,58,0.91 [0.53-1.59],0.7492035612464744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLK1,Protein delta homolog 1,23457,69,1.02 [0.71-1.48],0.9091240067375836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,23228,70,1.54 [0.79-3.00],0.2021057763371876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL4,Delta-like protein 4,19543,57,0.91 [0.63-1.30],0.6042469743520084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMD,Dystrophin,19543,57,0.92 [0.54-1.58],0.7630183659391756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,19543,57,0.64 [0.44-0.93],0.0204682006237313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA1,DnaJ homolog subfamily A member 1,19396,57,0.90 [0.50-1.64],0.7365517662314132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA2,DnaJ homolog subfamily A member 2,23363,70,1.15 [0.89-1.49],0.2923904958799805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA4,DnaJ homolog subfamily A member 4,20044,58,0.87 [0.61-1.23],0.4316245446035978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB1,DnaJ homolog subfamily B member 1,23054,68,1.08 [0.84-1.39],0.5300640337463052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB14,DnaJ homolog subfamily B member 14,20029,58,1.04 [0.70-1.53],0.8530985106537321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB2,DnaJ homolog subfamily B member 2,19647,60,1.02 [0.65-1.62],0.9235073664926956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB6,DnaJ homolog subfamily B member 6,19466,60,1.11 [0.83-1.49],0.4800435860527918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,22746,68,1.14 [0.81-1.62],0.455953669394605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC21,DnaJ homolog subfamily C member 21,20044,58,0.68 [0.34-1.38],0.2874230141533902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19543,57,0.89 [0.66-1.21],0.4587801177009122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC9,DnaJ homolog subfamily C member 9,20029,58,1.07 [0.77-1.48],0.6853665724757991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNER,Delta and Notch-like epidermal growth factor-related receptor,23093,71,0.93 [0.42-2.08],0.8630815565878434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNLZ,DNL-type zinc finger protein,19446,57,0.92 [0.65-1.30],0.6364271538654067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM1,Dynamin-1,20029,58,1.13 [0.91-1.42],0.2692878637903723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM3,Dynamin-3,20053,58,0.89 [0.55-1.44],0.6327979003588295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNMBP,Dynamin-binding protein,22963,70,1.10 [0.78-1.55],0.5882511437603373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPEP,Aspartyl aminopeptidase,20044,58,1.08 [0.69-1.70],0.7274052868999336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,23203,71,1.24 [0.83-1.86],0.3004191806024932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOC2B,Double C2-like domain-containing protein beta,19557,56,1.18 [0.63-2.18],0.6062363934399893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOCK9,Dedicator of cytokinesis protein 9,19446,57,1.14 [0.94-1.37],0.1872883629443069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK1,Docking protein 1,20044,58,1.09 [0.90-1.32],0.3575424618968582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK2,Docking protein 2,23166,69,1.08 [0.91-1.29],0.3659578203648802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP1,Dipeptidase 1,22930,70,0.84 [0.54-1.31],0.4453205944517571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP2,Dipeptidase 2,23054,68,0.89 [0.44-1.80],0.741557154952754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP10,Inactive dipeptidyl peptidase 10,23141,70,0.82 [0.45-1.49],0.513437198739946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP4,Dipeptidyl peptidase 4,22748,68,1.59 [0.73-3.47],0.2484253957760356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,23054,68,1.02 [0.55-1.90],0.9381460007621542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP7,Dipeptidyl peptidase 2,22988,69,1.26 [0.90-1.75],0.1719319957350659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPT,Dermatopontin,23457,69,1.75 [0.74-4.14],0.2045117126187713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,23303,71,1.51 [1.15-1.99],0.0028507643985035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRAXIN,Draxin,22963,70,1.03 [0.63-1.69],0.912352467708988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRG2,Developmentally-regulated GTP-binding protein 2,23054,68,1.08 [0.74-1.56],0.6953602590256328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSC2,Desmocollin-2,22899,66,1.10 [0.59-2.03],0.7711094867128042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,20053,58,2.19 [1.13-4.23],0.019631860422753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG2,Desmoglein-2,23180,69,0.66 [0.30-1.44],0.2929968810341152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG3,Desmoglein-3,23287,71,0.77 [0.42-1.39],0.3773183747220676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG4,Desmoglein-4,22978,68,0.89 [0.57-1.37],0.5858170688456544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTD1,D-aminoacyl-tRNA deacylase 1,19647,60,1.02 [0.77-1.36],0.8781743746888765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTNB,Dystrobrevin beta,19982,60,1.14 [0.66-1.95],0.6399818242833004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19557,56,1.00 [0.64-1.55],0.9892628622186228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,23054,68,2.16 [1.06-4.39],0.033038247761515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTYMK,Thymidylate kinase,20092,59,0.98 [0.68-1.42],0.918740586115238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUOX2,Dual oxidase 2,22746,68,1.13 [0.87-1.48],0.3653722883828926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP13,Dual specificity protein phosphatase 13 isoform A,20022,60,1.11 [0.63-1.96],0.7153977130558371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP29,Dual specificity phosphatase 29,19557,56,1.22 [0.88-1.68],0.2278535365670282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP3,Dual specificity protein phosphatase 3,22655,70,1.12 [0.89-1.40],0.3366936484412134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20029,58,1.08 [0.85-1.38],0.5155606013599348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DXO,Decapping and exoribonuclease protein,20044,58,1.10 [0.64-1.91],0.7294368805094994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20022,60,1.14 [0.70-1.84],0.600597799422012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT1,Dynein light chain Tctex-type 1,19557,56,0.81 [0.56-1.17],0.2602326815926818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT3,Dynein light chain Tctex-type 3,20022,60,0.85 [0.48-1.51],0.5901097949438453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22963,70,1.07 [0.85-1.33],0.5710966723346214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBI3_IL27,Interleukin-27,23340,71,1.21 [0.61-2.39],0.5891652487238884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECE1,Endothelin-converting enzyme 1,22655,70,0.84 [0.46-1.53],0.568278743287016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20092,59,1.38 [1.03-1.83],0.0281104517183226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19543,57,1.08 [0.83-1.41],0.5450677382650233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECI2,Enoyl-CoA delta isomerase 2,19410,56,1.00 [0.66-1.51],0.9852031657001478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECM1,Extracellular matrix protein 1,19593,58,0.80 [0.42-1.53],0.5088931654437211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECSCR,Endothelial cell-specific chemotaxis regulator,19446,57,1.01 [0.60-1.68],0.9740692216583744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDA2R,Tumor necrosis factor receptor superfamily member 27,23366,71,1.48 [0.89-2.46],0.1345976760371216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDAR,Tumor necrosis factor receptor superfamily member EDAR,23141,70,1.13 [0.90-1.43],0.2841034890878308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDDM3B,Epididymal secretory protein E3-beta,20022,60,1.12 [0.75-1.67],0.5826329903691878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19410,56,1.02 [0.50-2.09],0.946822214081134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDF1,Endothelial differentiation-related factor 1,20053,58,1.01 [0.70-1.46],0.9570282706527444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22746,68,0.97 [0.53-1.77],0.921259750535576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDN1,Endothelin-1,19543,57,1.57 [0.68-3.62],0.2944290064406981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDNRB,Endothelin receptor type B,19503,59,0.56 [0.26-1.22],0.1464930007378425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EEF1D,Elongation factor 1-delta,20092,59,1.05 [0.80-1.38],0.7049969886454313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB14,EF-hand calcium-binding domain-containing protein 14,20029,58,1.17 [0.53-2.60],0.7028411070739451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB2,Dynein regulatory complex protein 8,19747,59,1.05 [0.52-2.14],0.8947446136412431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23239,70,1.44 [0.75-2.76],0.2698348131379253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFHD1,EF-hand domain-containing protein D1,20053,58,1.30 [0.69-2.42],0.4167246191268002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA1,Ephrin-A1,23138,69,1.57 [0.79-3.11],0.1977423208857478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,22923,70,2.09 [1.21-3.59],0.0080560495762811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,19557,56,1.41 [1.05-1.90],0.0237649950045792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGF,Pro-epidermal growth factor,23096,71,1.18 [0.96-1.45],0.1096626258199894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFL7,Epidermal growth factor-like protein 7,22619,68,1.29 [0.77-2.17],0.3396363155427592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,20029,58,1.89 [0.94-3.80],0.0761220242814564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,23457,69,0.34 [0.10-1.22],0.0985775317917568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGLN1,Egl nine homolog 1,23141,70,1.15 [0.84-1.57],0.3815699637397967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHBP1,EH domain-binding protein 1,20092,59,1.02 [0.73-1.42],0.9191108985885472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHD3,EH domain-containing protein 3,19543,57,1.12 [0.90-1.40],0.2958864300384737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20044,58,0.74 [0.43-1.28],0.2825736348799637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19952,58,1.22 [0.98-1.52],0.0709805503314427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19410,56,0.98 [0.66-1.46],0.930613905814638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19543,57,0.69 [0.35-1.38],0.294040400538152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4B,Eukaryotic translation initiation factor 4B,22963,70,1.29 [0.88-1.91],0.1956478516630354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4E,Eukaryotic translation initiation factor 4E,19503,59,1.01 [0.77-1.35],0.9204619068793138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,23166,69,1.22 [0.90-1.67],0.199030373251912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23437,70,1.13 [0.91-1.41],0.2574749008862029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20053,58,1.01 [0.69-1.47],0.97152662871437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5,Eukaryotic translation initiation factor 5,19410,56,0.79 [0.41-1.52],0.4760084146209116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5A,Eukaryotic translation initiation factor 5A-1,22757,70,0.98 [0.50-1.93],0.9517344569855976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAC1,Zinc phosphodiesterase ELAC protein 1,20053,58,0.96 [0.72-1.29],0.7955106512122718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAVL4,ELAV-like protein 4,19446,57,0.99 [0.73-1.35],0.9495232706246683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELN,Elastin,20092,59,1.08 [0.52-2.21],0.8412650018769012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOA,Elongin-A,23054,68,1.23 [0.91-1.66],0.1787040070397538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOB,Elongin-B,19410,56,1.03 [0.53-1.99],0.9403342481302778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENAH,Protein enabled homolog,22757,70,1.46 [0.97-2.17],0.0668267656142718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENDOU,Poly(U)-specific endoribonuclease,18542,52,1.05 [0.65-1.70],0.8343145823371846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENG,Endoglin,23457,69,0.71 [0.20-2.47],0.5894742152832526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO1,Alpha-enolase,23159,69,1.13 [0.86-1.49],0.3622539973590557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO2,Gamma-enolase,23375,71,1.16 [0.84-1.60],0.3572402626331746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO3,Beta-enolase,19543,57,1.12 [0.75-1.66],0.5864024661766927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOPH1,Enolase-phosphatase E1,20022,60,0.65 [0.40-1.06],0.0836825383167479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19410,56,1.04 [0.41-2.61],0.9356040520120054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPEP,Glutamyl aminopeptidase,19410,56,1.13 [0.66-1.93],0.6578842027045764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23457,69,0.64 [0.26-1.55],0.3198895903247383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23248,71,1.14 [0.69-1.90],0.6030101867188908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19543,57,0.81 [0.40-1.64],0.559440330831456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22456,67,1.10 [0.84-1.43],0.4869333264386905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENSA,Alpha-endosulfine,20022,60,1.41 [0.99-2.02],0.0582892644801213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22619,68,1.17 [0.70-1.95],0.539151519538088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22746,68,0.56 [0.22-1.40],0.2129020105381718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22746,68,0.85 [0.40-1.83],0.6827542806555029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTR1,Endosome-associated-trafficking regulator 1,19543,57,0.95 [0.61-1.47],0.8042775485547071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EP300,Histone acetyltransferase p300,19503,59,1.38 [0.70-2.72],0.3471738545697732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPB41L5,Band 4.1-like protein 5,19557,56,0.97 [0.64-1.46],0.8672116083767133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPCAM,Epithelial cell adhesion molecule,23125,71,0.93 [0.74-1.17],0.5472525148382927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPGN,Epigen,20022,60,0.80 [0.40-1.60],0.5227057446032048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA1,Ephrin type-A receptor 1,23203,71,0.90 [0.47-1.71],0.7459804760860431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,22655,70,0.56 [0.35-0.88],0.0128368217329864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA2,Ephrin type-A receptor 2,22302,66,1.05 [0.52-2.11],0.8947632889905567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA4,Ephrin type-A receptor 4,19647,60,0.83 [0.36-1.93],0.6653566486518933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB4,Ephrin type-B receptor 4,23457,69,1.67 [0.76-3.67],0.2016961559740722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB6,Ephrin type-B receptor 6,22930,70,1.10 [0.58-2.10],0.7704224584952672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHX2,Bifunctional epoxide hydrolase 2,22746,68,1.20 [0.88-1.63],0.2449164332495649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPN1,Epsin-1,19747,59,1.07 [0.60-1.90],0.8245748252573539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,23141,70,1.09 [0.83-1.43],0.5241421099523198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPPK1,Epiplakin,19543,57,1.10 [0.80-1.51],0.5659151296757307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23329,71,1.21 [0.61-2.37],0.5890520520675043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB2,Receptor tyrosine-protein kinase erbB-2,23228,70,1.73 [0.72-4.14],0.2218418690891605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB3,Receptor tyrosine-protein kinase erbB-3,23045,71,0.92 [0.32-2.68],0.8823398765391968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB4,Receptor tyrosine-protein kinase erbB-4,23228,70,1.19 [0.49-2.89],0.6959272113829034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBIN,Erbin,23054,68,1.11 [0.90-1.36],0.3498945035244791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,19557,56,1.34 [1.05-1.70],0.016443905849842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERCC1,DNA excision repair protein ERCC-1,19396,57,1.32 [0.74-2.37],0.3527649719301682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EREG,Proepiregulin,22930,70,1.25 [0.97-1.60],0.0787211858679496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERI1,3'-5' exoribonuclease 1,19747,59,0.80 [0.37-1.73],0.5728170998905528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,19503,59,1.46 [0.87-2.46],0.1490876647567736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20022,60,0.73 [0.36-1.45],0.3669541003001436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP29,Endoplasmic reticulum resident protein 29,19647,60,1.07 [0.87-1.32],0.5101229623404628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP44,Endoplasmic reticulum resident protein 44,23018,67,1.06 [0.47-2.44],0.8822780411556416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19410,56,1.23 [0.72-2.11],0.4481627665675197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESAM,Endothelial cell-selective adhesion molecule,23457,69,1.62 [0.88-2.98],0.1251532155778013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,23129,71,1.37 [0.76-2.48],0.300647479672948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESPL1,Separin,19396,57,1.02 [0.64-1.62],0.9432370427003304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESR1,Estrogen receptor,19503,59,0.59 [0.31-1.11],0.1006793859838744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESYT2,Extended synaptotagmin-2,20044,58,0.99 [0.73-1.34],0.9565584892942544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI2B,Protein EVI2B,19396,57,0.81 [0.39-1.69],0.5803346959283697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI5,Ecotropic viral integration site 5 protein homolog,19503,59,1.17 [0.89-1.55],0.2528821873055682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVPL,Envoplakin,19747,59,1.30 [0.68-2.50],0.4323492278796089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXOSC10,Exosome component 10,19410,56,0.79 [0.45-1.36],0.3900983729704775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXTL1,Exostosin-like 1,19410,56,1.14 [0.71-1.85],0.5836485951609215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EZR,Ezrin,23375,71,1.14 [0.50-2.61],0.7548504459027512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F10,Coagulation factor X,20118,60,0.87 [0.36-2.09],0.7564693219101936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11,Coagulation factor XI,19829,60,1.07 [0.51-2.23],0.8647650539912664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11R,Junctional adhesion molecule A,23180,69,1.34 [0.93-1.92],0.1200686556344893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F12,Coagulation factor XII,20117,60,0.97 [0.54-1.73],0.9073900147284708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F13B,Coagulation factor XIII B chain,20015,60,1.13 [0.43-2.97],0.8079015026479263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2,Prothrombin,20117,60,0.44 [0.09-2.27],0.3288162149681115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2R,Proteinase-activated receptor 1,23212,71,1.38 [0.97-1.98],0.0759234488614344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,23218,70,0.43 [0.19-0.98],0.0452172805363049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F7,Coagulation factor VII,23233,70,1.38 [0.69-2.77],0.3645063111882158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,23240,70,1.75 [0.55-5.53],0.3406853888016464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",23129,71,1.14 [0.93-1.41],0.2152128910492848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP2,"Fatty acid-binding protein, intestinal",23166,69,1.01 [0.78-1.31],0.957648987152736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP3,"Fatty acid-binding protein, heart",20092,59,1.31 [0.87-1.99],0.1974699183536706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",23457,69,1.69 [1.16-2.46],0.005979482255768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP5,Fatty acid-binding protein 5,23296,71,1.30 [0.97-1.75],0.0786507234931794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP6,Gastrotropin,22714,68,1.08 [0.74-1.56],0.7006104964926576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP9,Fatty acid-binding protein 9,23141,70,1.08 [0.75-1.55],0.690999951501577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FADD,FAS-associated death domain protein,23166,69,1.08 [0.82-1.43],0.5691163088536779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM13A,Protein FAM13A,20029,58,0.96 [0.66-1.40],0.8330838687458476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171A2,Protein FAM171A2,20053,58,0.94 [0.80-1.12],0.5046130625314966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171B,Protein FAM171B,20022,60,0.69 [0.38-1.24],0.219072939092704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM172A,Cotranscriptional regulator FAM172A,19543,57,1.00 [0.65-1.52],0.9874123249363892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,20092,59,2.07 [0.94-4.56],0.0709473925486288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3B,Protein FAM3B,23054,68,1.23 [0.68-2.22],0.4963850535435237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3C,Protein FAM3C,23136,69,1.38 [0.70-2.72],0.3576915349728657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,20029,58,1.13 [0.85-1.51],0.3988310085987144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAP,Prolyl endopeptidase FAP,23457,69,0.92 [0.42-1.99],0.8230590594850493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FARSA,Phenylalanine--tRNA ligase alpha subunit,19557,56,0.93 [0.63-1.37],0.7216163412267069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAS,Tumor necrosis factor receptor superfamily member 6,23381,69,1.33 [0.82-2.14],0.2473883696292739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FASLG,Tumor necrosis factor ligand superfamily member 6,23437,70,1.16 [0.66-2.04],0.6008190069574375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBLN2,Fibulin-2,20102,59,1.26 [0.60-2.65],0.545334342888601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBN2,Fibrillin-2,19557,56,0.92 [0.59-1.42],0.6924577554076234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBP1,"Fructose-1,6-bisphosphatase 1",23166,69,1.03 [0.77-1.37],0.8592383573696336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20092,59,1.35 [0.97-1.89],0.0764897043202591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAR,Immunoglobulin alpha Fc receptor,23141,70,1.21 [0.79-1.85],0.3713671085847907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20053,58,1.48 [0.54-4.03],0.4410521100932859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER2,Low affinity immunoglobulin epsilon Fc receptor,23180,69,0.76 [0.50-1.15],0.1956540467487472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23083,70,1.16 [0.78-1.72],0.4660690197871998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22619,68,1.37 [1.00-1.88],0.0510220071820461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,23198,70,1.03 [0.67-1.57],0.9097299050812572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN1,Ficolin-1,20082,60,1.44 [0.89-2.33],0.1372577503658867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN2,Ficolin-2,23084,70,1.15 [0.68-1.94],0.6130034522992802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL1,Fc receptor-like protein 1,23166,69,1.04 [0.65-1.65],0.878638949703157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,23327,69,1.53 [1.09-2.15],0.0141569185519035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL3,Fc receptor-like protein 3,22757,70,1.26 [0.87-1.84],0.2243172832747275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL5,Fc receptor-like protein 5,23180,69,1.19 [0.84-1.70],0.3331031200250715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL6,Fc receptor-like protein 6,23141,70,1.11 [0.82-1.51],0.4944344411531497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRLB,Fc receptor-like B,22619,68,1.17 [0.88-1.58],0.2828094560628444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX1,"Adrenodoxin, mitochondrial",19410,56,0.91 [0.59-1.43],0.6948176416728485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX2,"Ferredoxin-2, mitochondrial",19410,56,0.91 [0.56-1.47],0.6918732124581612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FEN1,Flap endonuclease 1,22619,68,0.96 [0.69-1.34],0.825278106619791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FES,Tyrosine-protein kinase Fes/Fps,22619,68,0.95 [0.60-1.50],0.8106781710218144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FETUB,Fetuin-B,23240,70,1.43 [0.71-2.85],0.3163117007508073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGA,Fibrinogen alpha chain,19657,60,1.63 [0.76-3.49],0.2103021176190475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20053,58,1.08 [0.79-1.47],0.6376740291046261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,19503,59,0.32 [0.11-0.91],0.0329453028493865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF16,Fibroblast growth factor 16,19503,59,1.18 [0.71-1.95],0.5205987212862169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF19,Fibroblast growth factor 19,23248,71,1.08 [0.83-1.41],0.576255945210109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF2,Fibroblast growth factor 2,23141,70,1.17 [0.87-1.57],0.2901492133419896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF20,Fibroblast growth factor 20,19503,59,0.78 [0.39-1.55],0.4733217279794629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,23340,71,1.21 [1.04-1.42],0.0166308191556403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,23325,71,1.33 [0.96-1.84],0.0853267968625311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF3,Fibroblast growth factor 3,19503,59,0.69 [0.26-1.86],0.4676696627568545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF5,Fibroblast growth factor 5,22757,70,0.80 [0.42-1.51],0.4928193974511972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF6,Fibroblast growth factor 6,19503,59,0.52 [0.22-1.23],0.1374358608544586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF7,Fibroblast growth factor 7,19396,57,1.21 [0.94-1.54],0.1327465874848408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF9,Fibroblast growth factor 9,19362,57,1.24 [0.66-2.31],0.5062355585485303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,23228,70,0.67 [0.36-1.26],0.2160136260885288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP2,Fibroblast growth factor-binding protein 2,20102,59,0.77 [0.47-1.27],0.3083336370002149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP3,Fibroblast growth factor-binding protein 3,20044,58,1.43 [0.73-2.80],0.2918434001566379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,23228,70,2.89 [1.24-6.69],0.0134949561590795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR4,Fibroblast growth factor receptor 4,19647,60,0.86 [0.54-1.36],0.5071414165745125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,20118,60,1.54 [1.09-2.20],0.0157054168179446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGR,Tyrosine-protein kinase Fgr,22655,70,1.00 [0.71-1.40],0.9775628733211206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FH,"Fumarate hydratase, mitochondrial",19446,57,0.92 [0.65-1.31],0.6398306251706957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19410,56,0.77 [0.42-1.40],0.3847433288769376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIT,Bis(5'-adenosyl)-triphosphatase,22655,70,1.20 [0.89-1.62],0.2270246839251172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FIS1,Mitochondrial fission 1 protein,23128,71,1.17 [0.89-1.52],0.2567781421113986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20053,58,0.99 [0.77-1.27],0.9194088753196846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23255,69,1.09 [0.91-1.31],0.3548265311123539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22963,70,1.27 [0.77-2.09],0.3510433623125812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22963,70,1.12 [0.89-1.41],0.3372247738642651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22622,70,0.77 [0.46-1.29],0.3269507230506992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBPL,FK506-binding protein-like,20029,58,0.95 [0.62-1.45],0.8091763820083798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLI1,Friend leukemia integration 1 transcription factor,22619,68,1.06 [0.88-1.28],0.5390060820539968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22963,70,1.70 [0.84-3.43],0.1392166129843206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT1,Vascular endothelial growth factor receptor 1,23015,67,1.33 [0.60-2.94],0.486048277722409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3,Receptor-type tyrosine-protein kinase FLT3,22619,68,0.63 [0.30-1.35],0.2358486768139773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3LG,Fms-related tyrosine kinase 3 ligand,23437,70,1.47 [0.81-2.68],0.2076987068936592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT4,Vascular endothelial growth factor receptor 3,23228,70,1.01 [0.54-1.88],0.9755863053077416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMNL1,Formin-like protein 1,22655,70,1.10 [0.83-1.46],0.5003134684253316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMR1,Synaptic functional regulator FMR1,22619,68,0.64 [0.34-1.19],0.1568585682331277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FN1,Fibronectin,20117,60,0.66 [0.26-1.67],0.3794820444582151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNDC1,Fibronectin type III domain-containing protein 1,20044,58,1.29 [0.76-2.20],0.3475687044402499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20022,60,0.84 [0.40-1.79],0.658789507941579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLH1,Glutamate carboxypeptidase 2,19503,59,0.65 [0.41-1.03],0.0683570557026635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR1,Folate receptor alpha,23131,70,1.21 [0.60-2.45],0.5890820481826646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR2,Folate receptor beta,23375,71,1.12 [0.55-2.28],0.7590031258851144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR3,Folate receptor gamma,23153,70,0.92 [0.80-1.04],0.1914585821138583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOS,Proto-oncogene c-Fos,19362,57,0.87 [0.43-1.78],0.7040242266056618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOSB,Protein fosB,22655,70,0.60 [0.30-1.19],0.1446498353075239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXJ3,Forkhead box protein J3,19503,59,1.01 [0.58-1.76],0.9587984874539044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO1,Forkhead box protein O1,23141,70,1.22 [0.96-1.55],0.1079219530755203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO3,Forkhead box protein O3,22619,68,0.88 [0.69-1.12],0.304617945182449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD4B,FERM domain-containing protein 4B,19410,56,0.93 [0.64-1.36],0.7098721435931624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD7,FERM domain-containing protein 7,19557,56,0.85 [0.40-1.82],0.6802069667284905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRZB,Secreted frizzled-related protein 3,22893,70,0.69 [0.31-1.51],0.3510662499647619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,19543,57,1.79 [1.31-2.43],0.0002054517868914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FST,Follistatin,23212,71,1.06 [0.69-1.62],0.7957751279134273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL1,Follistatin-related protein 1,19543,57,1.00 [0.33-3.08],0.9939237064909304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL3,Follistatin-related protein 3,23097,70,1.33 [0.71-2.50],0.3797201827905346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,20004,58,1.23 [0.93-1.63],0.1558239968958596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,23298,69,1.12 [0.85-1.47],0.4279675694981075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,19647,60,1.59 [1.11-2.29],0.0118358972062538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FURIN,Furin,23228,70,1.26 [0.66-2.38],0.4855294131878379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,22578,68,1.53 [0.97-2.41],0.0661906683657044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19715,58,0.90 [0.59-1.38],0.6420516515247694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23375,71,0.75 [0.48-1.16],0.1919593560895601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT8,"Alpha-(1,6)-fucosyltransferase",22963,70,1.33 [0.94-1.88],0.1085904122033866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXN,"Frataxin, mitochondrial",23366,71,1.20 [0.91-1.59],0.1997538115976597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXYD5,FXYD domain-containing ion transport regulator 5,22757,70,1.05 [0.76-1.46],0.7487740515944868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FYB1,FYN-binding protein 1,23137,69,1.14 [0.91-1.44],0.2625270881652945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD10,Frizzled-10,19557,56,1.03 [0.66-1.60],0.9068401024562474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,19446,57,1.34 [0.84-2.15],0.2220375622552668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAP,Gamma-aminobutyric acid receptor-associated protein,20022,60,1.06 [0.65-1.74],0.8069675509330515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19747,59,0.90 [0.59-1.38],0.6253963784281962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19446,57,0.77 [0.48-1.26],0.3068184719177469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD1,Glutamate decarboxylase 1,19396,57,1.55 [0.58-4.11],0.3783468603826657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD2,Glutamate decarboxylase 2,19503,59,0.72 [0.37-1.40],0.3381994524383753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19747,59,0.85 [0.46-1.57],0.6092586054741334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19543,57,0.95 [0.58-1.56],0.8494185801301286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAGE2A,G antigen 2A,19396,57,1.13 [0.81-1.60],0.4685398357787492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAL,Galanin peptides,23248,71,0.99 [0.72-1.36],0.945369266627199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23054,68,2.19 [1.04-4.61],0.0386271140729244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23366,71,1.08 [0.50-2.35],0.8474106147001729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22757,70,1.16 [0.71-1.88],0.5571213810795514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20092,59,0.48 [0.20-1.15],0.0995999360399098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT7,N-acetylgalactosaminyltransferase 7,23054,68,1.40 [0.49-3.95],0.5307990935286762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAMT,Guanidinoacetate N-methyltransferase,19410,56,0.81 [0.35-1.88],0.6247841927496802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19214,58,1.78 [0.71-4.47],0.2162537100733206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GART,Trifunctional purine biosynthetic protein adenosine-3,20053,58,0.76 [0.26-2.21],0.6100080299033039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS2,Growth arrest-specific protein 2,19747,59,1.16 [0.76-1.77],0.4903563987404458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS6,Growth arrest-specific protein 6,23314,69,1.14 [0.49-2.67],0.7578677285238192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GASK1A,Golgi-associated kinase 1A,19410,56,1.08 [0.59-1.98],0.8034396090819171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,20044,58,1.33 [1.15-1.54],0.0001374920022377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19396,57,2.01 [0.82-4.94],0.1292544408876198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19543,57,0.99 [0.70-1.38],0.9381847162422596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBA,Lysosomal acid glucosylceramidase,19557,56,1.20 [0.76-1.88],0.4299336387246351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,20005,58,1.27 [0.88-1.84],0.2063818536000297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP2,Guanylate-binding protein 2,22757,70,1.13 [0.80-1.59],0.4996830243802879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP4,Guanylate-binding protein 4,22655,70,1.22 [0.81-1.83],0.3485875925971072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP6,Guanylate-binding protein 6,19410,56,0.69 [0.34-1.42],0.3181763931444726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GC,Vitamin D-binding protein,20117,60,0.58 [0.21-1.56],0.2779898973019717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCC1,GRIP and coiled-coil domain-containing protein 1,20044,58,1.05 [0.83-1.32],0.684847668964121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCG,Pro-glucagon,22619,68,1.18 [0.99-1.39],0.0590952634083995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19149,59,1.23 [0.78-1.94],0.368933254480157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCLM,Glutamate--cysteine ligase regulatory subunit,19410,56,0.75 [0.39-1.45],0.3960128980871793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23054,68,0.66 [0.35-1.24],0.192772387357775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,23457,69,2.12 [1.53-2.94],6.819102663136367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF2,Growth/differentiation factor 2,23166,69,0.76 [0.42-1.40],0.3786662520275415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,22655,70,1.82 [1.14-2.92],0.0127027294389513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GET3,ATPase GET3,20092,59,0.69 [0.40-1.20],0.1900809014448701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,22581,68,1.47 [0.96-2.26],0.0800124320022006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFER,FAD-linked sulfhydryl oxidase ALR,22619,68,1.24 [0.89-1.71],0.2068959365572839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22619,68,1.06 [0.90-1.24],0.5143803177006634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA1,GDNF family receptor alpha-1,23340,71,1.36 [0.67-2.79],0.3984450643934741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA2,GDNF family receptor alpha-2,23054,68,1.18 [0.42-3.31],0.7576627737150403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA3,GDNF family receptor alpha-3,22891,70,1.29 [0.61-2.74],0.5096371389576699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRAL,GDNF family receptor alpha-like,19464,57,0.68 [0.44-1.04],0.0781211653150743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGA1,ADP-ribosylation factor-binding protein GGA1,22655,70,0.99 [0.71-1.37],0.9414974872087264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGACT,Gamma-glutamylaminecyclotransferase,20092,59,1.14 [0.81-1.60],0.468214169472084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGCT,Gamma-glutamylcyclotransferase,20059,59,0.91 [0.54-1.55],0.7398982873154557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGH,Gamma-glutamyl hydrolase,22790,69,1.48 [0.82-2.67],0.1930887339760313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,23138,69,1.71 [1.21-2.42],0.0022320263067787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT5,Glutathione hydrolase 5 proenzyme,22963,70,1.00 [0.40-2.52],0.9942539260206048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH1,Somatotropin,23136,69,1.01 [0.90-1.14],0.8714111837801145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,22619,68,1.03 [0.90-1.17],0.6800962462156022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHR,Growth hormone receptor,19647,60,1.57 [0.65-3.79],0.3175841524804331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRHR,Growth hormone-releasing hormone receptor,22655,70,0.79 [0.50-1.26],0.3288769247594318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRL,Appetite-regulating hormone,23166,69,0.95 [0.74-1.23],0.7054001389302874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GID8,Glucose-induced degradation protein 8 homolog,20053,58,1.02 [0.49-2.13],0.9659079978161164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIGYF2,GRB10-interacting GYF protein 2,20053,58,0.84 [0.59-1.18],0.3077839869074195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP7,GTPase IMAP family member 7,19647,60,1.42 [0.76-2.63],0.2713340373212107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,19396,57,1.75 [1.26-2.45],0.0009454347632239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIP,Gastric inhibitory polypeptide,19543,57,1.43 [0.92-2.21],0.1136591585153363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,20044,58,1.93 [0.99-3.76],0.053744852291186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC3,PDZ domain-containing protein GIPC3,20029,58,1.06 [0.82-1.37],0.6690549667913417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPR,Gastric inhibitory polypeptide receptor,19503,59,0.94 [0.53-1.69],0.8441492410774873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIT1,ARF GTPase-activating protein GIT1,19503,59,1.08 [0.83-1.40],0.5659413512645834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GJA8,Gap junction alpha-8 protein,19396,57,0.94 [0.60-1.47],0.7928288093463964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GKN1,Gastrokine-1,22236,68,0.88 [0.40-1.91],0.7413522326535713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLA,Alpha-galactosidase A,19615,60,1.22 [0.63-2.34],0.5591401143977709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLB1,Beta-galactosidase,22963,70,1.17 [0.72-1.90],0.5293886091316042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLI2,Zinc finger protein GLI2,19503,59,0.59 [0.24-1.49],0.2663445442660695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLO1,Lactoylglutathione lyase,22746,68,1.27 [0.88-1.83],0.19920457326695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLOD4,Glyoxalase domain-containing protein 4,23092,71,1.41 [0.76-2.58],0.2728337414281384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLP1R,Glucagon-like peptide 1 receptor,19446,57,0.99 [0.49-1.99],0.9665476345710748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX,Glutaredoxin-1,23020,69,1.09 [0.76-1.56],0.6500849789304588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19647,60,1.08 [0.82-1.43],0.5813926614244198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22655,70,1.05 [0.69-1.61],0.8094931288682801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLYR1,Putative oxidoreductase GLYR1,20022,60,1.29 [0.91-1.82],0.1493009428193322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GM2A,Ganglioside GM2 activator,19613,57,1.39 [0.80-2.43],0.2468497995017932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMFG,Glia maturation factor gamma,20092,59,1.09 [0.77-1.54],0.6341440174077597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR,GMP reductase 1,23437,70,1.24 [0.79-1.94],0.3417402241434311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR2,GMP reductase 2,19647,60,1.11 [0.76-1.62],0.5774774721428979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNAS,Neuroendocrine secretory protein 55,20053,58,1.22 [0.95-1.57],0.1277458221456114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22619,68,1.06 [0.77-1.47],0.719505357641834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19557,56,1.04 [0.63-1.72],0.8700836889419297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,23180,69,1.57 [1.08-2.26],0.0170502825488971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA1,Glucosamine-6-phosphate isomerase 1,19543,57,1.24 [0.68-2.27],0.4789978075397565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA2,Glucosamine-6-phosphate isomerase 2,19647,60,0.93 [0.48-1.83],0.8440591831193567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLGA3,Golgin subfamily A member 3,20053,58,1.07 [0.78-1.48],0.676604277111742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLM2,Protein GOLM2,23375,71,1.40 [0.70-2.79],0.3368349790069576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,23141,70,1.09 [0.88-1.34],0.420335298583255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GORASP2,Golgi reassembly-stacking protein 2,20029,58,0.84 [0.49-1.45],0.5294692064201774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOT1,"Aspartate aminotransferase, cytoplasmic",20102,59,1.05 [0.58-1.87],0.8815617666678457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BA,Platelet glycoprotein Ib alpha chain,23088,70,1.47 [0.80-2.72],0.2188522686007669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BB,Platelet glycoprotein Ib beta chain,19410,56,1.06 [0.73-1.54],0.7586992648388071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22455,68,0.98 [0.75-1.27],0.8695148601870519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP5,Platelet glycoprotein V,19647,60,1.61 [0.80-3.25],0.1865375463333696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP6,Platelet glycoprotein VI,23137,69,1.19 [0.93-1.51],0.1705200427459187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPA33,Cell surface A33 antigen,23054,68,0.95 [0.81-1.11],0.5243258157698643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC1,Glypican-1,23366,71,1.11 [0.55-2.26],0.7662642765515348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC5,Glypican-5,22963,70,1.07 [0.73-1.57],0.7188953452857773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,20022,60,1.39 [0.91-2.14],0.1320933011814891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPHA2,Glycoprotein hormone alpha-2,20029,58,0.83 [0.43-1.61],0.5859242084110974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPI,Glucose-6-phosphate isomerase,20118,60,1.18 [0.71-1.95],0.5226393858250431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20029,58,0.84 [0.62-1.15],0.2782740770445555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPKOW,G-patch domain and KOW motifs-containing protein,22655,70,1.04 [0.52-2.06],0.91511681484753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPNMB,Transmembrane glycoprotein NMB,22540,69,1.54 [0.74-3.21],0.2465262500036834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,19446,57,1.18 [0.80-1.74],0.3955473564118892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR158,Probable G-protein coupled receptor 158,20053,58,0.77 [0.35-1.72],0.525103595408364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR15L,Protein GPR15L,20029,58,1.15 [0.78-1.69],0.4853673901351683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR37,Prosaposin receptor GPR37,22746,68,1.33 [0.96-1.85],0.084034511202776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,20022,60,1.58 [1.17-2.13],0.0027876240808772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRAP2,GRB2-related adapter protein 2,23166,69,1.10 [0.93-1.30],0.2683379551904306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20092,59,0.99 [0.66-1.48],0.9674617024619584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIK2,"Glutamate receptor ionotropic, kainate 2",20053,58,0.56 [0.27-1.17],0.122133538300854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19446,57,1.03 [0.64-1.63],0.9160168256130332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRK5,G protein-coupled receptor kinase 5,22746,68,0.83 [0.52-1.33],0.449132820191367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,23055,68,2.71 [1.35-5.44],0.005018427865741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRP,Gastrin-releasing peptide,19543,57,1.12 [0.70-1.79],0.6483559010940321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",23054,68,1.50 [1.11-2.03],0.0081690368875951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRSF1,G-rich sequence factor 1,19288,57,0.88 [0.63-1.22],0.4368659858167085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSAP,Gamma-secretase-activating protein,22619,68,0.82 [0.60-1.14],0.2387368517075972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSN,Gelsolin,20034,59,0.65 [0.18-2.38],0.5194060282606137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",20008,60,2.25 [0.82-6.18],0.116716072496266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA1,Glutathione S-transferase A1,23130,69,1.20 [0.93-1.53],0.1541377373686979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA3,Glutathione S-transferase A3,22619,68,1.06 [0.80-1.40],0.7054734585903306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTM4,Glutathione S-transferase Mu 4,19410,56,1.09 [0.79-1.50],0.6066126707501374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,22509,69,0.72 [0.51-1.02],0.066739431435679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTT2B,Glutathione S-transferase theta-2B,20044,58,1.04 [0.93-1.15],0.4971908229325974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19747,59,1.32 [1.03-1.69],0.0307127161756264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTPBP2,GTP-binding protein 2,19557,56,1.10 [0.80-1.51],0.548240352278428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCA2A,Guanylin,23060,69,1.51 [0.84-2.70],0.1692941303199116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCY2C,Heat-stable enterotoxin receptor,19747,59,1.02 [0.74-1.40],0.9175812885751302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUK1,Guanylate kinase,19410,56,0.95 [0.48-1.89],0.880857729326232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUSB,Beta-glucuronidase,23266,69,1.26 [0.90-1.76],0.1757454521841323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GYS1,"Glycogen [starch] synthase, muscle",22746,68,1.14 [0.91-1.43],0.2640559618060248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,23437,70,1.88 [1.08-3.26],0.0255029542828428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMB,Granzyme B,23141,70,1.20 [0.93-1.56],0.1547910651583514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMH,Granzyme H,22746,68,1.14 [0.90-1.43],0.2719193381168139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,H2AP,Huntingtin-interacting protein M,19396,57,0.80 [0.42-1.50],0.4865298447111064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19410,56,0.77 [0.46-1.29],0.3170442054816202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23304,70,1.13 [0.84-1.51],0.417159805101388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,23366,71,1.22 [1.04-1.43],0.0160851549411223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HARS1,"Histidine--tRNA ligase, cytoplasmic",23180,69,1.17 [0.89-1.55],0.2542567475329675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR1,Hepatitis A virus cellular receptor 1,23330,70,1.06 [0.77-1.47],0.7138384133695665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR2,Hepatitis A virus cellular receptor 2,23180,69,1.31 [0.73-2.34],0.3689519441733592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBEGF,Proheparin-binding EGF-like growth factor,23304,70,1.13 [0.85-1.50],0.4044302208512348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBQ1,Hemoglobin subunit theta-1,23366,71,1.11 [0.81-1.53],0.5173572785187682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBZ,Hemoglobin subunit zeta,20092,59,0.93 [0.74-1.17],0.5524112352154124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCG22,Protein PBMUCL2,19410,56,0.86 [0.49-1.49],0.5812996515488522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCLS1,Hematopoietic lineage cell-specific protein,23437,70,1.22 [0.83-1.78],0.3128650230582432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC8,Histone deacetylase 8,19503,59,0.58 [0.30-1.11],0.0975852082791752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC9,Histone deacetylase 9,19446,57,0.61 [0.34-1.07],0.0863377557938484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDDC2,5'-deoxynucleotidase HDDC2,20029,58,1.01 [0.58-1.76],0.9759800906082728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGF,Hepatoma-derived growth factor,23327,71,1.10 [0.88-1.39],0.3960038564492617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGFL2,Hepatoma-derived growth factor-related protein 2,20044,58,0.94 [0.63-1.40],0.7517714833221244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEBP1,Heme-binding protein 1,22746,68,0.93 [0.60-1.43],0.7333121977475503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,19647,60,2.43 [1.01-5.85],0.0481043753304257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPACAM2,HEPACAM family member 2,20044,58,0.75 [0.42-1.33],0.3247700648843891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPH,Hephaestin,20092,59,1.17 [0.46-2.97],0.7450190722249302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEXIM1,Protein HEXIM1,23141,70,1.15 [0.88-1.49],0.3041141958453954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGF,Hepatocyte growth factor,23437,70,1.72 [0.99-3.00],0.0532353187331939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGFAC,Hepatocyte growth factor activator,19938,60,1.04 [0.42-2.60],0.9283205870348492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22619,68,1.07 [0.82-1.41],0.6076301658961911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HHEX,Hematopoietically-expressed homeobox protein HHEX,20044,58,1.05 [0.76-1.46],0.7533693260101377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIF1A,Hypoxia-inducible factor 1-alpha,19503,59,0.66 [0.38-1.15],0.1440500688316868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1,Huntingtin-interacting protein 1,19410,56,1.11 [0.54-2.31],0.77016189866311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,20005,58,1.36 [0.94-1.98],0.10752870262455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,20053,58,1.40 [0.86-2.29],0.1781070401787474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HK2,Hexokinase-2,22746,68,0.82 [0.37-1.82],0.6315459484444534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20053,58,0.67 [0.31-1.41],0.2870758136152906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23063,69,2.13 [1.31-3.46],0.0023098349297647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23141,70,1.62 [0.83-3.16],0.1611500824071295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMBS,Porphobilinogen deaminase,23366,71,0.94 [0.57-1.56],0.8162966823593021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMCN2,Hemicentin-2,19611,60,1.04 [0.68-1.60],0.8614638774552046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19543,57,0.94 [0.55-1.60],0.8202754196826562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19410,56,1.14 [0.66-1.97],0.6358902059657343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMMR,Hyaluronan mediated motility receptor,19356,57,0.87 [0.48-1.55],0.6271901903793007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX1,Heme oxygenase 1,22912,68,0.95 [0.61-1.47],0.8228540094132368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX2,Heme oxygenase 2,22655,70,1.15 [0.75-1.76],0.520990472817463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNF1A,Hepatocyte nuclear factor 1-alpha,19557,56,0.67 [0.40-1.15],0.1446355255061212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,22860,70,1.67 [1.09-2.55],0.0190605296535661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22668,68,1.03 [0.78-1.36],0.8285243875042728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20053,58,0.90 [0.53-1.52],0.6959733405274913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPCAL1,Hippocalcin-like protein 1,23437,70,1.30 [0.97-1.75],0.0813689776038795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPGDS,Hematopoietic prostaglandin D synthase,22619,68,1.00 [0.57-1.78],0.9881045671684664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPSE,Heparanase,19851,59,1.17 [0.90-1.52],0.2513473864494863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRAS,GTPase Hras,19711,59,1.01 [0.78-1.31],0.911609066645321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19543,57,1.13 [0.53-2.37],0.7557306999768348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRG,Histidine-rich glycoprotein,20015,60,0.89 [0.46-1.72],0.723722760683922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS1BP3,HCLS1-binding protein 3,19543,57,1.18 [0.89-1.56],0.2473398363421195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,23054,68,0.96 [0.54-1.70],0.882608386688249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23366,71,1.86 [1.27-2.72],0.0013194005318805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19503,59,1.42 [0.77-2.64],0.2610001922712334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSBP1,Heat shock factor-binding protein 1,19543,57,1.10 [0.84-1.43],0.5001420722864329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23141,70,0.88 [0.52-1.48],0.620550838476483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20044,58,1.37 [0.92-2.05],0.1234644223196011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19410,56,1.26 [0.79-2.01],0.3274969575890714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19543,57,0.79 [0.46-1.35],0.3849212302907651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,22546,70,1.34 [1.08-1.66],0.0076395601341955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA1A,Heat shock 70 kDa protein 1A,23203,71,1.15 [0.87-1.53],0.3263353125337476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA2,Heat shock-related 70 kDa protein 2,20022,60,1.58 [0.94-2.66],0.0843727136827096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB1,Heat shock protein beta-1,22808,68,1.10 [0.80-1.51],0.5463205491178237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB6,Heat shock protein beta-6,23366,71,1.23 [0.75-2.04],0.4104685147834657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23012,70,2.03 [1.04-3.98],0.0379246989238926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1A,5-hydroxytryptamine receptor 1A,19446,57,1.00 [0.70-1.42],0.9951813882664194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1B,5-hydroxytryptamine receptor 1B,19446,57,0.77 [0.39-1.51],0.4501294934373768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTRA2,"Serine protease HTRA2, mitochondrial",23228,70,1.28 [0.91-1.79],0.152712425964006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYAL1,Hyaluronidase-1,23067,70,1.44 [0.59-3.55],0.4245687704373873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYOU1,Hypoxia up-regulated protein 1,23457,69,0.82 [0.33-2.05],0.6719341359525268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICA1,Islet cell autoantigen 1,22757,70,1.17 [0.90-1.52],0.2327299170032704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM1,Intercellular adhesion molecule 1,23082,70,1.79 [0.90-3.55],0.0977583833590339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM2,Intercellular adhesion molecule 2,23457,69,0.84 [0.44-1.61],0.6023034504443177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM3,Intercellular adhesion molecule 3,23457,69,1.41 [0.67-3.00],0.36829719434475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM4,Intercellular adhesion molecule 4,23141,70,0.99 [0.66-1.48],0.948685997990114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM5,Intercellular adhesion molecule 5,23166,69,0.97 [0.62-1.52],0.898243021864718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICOSLG,ICOS ligand,23054,68,0.84 [0.27-2.58],0.7597657288258237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ID4,DNA-binding protein inhibitor ID-4,19747,59,0.91 [0.49-1.68],0.760475869323062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22655,70,0.86 [0.54-1.35],0.5074395135390504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDO1,"Indoleamine 2,3-dioxygenase 1",19543,57,0.92 [0.61-1.39],0.6981322311014515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDS,Iduronate 2-sulfatase,23437,70,4.78 [0.87-26.25],0.0714488800456148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDUA,Alpha-L-iduronidase,23366,71,0.85 [0.55-1.30],0.4454466985062878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19550,57,2.12 [1.27-3.54],0.0042766363356111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19747,59,1.47 [0.96-2.25],0.0763106910202915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19747,59,1.41 [0.80-2.49],0.2395098170016772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNAR1,Interferon alpha/beta receptor 1,20029,58,0.49 [0.22-1.12],0.0923963662541855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNG,Interferon gamma,22757,70,0.97 [0.81-1.16],0.7211544028330086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR1,Interferon gamma receptor 1,23248,71,1.41 [0.55-3.62],0.4808032342554391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR2,Interferon gamma receptor 2,22963,70,1.04 [0.70-1.54],0.8567587885201055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL1,Interferon lambda-1,22655,70,1.10 [0.70-1.74],0.6804604872380882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL2,Interferon lambda-2,19446,57,1.14 [0.79-1.65],0.4875747725768672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNLR1,Interferon lambda receptor 1,23141,70,1.11 [0.63-1.98],0.7151966841957527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNW1,Interferon omega-1,19410,56,1.13 [0.59-2.15],0.7143335809686177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFT20,Intraflagellar transport protein 20 homolog,19557,56,0.91 [0.49-1.69],0.7722872036161544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGBP1,Immunoglobulin-binding protein 1,20053,58,0.96 [0.63-1.45],0.8470827808267964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19446,57,1.36 [0.96-1.92],0.0797299074687113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20102,59,0.42 [0.21-0.83],0.0127604159598998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF1R,Insulin-like growth factor 1 receptor,23054,68,1.17 [0.44-3.12],0.7546119208763412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19410,56,0.53 [0.25-1.12],0.0948864082543156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2R,Cation-independent mannose-6-phosphate receptor,23180,69,1.20 [0.49-2.91],0.6943176312016075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP1,Insulin-like growth factor-binding protein 1,23424,69,1.02 [0.86-1.21],0.8382859942663652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP2,Insulin-like growth factor-binding protein 2,23422,69,0.89 [0.62-1.28],0.5349734178059975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,23274,70,0.54 [0.30-0.97],0.0391460183690228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP4,Insulin-like growth factor-binding protein 4,22904,68,0.98 [0.60-1.61],0.9468312807187286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP6,Insulin-like growth factor-binding protein 6,23087,70,1.34 [0.71-2.53],0.3591707517110845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,23457,69,1.69 [0.99-2.90],0.0541763541619849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBPL1,Insulin-like growth factor-binding protein-like 1,23166,69,1.66 [0.91-3.01],0.0974380500917129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFL4,Insulin growth factor-like family member 4,19503,59,1.12 [0.84-1.50],0.4383613190719996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGHMBP2,DNA-binding protein SMUBP-2,19410,56,0.86 [0.53-1.42],0.5660307492160472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLC2,Immunoglobulin lambda constant 2,20090,60,1.64 [0.90-2.98],0.1041579767659093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLON5,IgLON family member 5,19396,57,1.13 [0.90-1.41],0.2965949542460352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF21,Immunoglobulin superfamily member 21,19543,57,0.82 [0.42-1.62],0.5736047945063634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF3,Immunoglobulin superfamily member 3,23054,68,1.47 [0.91-2.39],0.1155606334381243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,23166,69,2.06 [1.17-3.60],0.0116224033103733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF9,Protein turtle homolog A,20092,59,1.24 [0.94-1.64],0.1287325116458685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKBKG,NF-kappa-B essential modulator,23141,70,1.22 [0.96-1.54],0.1036143543012543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,22619,68,0.61 [0.41-0.92],0.0182254056498274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10,Interleukin-10,22757,70,1.11 [0.87-1.42],0.4047403795224588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RA,Interleukin-10 receptor subunit alpha,22757,70,0.83 [0.53-1.30],0.4193451707071199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RB,Interleukin-10 receptor subunit beta,23248,71,1.55 [0.81-2.99],0.1887221861031206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL11,Interleukin-11,22757,70,0.92 [0.64-1.33],0.6555220950154836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12A_IL12B,Interleukin-12,23054,68,1.00 [0.76-1.32],0.9833721016465646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12B,Interleukin-12 subunit beta,23437,70,1.08 [0.74-1.57],0.6966735268102536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,22757,70,1.74 [1.01-3.00],0.044768370871049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB2,Interleukin-12 receptor subunit beta-2,19503,59,0.97 [0.52-1.82],0.9356977744767018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13,Interleukin-13,22757,70,1.10 [0.74-1.62],0.6362147070451339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA1,Interleukin-13 receptor subunit alpha-1,22876,70,1.45 [0.59-3.52],0.4149956350267951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA2,Interleukin-13 receptor subunit alpha-2,19446,57,1.03 [0.43-2.49],0.9465000014939088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15,Interleukin-15,23141,70,1.60 [0.87-2.92],0.1270986547492436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15RA,Interleukin-15 receptor subunit alpha,22757,70,1.55 [0.86-2.82],0.1471861358852974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL16,Pro-interleukin-16,23437,70,1.23 [0.80-1.91],0.3482233265576446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17A,Interleukin-17A,22712,68,0.78 [0.45-1.36],0.3808016543931043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17C,Interleukin-17C,22757,70,1.04 [0.77-1.39],0.8110457697953344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17D,Interleukin-17D,22757,70,1.28 [0.79-2.07],0.3122053515365925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17F,Interleukin-17F,22757,70,0.79 [0.55-1.12],0.1834868777055034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RA,Interleukin-17 receptor A,23180,69,1.39 [0.87-2.21],0.1682779808773819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RB,Interleukin-17 receptor B,22851,69,1.12 [0.76-1.67],0.566746239809508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18,Interleukin-18,23050,71,1.28 [0.82-2.00],0.2802080895982464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,23274,70,1.53 [0.81-2.88],0.1890356252088086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,23437,70,1.78 [0.96-3.29],0.0675630195829374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18RAP,Interleukin-18 receptor accessory protein,22816,70,1.00 [0.88-1.13],0.9794358359194176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL19,Interleukin-19,22588,68,0.95 [0.70-1.29],0.7537752313957577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1A,Interleukin-1 alpha,22757,70,1.12 [0.82-1.52],0.4820505758186594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1B,Interleukin-1 beta,22648,69,1.26 [0.91-1.74],0.1704207896457634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R1,Interleukin-1 receptor type 1,23138,69,1.08 [0.43-2.70],0.8759826853556867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R2,Interleukin-1 receptor type 2,23088,71,1.70 [0.60-4.86],0.3188957603730598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,23180,69,0.64 [0.39-1.06],0.0832062775370342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL1,Interleukin-1 receptor-like 1,23381,69,1.31 [0.83-2.07],0.2388447867715276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL2,Interleukin-1 receptor-like 2,22757,70,0.86 [0.50-1.50],0.603195921817481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RN,Interleukin-1 receptor antagonist protein,23091,71,1.36 [0.97-1.91],0.0705880274107014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,22757,70,1.42 [0.76-2.65],0.27505832915843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,22757,70,0.56 [0.32-0.99],0.0466397307668361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RA,Interleukin-20 receptor subunit alpha,22757,70,1.00 [0.62-1.61],0.9901538860400048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RB,Interleukin-20 receptor subunit beta,19503,59,0.97 [0.53-1.78],0.9325438713921972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL21R,Interleukin-21 receptor,19503,59,1.15 [0.78-1.70],0.4769418648000586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22,Interleukin-22,20022,60,0.89 [0.62-1.29],0.5457776639368548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22RA1,Interleukin-22 receptor subunit alpha-1,22757,70,0.94 [0.57-1.56],0.8049495281811504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL24,Interleukin-24,22757,70,0.96 [0.61-1.50],0.8471276101665419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL25,Interleukin-25,19325,57,1.14 [0.54-2.43],0.7302874909418766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RA,Interleukin-2 receptor subunit alpha,23022,67,1.35 [0.82-2.20],0.2341565408333762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RB,Interleukin-2 receptor subunit beta,22757,70,1.30 [0.78-2.15],0.3148650514519513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RG,Cytokine receptor common subunit gamma,20022,60,1.35 [0.75-2.42],0.3109617049530453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3,Interleukin-3,19396,57,1.25 [0.79-1.96],0.336361189838446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31,Interleukin-31,19503,59,0.80 [0.47-1.36],0.410242965413036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31RA,Interleukin-31 receptor subunit alpha,19436,59,0.98 [0.50-1.92],0.942886174096423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,23141,70,1.52 [1.00-2.31],0.0490444173558962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL33,Interleukin-33,22757,70,1.17 [0.68-2.00],0.5674914702414569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL34,Interleukin-34,22613,70,1.06 [0.58-1.94],0.8398021452787117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36A,Interleukin-36 alpha,19503,59,0.83 [0.50-1.38],0.4794657423313038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36G,Interleukin-36 gamma,19436,59,0.99 [0.68-1.43],0.9467065498435412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3RA,Interleukin-3 receptor subunit alpha,22757,70,1.57 [0.83-2.95],0.1615557562251437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4,Interleukin-4,22757,70,1.25 [0.94-1.65],0.1216307588396901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,23141,70,1.59 [0.94-2.71],0.0855949104636099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,22757,70,0.97 [0.83-1.14],0.728380926911903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,23141,70,1.41 [1.00-1.99],0.0500976323059571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6,Interleukin-6,23054,68,0.86 [0.63-1.17],0.3364074416363408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6R,Interleukin-6 receptor subunit alpha,23053,70,1.35 [0.73-2.49],0.3326892677993512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6ST,Interleukin-6 receptor subunit beta,23166,69,1.13 [0.33-3.84],0.84539234070842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7,Interleukin-7,23141,70,1.26 [0.91-1.73],0.1571944672746435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7R,Interleukin-7 receptor subunit alpha,23180,69,0.90 [0.60-1.35],0.6106916826079871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL9,Interleukin-9,19747,59,1.11 [0.73-1.69],0.6312545096631126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22614,70,1.08 [0.75-1.54],0.6855391395948962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,20022,60,1.65 [1.11-2.46],0.0130658706247815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPA1,Inositol monophosphatase 1,22963,70,1.15 [0.81-1.62],0.4402521784249252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPACT,Protein IMPACT,20044,58,0.99 [0.63-1.57],0.9818483713581144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPG1,Interphotoreceptor matrix proteoglycan 1,19446,57,1.01 [0.43-2.37],0.9779981730171252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ING1,Inhibitor of growth protein 1,22622,70,1.01 [0.65-1.58],0.9484382496811556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,19647,60,1.52 [0.99-2.35],0.0570793663906408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBC,Inhibin beta C chain,23180,69,1.56 [0.89-2.72],0.1196700257170527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP1,Inositol polyphosphate 1-phosphatase,23054,68,1.17 [0.80-1.73],0.4176421601947013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19543,57,0.99 [0.63-1.54],0.95221493894418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20053,58,0.64 [0.32-1.30],0.219458232941745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",23054,68,1.21 [0.97-1.51],0.0884735026447766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL3,Insulin-like 3,20044,58,0.89 [0.68-1.16],0.3927988536019324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL4,Early placenta insulin-like peptide,20022,60,1.23 [0.79-1.92],0.3496640789692373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL5,Insulin-like peptide INSL5,20029,58,1.12 [0.88-1.43],0.3465002794742546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSR,Insulin receptor,19503,59,0.96 [0.22-4.25],0.9561408866873612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,22923,70,1.29 [1.02-1.64],0.036022127655673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IQGAP2,Ras GTPase-activating-like protein IQGAP2,23054,68,1.38 [0.95-1.99],0.0889720585943831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22746,68,1.07 [0.85-1.36],0.5545507711859534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK1,Interleukin-1 receptor-associated kinase 1,22757,70,1.10 [0.81-1.48],0.551352673044012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK4,Interleukin-1 receptor-associated kinase 4,23141,70,1.19 [0.96-1.47],0.103484044595355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22327,69,1.00 [0.57-1.77],0.9896523401045236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM1,Isthmin-1,23141,70,1.03 [0.61-1.72],0.9179352147530816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM2,Isthmin-2,20102,59,1.34 [0.86-2.09],0.1926315281170094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IST1,IST1 homolog,19875,58,1.06 [0.81-1.37],0.6842876993996474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,23141,70,0.45 [0.25-0.84],0.0114622031766454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA2,Integrin alpha-2,19647,60,1.05 [0.51-2.14],0.9032465751073868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA5,Integrin alpha-5,23180,69,1.23 [0.52-2.89],0.6355224601505435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA6,Integrin alpha-6,23141,70,1.24 [0.85-1.82],0.2690686787875008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAL,Integrin alpha-L,19503,59,0.96 [0.54-1.70],0.8859720805037535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAM,Integrin alpha-M,23180,69,1.10 [0.57-2.13],0.7848135389520068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,23366,71,0.31 [0.09-1.04],0.0572391127462211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAX,Integrin alpha-X,19747,59,0.80 [0.48-1.34],0.3945785723373686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,23162,70,0.98 [0.36-2.70],0.9661103395754044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP1,Integrin beta-1-binding protein 1,22619,68,0.86 [0.50-1.47],0.5832903671058198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP2,Integrin beta-1-binding protein 2,22746,68,1.06 [0.88-1.29],0.528055006647294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB2,Integrin beta-2,23055,69,0.90 [0.42-1.92],0.7914704061959195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,23228,70,1.46 [0.88-2.44],0.1434899638854461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB6,Integrin beta-6,22757,70,0.88 [0.44-1.76],0.7131200006660299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB7,Integrin beta-7,23366,71,1.22 [0.79-1.89],0.3669589073050423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,20102,59,1.60 [0.89-2.86],0.1137583335205767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20117,60,0.92 [0.24-3.54],0.8983021955774396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23274,70,1.61 [0.92-2.81],0.0923335569042714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20117,60,1.13 [0.45-2.87],0.7935321264456502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20022,60,0.60 [0.31-1.14],0.1197102000756671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITM2A,Integral membrane protein 2A,23141,70,1.22 [0.87-1.71],0.2544265052982473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPA,Inosine triphosphate pyrophosphatase,19410,56,0.93 [0.63-1.37],0.725157069711784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19543,57,1.18 [0.85-1.65],0.3176855415093405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19446,57,1.16 [0.68-1.96],0.5898113319788753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22655,70,0.73 [0.46-1.14],0.1648220007044555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IZUMO1,Izumo sperm-egg fusion protein 1,19396,57,1.25 [0.81-1.95],0.3137780033337242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM2,Junctional adhesion molecule B,23375,71,1.54 [0.74-3.23],0.2507011598729907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM3,Junctional adhesion molecule C,19647,60,1.33 [0.85-2.10],0.2120179308930891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JCHAIN,Immunoglobulin J chain,22757,70,0.91 [0.64-1.28],0.5873375776623233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19396,57,0.79 [0.48-1.32],0.3739447300225652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JPT2,Jupiter microtubule associated homolog 2,20029,58,1.10 [0.83-1.47],0.5012739808094525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JUN,Transcription factor AP-1,22757,70,0.65 [0.37-1.14],0.1344679560431675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,23054,68,0.96 [0.60-1.55],0.8725339000935188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZN,Kazrin,20029,58,1.09 [0.86-1.39],0.481918937062332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNC4,Potassium voltage-gated channel subfamily C member 4,19446,57,0.96 [0.59-1.56],0.8693995358792161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNH2,Potassium voltage-gated channel subfamily H member 2,19557,56,1.14 [0.84-1.53],0.4013930807175303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,22655,70,0.81 [0.49-1.33],0.4014211292943501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCTD5,BTB/POZ domain-containing protein KCTD5,19662,57,0.93 [0.53-1.65],0.8042655812668733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDM3A,Lysine-specific demethylase 3A,19503,59,0.83 [0.57-1.21],0.3320394921422507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDR,Vascular endothelial growth factor receptor 2,23228,70,0.74 [0.33-1.66],0.4651984052350574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KEL,Kell blood group glycoprotein,22655,70,1.36 [0.76-2.42],0.299843658183119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHDC3L,KH domain-containing protein 3,19396,57,1.06 [0.75-1.50],0.7411980749782852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHK,Ketohexokinase,19543,57,1.11 [0.74-1.67],0.6146377968887449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA0319,Dyslexia-associated protein KIAA0319,20044,58,1.31 [0.61-2.80],0.4861004820553999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549,UPF0606 protein KIAA1549,19747,59,1.36 [0.99-1.86],0.061761526420299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549L,UPF0606 protein KIAA1549L,19747,59,0.75 [0.29-1.92],0.5437432107962105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA2013,Uncharacterized protein KIAA2013,20022,60,0.89 [0.52-1.50],0.6543143536764546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF1C,Kinesin-like protein KIF1C,19410,56,0.73 [0.30-1.75],0.4766392764941218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF20B,Kinesin-like protein KIF20B,19446,57,0.91 [0.63-1.31],0.6154945758077894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,19410,56,1.43 [1.14-1.80],0.0021202451247746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIFBP,KIF-binding protein,23054,68,1.08 [0.84-1.39],0.558757708511407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20022,60,1.06 [0.81-1.40],0.6548155315904889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22619,68,1.17 [0.89-1.53],0.2571643285392847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20029,58,0.93 [0.80-1.08],0.3352380424257141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22619,68,0.96 [0.81-1.14],0.6548123659856311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19396,57,1.14 [0.88-1.46],0.3233380115177979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL1,Kin of IRRE-like protein 1,19446,57,1.15 [0.78-1.68],0.4805849592053952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL2,Kin of IRRE-like protein 2,22655,70,1.18 [0.71-1.97],0.5166416684913748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIT,Mast/stem cell growth factor receptor Kit,23240,70,1.05 [0.51-2.14],0.896274475255323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,23166,69,0.56 [0.33-0.96],0.0351768481480963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLB,Beta-klotho,22655,70,1.11 [0.84-1.47],0.4650264583193927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLF4,Krueppel-like factor 4,19446,57,1.24 [0.72-2.14],0.4376860508550075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLHL41,Kelch-like protein 41,20053,58,0.68 [0.38-1.21],0.1879879539231217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK1,Kallikrein-1,22953,69,1.03 [0.88-1.21],0.726562569263652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK10,Kallikrein-10,23164,70,0.89 [0.52-1.50],0.6487505371363711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK11,Kallikrein-11,23009,70,1.54 [0.90-2.62],0.1133735873478065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,22619,68,0.85 [0.73-1.00],0.0465043111087125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK13,Kallikrein-13,22632,68,0.85 [0.53-1.37],0.5045690194617358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK14,Kallikrein-14,23366,71,1.00 [0.64-1.55],0.9884129547265396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK15,Kallikrein-15,19981,59,1.16 [0.71-1.89],0.5444777269218671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK3,Prostate-specific antigen,20102,59,0.91 [0.74-1.13],0.4105407884019417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK4,Kallikrein-4,23366,71,0.97 [0.70-1.36],0.8705909605747627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK6,Kallikrein-6,23186,70,1.66 [0.84-3.25],0.1429790448087678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK7,Kallikrein-7,19162,58,1.22 [0.67-2.23],0.5120442132910137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK8,Kallikrein-8,22382,69,1.05 [0.58-1.88],0.8796954249551185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLKB1,Plasma kallikrein,19706,58,1.23 [0.45-3.38],0.6889947270534957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23437,70,1.41 [0.84-2.36],0.1890433706536357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19446,57,0.82 [0.49-1.35],0.430185573008377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,23437,70,1.10 [0.71-1.70],0.677326909989631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19503,59,1.12 [0.71-1.75],0.6339152884355489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRK1,NKG2-D type II integral membrane protein,20044,58,1.25 [0.74-2.12],0.4110512128121252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT14,"Keratin, type I cytoskeletal 14",21967,68,0.58 [0.25-1.36],0.210440875291026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT17,"Keratin, type I cytoskeletal 17",19410,56,0.80 [0.39-1.61],0.5251522472587357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",23054,68,1.30 [1.03-1.65],0.0277049842632304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT19,"Keratin, type I cytoskeletal 19",23098,70,1.04 [0.77-1.42],0.7877223871958235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT5,"Keratin, type II cytoskeletal 5",22655,70,1.03 [0.68-1.55],0.8899742993830771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT6C,"Keratin, type II cytoskeletal 6C",19410,56,0.83 [0.39-1.81],0.6476930677808532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",19446,57,1.37 [1.11-1.69],0.0031364530380643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYAT1,Kynurenine--oxoglutarate transaminase 1,23131,69,1.17 [0.81-1.68],0.396744689325105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYNU,Kynureninase,23437,70,1.46 [0.93-2.28],0.1004140077850496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L1CAM,Neural cell adhesion molecule L1,23228,70,0.91 [0.45-1.83],0.7815899310828224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20092,59,1.12 [0.85-1.48],0.4065975164024017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACRT,Extracellular glycoprotein lacritin,19983,59,0.80 [0.44-1.48],0.4857898332129021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACTB2,Endoribonuclease LACTB2,23166,69,1.20 [0.88-1.65],0.2495373360349755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAG3,Lymphocyte activation gene 3 protein,23054,68,1.23 [0.75-2.01],0.4171809002930541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23129,71,1.38 [0.93-2.03],0.1059086751763233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22963,70,1.05 [0.86-1.29],0.620646305057015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA1,Laminin subunit alpha-1,19410,56,1.17 [0.76-1.80],0.4737955377220504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA4,Laminin subunit alpha-4,23248,71,1.62 [0.90-2.92],0.1070890201225761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMB1,Laminin subunit beta-1,19543,57,1.25 [0.54-2.89],0.5977766210707611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP1,Lysosome-associated membrane glycoprotein 1,19553,57,0.60 [0.20-1.81],0.363728574927335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP2,Lysosome-associated membrane glycoprotein 2,22462,62,0.77 [0.26-2.26],0.6398986206929523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,23399,69,1.24 [0.84-1.82],0.2772306778720484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMTOR5,Ragulator complex protein LAMTOR5,20022,60,0.73 [0.37-1.42],0.354342911300804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAP3,Cytosol aminopeptidase,22757,70,0.98 [0.63-1.52],0.925782795986824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LARP1,La-related protein 1,20022,60,0.97 [0.65-1.46],0.9000924960429239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT,Linker for activation of T-cells family member 1,23437,70,1.24 [0.93-1.65],0.1401635274476746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT2,Linker for activation of T-cells family member 2,23054,68,1.09 [0.92-1.29],0.3240330058892348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LATS1,Serine/threonine-protein kinase LATS1,19503,59,1.00 [0.75-1.34],0.995061398854268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAYN,Layilin,22930,70,1.45 [0.83-2.54],0.1961496551118722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,23274,70,1.20 [0.84-1.71],0.3182663985174037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBR,Delta(14)-sterol reductase LBR,23375,71,1.08 [0.81-1.43],0.614289161425897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCAT,Phosphatidylcholine-sterol acyltransferase,20118,60,2.00 [0.63-6.39],0.242146341804658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN15,Lipocalin-15,20053,58,0.83 [0.53-1.30],0.4198650244919225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN2,Neutrophil gelatinase-associated lipocalin,22475,70,1.18 [0.70-1.97],0.5385682473672921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCP1,Plastin-2,20102,59,1.05 [0.63-1.73],0.8566910314401905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLR,Low-density lipoprotein receptor,23237,68,1.01 [0.66-1.54],0.9623901509858792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLRAP1,Low density lipoprotein receptor adapter protein 1,20053,58,1.14 [0.89-1.47],0.2971154342254508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,20092,59,1.83 [1.35-2.48],8.666206324609765e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEFTY2,Left-right determination factor 2,23340,71,1.02 [0.68-1.53],0.9223667194618776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,19000,59,1.37 [0.99-1.88],0.0548467144559659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LELP1,Late cornified envelope-like proline-rich protein 1,19446,57,0.96 [0.66-1.40],0.8369482905652886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEO1,RNA polymerase-associated protein LEO1,20053,58,0.97 [0.41-2.29],0.9536066791098216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEP,Leptin,23166,69,1.02 [0.75-1.37],0.9180531752222666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEPR,Leptin receptor,23166,69,0.92 [0.47-1.83],0.8213207863955587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LETM1,Mitochondrial proton/calcium exchanger protein,20053,58,1.17 [0.75-1.83],0.4828240019503094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,23166,69,1.87 [1.11-3.16],0.019517057342474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3,Galectin-3,23239,68,1.00 [0.49-2.05],0.997898971588506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3BP,Galectin-3-binding protein,20117,60,1.03 [0.47-2.29],0.9325622396840544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,23129,71,1.30 [0.91-1.85],0.1517426092264824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,23101,71,1.47 [0.99-2.18],0.0560675171968766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS8,Galectin-8,23375,71,1.21 [0.86-1.68],0.2726630630198173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,23137,71,1.69 [0.91-3.17],0.0988682157799311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,23248,71,1.71 [0.98-2.98],0.0566641492693498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHB,Lutropin subunit beta,22619,68,0.99 [0.78-1.27],0.954660227867984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,23166,71,1.14 [0.81-1.60],0.4561575006257923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,22655,70,0.54 [0.32-0.89],0.0165107719349029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,23141,70,1.70 [0.73-3.96],0.2168844663002973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23180,69,0.97 [0.55-1.70],0.9026501052336834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20102,59,1.28 [0.95-1.73],0.1015917631872069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19410,56,1.03 [0.62-1.71],0.9080060093922734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23136,69,1.40 [0.74-2.64],0.3045879831666569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20092,59,0.97 [0.70-1.34],0.8502024645784867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23457,69,2.35 [1.11-4.99],0.0254387533117087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23346,69,2.15 [1.13-4.08],0.0188888738123986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22757,70,1.87 [1.20-2.91],0.0054407605609647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23457,69,0.99 [0.73-1.33],0.9269033251448467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIPF,Gastric triacylglycerol lipase,19543,57,1.04 [0.69-1.56],0.8642274400528781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB1,Lamin-B1,19994,58,0.79 [0.52-1.21],0.276344496048776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,20044,58,1.77 [0.80-3.89],0.1579112178151175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD1,Leiomodin-1,20053,58,1.42 [0.77-2.62],0.2551033966039038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD2,Leiomodin-2,19446,57,1.26 [0.87-1.81],0.2211874410404451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LONP1,"Lon protease homolog, mitochondrial",19543,57,1.17 [0.88-1.56],0.2682163459651449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPA,Apolipoprotein(a),19663,60,0.96 [0.83-1.10],0.5312360574134181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPCAT2,Lysophosphatidylcholine acyltransferase 2,23054,68,1.17 [0.79-1.73],0.4304706090217599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPL,Lipoprotein lipase,23166,69,0.77 [0.51-1.17],0.221395028797787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,22347,68,1.45 [1.04-2.03],0.0279233981064156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPP,Lipoma-preferred partner,19410,56,1.10 [0.75-1.62],0.6226717357639883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19410,56,0.97 [0.67-1.42],0.8805447609862902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19557,56,1.25 [0.78-2.01],0.3518131430090595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRG1,Leucine-rich alpha-2-glycoprotein,20117,60,1.15 [0.45-2.90],0.7682929475185698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23304,70,0.94 [0.53-1.69],0.8492930447875222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19444,59,0.67 [0.24-1.83],0.4306478119071374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP1,Prolow-density lipoprotein receptor-related protein 1,23054,68,0.59 [0.26-1.38],0.2236886269238125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP11,Low-density lipoprotein receptor-related protein 11,23166,69,1.23 [0.70-2.16],0.4699235001021601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2,Low-density lipoprotein receptor-related protein 2,19557,56,1.22 [0.65-2.30],0.5399444951369718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2BP,LRP2-binding protein,19557,56,0.82 [0.55-1.23],0.3337692460295243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23375,71,1.06 [0.74-1.52],0.738070002830195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC25,Leucine-rich repeat-containing protein 25,23054,68,1.24 [0.79-1.93],0.352673729715604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC37A2,Leucine-rich repeat-containing protein 37A2,20029,58,1.40 [0.79-2.49],0.252741783542058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,19557,56,1.53 [0.99-2.36],0.0563248999542366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC59,Leucine-rich repeat-containing protein 59,20092,59,0.81 [0.47-1.40],0.4505694856465314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20022,60,0.93 [0.55-1.57],0.7958000951990083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRN1,Leucine-rich repeat neuronal protein 1,22757,70,1.14 [0.67-1.93],0.6353250967449726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19557,56,0.95 [0.50-1.80],0.8736970699768913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20053,58,0.73 [0.27-2.01],0.544078818680942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM1,U6 snRNA-associated Sm-like protein LSm1,22619,68,0.90 [0.59-1.36],0.6137541437404943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM8,U6 snRNA-associated Sm-like protein LSm8,19747,59,1.19 [0.93-1.52],0.1650638463880498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSP1,Lymphocyte-specific protein 1,23141,70,1.17 [0.71-1.93],0.5489475402006814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA,Lymphotoxin-alpha,23141,70,0.93 [0.54-1.60],0.7879571927902762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA4H,Leukotriene A-4 hydrolase,23366,71,1.01 [0.71-1.43],0.9571783336239372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTB,Lymphotoxin-beta,20022,60,0.89 [0.41-1.90],0.7565360557643644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,23457,69,1.66 [0.87-3.17],0.1262622010883964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,22619,68,1.18 [0.84-1.67],0.3291253694166289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBR,Tumor necrosis factor receptor superfamily member 3,23009,71,0.86 [0.41-1.78],0.6789565982011339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTO1,Protein LTO1 homolog,22757,70,1.18 [0.75-1.85],0.4640744865719529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LUZP2,Leucine zipper protein 2,20022,60,1.15 [0.70-1.91],0.5762314046164605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LXN,Latexin,22850,70,0.95 [0.69-1.29],0.7282544827889528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY6D,Lymphocyte antigen 6D,23018,71,1.37 [0.83-2.26],0.2147652500808396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY75,Lymphocyte antigen 75,23141,70,1.19 [0.69-2.06],0.5326262364812704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY9,T-lymphocyte surface antigen Ly-9,22877,68,1.39 [0.70-2.77],0.3429508936812599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY96,Lymphocyte antigen 96,22963,70,1.22 [0.70-2.12],0.4769092982621242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYAR,Cell growth-regulating nucleolar protein,22619,68,1.05 [0.73-1.51],0.7924315394152395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYN,Tyrosine-protein kinase Lyn,23054,68,1.13 [0.87-1.45],0.3577238894258943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD1,Ly6/PLAUR domain-containing protein 1,22655,70,0.64 [0.38-1.08],0.0977342393458083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD3,Ly6/PLAUR domain-containing protein 3,23052,70,0.95 [0.51-1.76],0.8634846510794023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD8,Ly6/PLAUR domain-containing protein 8,22619,68,1.18 [0.87-1.59],0.2952801173860276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPLA2,Acyl-protein thioesterase 2,19446,57,1.03 [0.83-1.30],0.7674929375429898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19557,56,1.01 [0.79-1.30],0.9119780094398338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20117,60,0.74 [0.20-2.68],0.6447729798433073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYZL2,Lysozyme-like protein 2,19396,57,1.11 [0.57-2.18],0.750594016137068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LZTFL1,Leucine zipper transcription factor-like protein 1,19647,60,1.19 [0.85-1.68],0.3061307082902062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,M6PR,Cation-dependent mannose-6-phosphate receptor,19543,57,1.27 [0.73-2.20],0.3923169771574447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22890,70,1.30 [0.95-1.77],0.0993161160533046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAEA,E3 ubiquitin-protein transferase MAEA,22619,68,0.62 [0.34-1.16],0.1346267460198482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAG,Myelin-associated glycoprotein,19557,56,1.18 [0.69-2.00],0.5413065388301603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGEA3,Melanoma-associated antigen 3,19747,59,0.89 [0.70-1.14],0.3596554925537104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGED1,Melanoma-associated antigen D1,22619,68,0.95 [0.61-1.49],0.831517080545601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC2,MAM domain-containing protein 2,20092,59,1.54 [0.78-3.01],0.2109142857228716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC4,Apical endosomal glycoprotein,20022,60,1.16 [0.77-1.76],0.476722189829096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19543,57,1.21 [0.44-3.27],0.7130804544585578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN2B2,Epididymis-specific alpha-mannosidase,20092,59,0.84 [0.55-1.27],0.4132502329253661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19396,57,0.89 [0.53-1.47],0.6402237127494308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANF,Mesencephalic astrocyte-derived neurotrophic factor,23248,71,1.11 [0.92-1.33],0.2702974371960223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC1,MANSC domain-containing protein 1,23228,70,0.98 [0.46-2.10],0.9627417777707216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC4,MANSC domain-containing protein 4,19410,56,1.34 [0.95-1.88],0.0936319331602111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19446,57,1.48 [0.68-3.21],0.3222836795922877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19410,56,1.00 [0.67-1.49],0.9999696140776896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2,Microtubule-associated protein 2,20044,58,0.99 [0.57-1.70],0.9687467990995936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20029,58,0.99 [0.67-1.47],0.9767667398722532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,23141,70,1.10 [0.88-1.36],0.4041825929227377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22619,68,0.97 [0.77-1.21],0.7738219502829781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22930,70,1.14 [0.94-1.38],0.175927515317366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK13,Mitogen-activated protein kinase 13,19396,57,1.37 [0.85-2.19],0.1925753239149532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK9,Mitogen-activated protein kinase 9,23141,70,1.43 [0.88-2.32],0.1476259631101873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPKAPK2,MAP kinase-activated protein kinase 2,19747,59,0.97 [0.69-1.37],0.8819811369238668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPRE3,Microtubule-associated protein RP/EB family member 3,19396,57,0.94 [0.76-1.15],0.5262148376156703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPT,Microtubule-associated protein tau,22655,70,0.89 [0.60-1.32],0.5610909980236856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARCO,Macrophage receptor MARCO,23166,69,1.60 [0.71-3.60],0.2563825273025772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARS1,"Methionine--tRNA ligase, cytoplasmic",19615,60,1.14 [0.86-1.53],0.3630391785187722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MASP1,Mannan-binding lectin serine protease 1,22930,70,1.26 [0.51-3.17],0.6159167581909789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,23165,71,1.71 [0.85-3.44],0.1358118986071581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN3,Matrilin-3,22923,70,0.84 [0.44-1.58],0.5827602559634548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAVS,Mitochondrial antiviral-signaling protein,22619,68,1.00 [0.79-1.27],0.9827084648470552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAX,Protein max,22655,70,1.18 [0.97-1.44],0.0959851368899586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MB,Myoglobin,23457,69,1.11 [0.77-1.60],0.5636578885402166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MBL2,Mannose-binding protein C,19838,60,1.01 [0.81-1.26],0.925725646090388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCAM,Cell surface glycoprotein MUC18,23274,70,1.13 [0.59-2.17],0.7026078216390148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20053,58,0.80 [0.41-1.55],0.5078852290467177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEMP1,Mast cell-expressed membrane protein 1,19503,59,1.05 [0.80-1.40],0.709348836966603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCFD2,Multiple coagulation factor deficiency protein 2,23047,69,1.53 [0.97-2.42],0.0687479743117124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCTS1,Malignant T-cell-amplified sequence 1,20029,58,0.70 [0.25-1.97],0.5030709888655325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22963,70,1.08 [0.79-1.47],0.6395709671296685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDH1,"Malate dehydrogenase, cytoplasmic",20013,60,1.24 [0.68-2.26],0.4789696225622053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,23151,70,1.39 [0.98-1.98],0.0648968256970397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDM1,Nuclear protein MDM1,19557,56,0.89 [0.38-2.07],0.7812682980402856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19543,57,1.05 [0.80-1.39],0.7196903040312999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED18,Mediator of RNA polymerase II transcription subunit 18,22619,68,1.14 [0.86-1.50],0.3758614230052089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED21,Mediator of RNA polymerase II transcription subunit 21,19410,56,1.05 [0.63-1.75],0.8410326155523968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF10,Multiple epidermal growth factor-like domains protein 10,23129,71,1.01 [0.60-1.72],0.9605509214406356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF11,Multiple epidermal growth factor-like domains protein 11,19410,56,1.18 [0.56-2.47],0.6625946753582503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF9,Multiple epidermal growth factor-like domains protein 9,23381,69,0.90 [0.30-2.71],0.8534200518452827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MELTF,Melanotransferrin,20092,59,0.99 [0.44-2.22],0.9831548152502538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MENT,Protein MENT,19647,60,0.47 [0.17-1.31],0.1493971854179523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1A,Meprin A subunit alpha,20029,58,1.06 [0.76-1.47],0.7284463307904109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1B,Meprin A subunit beta,23166,69,1.07 [0.89-1.30],0.4707414663370555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEPE,Matrix extracellular phosphoglycoprotein,23129,71,0.64 [0.28-1.44],0.2806431982553339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MERTK,Tyrosine-protein kinase Mer,23437,70,1.19 [0.51-2.75],0.686921618111533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MESD,LRP chaperone MESD,23180,69,1.10 [0.92-1.30],0.3012307215334086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MET,Hepatocyte growth factor receptor,23232,69,0.77 [0.26-2.29],0.6373148660162289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1,Methionine aminopeptidase 1,22655,70,0.51 [0.23-1.11],0.0885118546387088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",23141,70,1.16 [0.90-1.49],0.2524458633565864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP2,Methionine aminopeptidase 2,23340,71,1.31 [0.89-1.92],0.1701715149017766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3,Microfibril-associated glycoprotein 3,22746,68,1.12 [0.75-1.69],0.5739142409709188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,19557,56,0.48 [0.24-0.94],0.0316416944794396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,19647,60,1.91 [0.91-4.02],0.0874827085017147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP5,Microfibrillar-associated protein 5,23457,69,0.96 [0.57-1.63],0.8862084064165978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,23180,69,1.30 [0.81-2.06],0.2733346035257609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGLL,Monoglyceride lipase,23212,71,1.14 [0.89-1.46],0.2922805582359198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGMT,Methylated-DNA--protein-cysteine methyltransferase,23141,70,1.20 [1.00-1.45],0.0519638976727801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIA,Melanoma-derived growth regulatory protein,23228,70,1.43 [0.84-2.44],0.1842328760921474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICALL2,MICAL-like protein 2,19557,56,0.99 [0.68-1.44],0.9478463909014568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,23141,70,1.06 [0.91-1.24],0.4390121373297189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIF,Macrophage migration inhibitory factor,23134,69,1.18 [0.85-1.62],0.3213265698113415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MILR1,Allergin-1,22757,70,1.33 [0.89-1.98],0.158899566183665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20022,60,1.11 [0.88-1.40],0.3675786296336761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINK1,Misshapen-like kinase 1,20044,58,0.96 [0.73-1.25],0.7411711490291906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MITD1,MIT domain-containing protein 1,22963,70,1.09 [0.88-1.36],0.4265633341325326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MKI67,Proliferation marker protein Ki-67,19503,59,0.63 [0.28-1.39],0.2512485185216956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLLT1,Protein ENL,19396,57,0.73 [0.46-1.16],0.1773321972454755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLN,Promotilin,23141,70,0.91 [0.72-1.15],0.4510546876507805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,23054,68,1.40 [1.08-1.80],0.0098187538165951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,22390,66,1.21 [0.94-1.55],0.1406400911019209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP10,Stromelysin-2,23086,70,1.18 [0.83-1.68],0.3660726342164125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,23198,70,1.49 [1.04-2.13],0.028324155979765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP13,Collagenase 3,22655,70,0.78 [0.40-1.51],0.4648849054511229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP15,Matrix metalloproteinase-15,20092,59,0.60 [0.28-1.30],0.1973414097317487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP3,Stromelysin-1,23180,69,0.98 [0.64-1.51],0.929459911385992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP7,Matrilysin,22714,68,1.35 [0.86-2.11],0.1880444523448144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP8,Neutrophil collagenase,23338,71,1.16 [0.88-1.53],0.2902504927137802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP9,Matrix metalloproteinase-9,23145,69,1.13 [0.80-1.59],0.5024787124385782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19410,56,0.96 [0.57-1.62],0.8702091223089374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,19557,56,1.00 [0.63-1.58],0.9970463872895592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNAT1,CDK-activating kinase assembly factor MAT1,19747,59,0.91 [0.50-1.66],0.7669223473359927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNDA,Myeloid cell nuclear differentiation antigen,23130,69,1.02 [0.83-1.25],0.8551374414062343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOCS2,Molybdopterin synthase catalytic subunit,19647,60,1.20 [0.83-1.72],0.3300041289959902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOG,Myelin-oligodendrocyte glycoprotein,23366,71,1.17 [0.63-2.16],0.6222214466032565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORC3,MORC family CW-type zinc finger protein 3,20044,58,0.73 [0.27-2.00],0.5434478415374939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L1,Mortality factor 4-like protein 1,19747,59,0.86 [0.43-1.72],0.6743599634455157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L2,Mortality factor 4-like protein 2,19396,57,0.66 [0.29-1.50],0.3202852106676906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORN4,MORN repeat-containing protein 4,19396,57,0.71 [0.46-1.08],0.1107831875662802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPHOSPH8,M-phase phosphoprotein 8,22746,68,1.17 [0.89-1.53],0.254263233200243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPI,Mannose-6-phosphate isomerase,23054,68,1.10 [0.86-1.40],0.4635263169659976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,23212,71,1.33 [0.98-1.80],0.065738539999452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPO,Myeloperoxidase,23180,69,1.00 [0.63-1.57],0.9848065029650992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPRIP,Myosin phosphatase Rho-interacting protein,19990,59,0.69 [0.39-1.25],0.2208383936481328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,20118,60,2.99 [1.38-6.47],0.0053838049609624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRI1,Methylthioribose-1-phosphate isomerase,19557,56,1.17 [0.79-1.73],0.4381992889730812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL24,"39S ribosomal protein L24, mitochondrial",19410,56,0.49 [0.21-1.14],0.0966838592576378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL28,"39S ribosomal protein L28, mitochondrial",20053,58,0.89 [0.42-1.91],0.7730420911083036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL46,"39S ribosomal protein L46, mitochondrial",22655,70,0.55 [0.23-1.29],0.1701160822550902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL52,"39S ribosomal protein L52, mitochondrial",19356,57,1.17 [0.52-2.67],0.7011375825540656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20053,58,1.18 [0.86-1.62],0.302402977749717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPS16,"28S ribosomal protein S16, mitochondrial",19503,59,0.31 [0.09-1.07],0.0631139734991804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLN,Mesothelin,23014,68,1.11 [0.79-1.57],0.5406775725191417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLNL,Mesothelin-like protein,19557,56,0.64 [0.30-1.39],0.2601585064268524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSMB,Beta-microseminoprotein,23145,69,1.24 [0.92-1.68],0.157041871621844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,23375,71,1.87 [1.21-2.87],0.0044853358453995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSRA,Mitochondrial peptide methionine sulfoxide reductase,23228,70,1.20 [0.90-1.60],0.2245018974462969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MST1,Hepatocyte growth factor-like protein,19824,59,1.55 [0.88-2.72],0.1255801177365276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSTN,Growth/differentiation factor 8,22746,68,1.25 [0.84-1.84],0.2684779399981392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTDH,Protein LYRIC,19503,59,1.10 [0.85-1.43],0.463679768176403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20044,58,0.93 [0.33-2.62],0.8976856778586068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19747,59,1.07 [0.86-1.33],0.5458702621726158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTIF3,"Translation initiation factor IF-3, mitochondrial",20029,58,0.98 [0.74-1.31],0.9114607376379352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTPN,Myotrophin,22746,68,0.92 [0.47-1.82],0.8148842988913881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTR,Methionine synthase,19410,56,0.73 [0.44-1.20],0.2127779734021854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS1,Protein MTSS 1,20029,58,1.03 [0.82-1.29],0.8016055559521522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS2,Protein MTSS 2,20022,60,1.19 [0.94-1.52],0.1531614616651104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,19747,59,1.22 [0.80-1.85],0.3485886082061283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC13,Mucin-13,22655,70,1.22 [0.82-1.81],0.336513253389762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC16,Mucin-16,23054,68,1.06 [0.94-1.20],0.3247998327576423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC2,Mucin-2,20102,59,0.98 [0.75-1.27],0.8608968829903751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUCL3,Mucin-like protein 3,19396,57,0.83 [0.41-1.67],0.6020343878183737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,22757,70,1.36 [1.07-1.72],0.0112906782222414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MXRA8,Matrix remodeling-associated protein 8,19647,60,0.69 [0.31-1.56],0.3751608903964899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC1,"Myosin-binding protein C, slow-type",20092,59,1.12 [0.82-1.52],0.4913249916055298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC2,"Myosin-binding protein C, fast-type",19543,57,1.11 [0.85-1.46],0.4416438613647454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20053,58,0.93 [0.63-1.40],0.7426304490372534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYDGF,Myeloid-derived growth factor,20092,59,1.14 [0.89-1.46],0.3082617556649526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH4,Myosin-4,19410,56,0.61 [0.30-1.24],0.1697639938734796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH7B,Myosin-7B,19396,57,1.20 [0.71-2.04],0.494345362235439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH9,Myosin-9,20102,59,1.03 [0.83-1.28],0.8096633158285975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19410,56,1.10 [0.60-2.01],0.7628062977994313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL3,Myosin light chain 3,19543,57,1.05 [0.76-1.45],0.7754955714454462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL4,Myosin light chain 4,19543,57,0.77 [0.46-1.29],0.3235655690461136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL6B,Myosin light chain 6B,19557,56,0.79 [0.56-1.12],0.1882576392842411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19557,56,1.06 [0.67-1.67],0.8155680450322699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO6,Unconventional myosin-VI,20053,58,0.66 [0.30-1.45],0.3012808062515378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO9B,Unconventional myosin-IXb,22757,70,0.76 [0.53-1.10],0.1432974097225419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOC,Myocilin,23180,69,0.99 [0.62-1.60],0.9797929996962782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM1,Myomesin-1,19446,57,0.87 [0.47-1.60],0.6485188687345281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM2,Myomesin-2,19410,56,0.86 [0.52-1.43],0.5641563901222632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM3,Myomesin-3,19647,60,0.92 [0.71-1.19],0.5390148257446961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZB1,Marginal zone B- and B1-cell-specific protein,23201,71,1.30 [0.88-1.92],0.1800090617743274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZT1,Mitotic-spindle organizing protein 1,22619,68,1.09 [0.74-1.60],0.6528085603953839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA10,N-alpha-acetyltransferase 10,19410,56,0.82 [0.50-1.37],0.452888719934271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA80,N-alpha-acetyltransferase 80,19557,56,1.07 [0.86-1.31],0.5545509174811272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22856,70,0.86 [0.60-1.22],0.3960167815296085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NACC1,Nucleus accumbens-associated protein 1,20022,60,0.97 [0.62-1.53],0.9042237001198464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NADK,NAD kinase,23166,69,1.13 [0.80-1.59],0.4930774248575744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGA,Alpha-N-acetylgalactosaminidase,19472,59,0.62 [0.34-1.14],0.12430897198904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGK,N-acetyl-D-glucosamine kinase,19509,57,0.85 [0.54-1.35],0.4998173783436697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19647,60,2.73 [0.88-8.46],0.0823558322328043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAMPT,Nicotinamide phosphoribosyltransferase,22619,68,0.78 [0.49-1.25],0.3077807202842433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAP1L4,Nucleosome assembly protein 1-like 4,19989,58,0.76 [0.44-1.30],0.3103760123025623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAPRT,Nicotinate phosphoribosyltransferase,20044,58,0.77 [0.35-1.71],0.5181646410596035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NARS1,"Asparagine--tRNA ligase, cytoplasmic",20053,58,0.94 [0.55-1.61],0.8282853762362962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBL1,Neuroblastoma suppressor of tumorigenicity 1,23228,70,1.85 [0.88-3.89],0.1029837726479829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,22757,70,1.08 [0.77-1.52],0.6630355952607339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM1,Neural cell adhesion molecule 1,23274,70,0.93 [0.49-1.78],0.8300590771351761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,23180,69,0.46 [0.21-1.02],0.0548707014881253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,23375,71,0.45 [0.26-0.76],0.0026685177663754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCF2,Neutrophil cytosol factor 2,23094,70,1.00 [0.78-1.27],0.976640841910256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCK2,Cytoplasmic protein NCK2,23248,71,1.13 [0.93-1.37],0.2295766758775941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,22757,70,0.43 [0.21-0.88],0.0210135385038894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR1,Natural cytotoxicity triggering receptor 1,23110,69,1.21 [0.70-2.09],0.5053801616522706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20029,58,1.14 [0.56-2.32],0.7239636370754445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCS1,Neuronal calcium sensor 1,23366,71,1.42 [0.69-2.94],0.3425066146024147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,22655,70,0.69 [0.44-1.07],0.096364357577545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20022,60,0.86 [0.54-1.39],0.5478887821965832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19472,59,1.56 [0.80-3.03],0.193339277028338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20029,58,1.17 [0.88-1.54],0.2781336559735411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22619,68,0.91 [0.68-1.23],0.5565322184280217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,19410,56,1.87 [1.27-2.74],0.0014477866164083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECAP2,Adaptin ear-binding coat-associated protein 2,19410,56,0.91 [0.61-1.36],0.6425466289245788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN1,Nectin-1,19503,59,0.71 [0.31-1.63],0.4192933156150318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN2,Nectin-2,23136,69,1.50 [0.78-2.88],0.2225690865769122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN4,Nectin-4,23228,70,1.51 [0.85-2.67],0.16037661984996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19503,59,0.84 [0.51-1.40],0.5095641511251157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD9,Enhancer of filamentation 1,19503,59,0.93 [0.45-1.95],0.8491497553784347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,22588,70,1.95 [1.42-2.68],3.481838399957073e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEK7,Serine/threonine-protein kinase Nek7,19747,59,1.14 [0.85-1.54],0.3718091930665343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL1,Protein kinase C-binding protein NELL1,23228,70,1.09 [0.66-1.79],0.7466166660729294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL2,Protein kinase C-binding protein NELL2,23248,71,1.22 [0.61-2.44],0.5759915003519344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NENF,Neudesin,20022,60,0.79 [0.58-1.08],0.1332513692177028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEO1,Neogenin,20053,58,0.66 [0.20-2.13],0.4840509057293267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEXN,Nexilin,20118,60,0.87 [0.60-1.26],0.4591055235191097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,23437,70,2.00 [0.99-4.04],0.0526917943991274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFAT5,Nuclear factor of activated T-cells 5,19503,59,1.10 [0.83-1.44],0.5141123182443046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23141,70,1.24 [1.00-1.52],0.0465035199775164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22757,70,1.28 [0.93-1.75],0.1312805481769459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFE2,Transcription factor NF-E2 45 kDa subunit,19543,57,0.95 [0.67-1.35],0.7859834778191275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,20053,58,0.30 [0.11-0.82],0.0191986632697122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19410,56,1.07 [0.75-1.51],0.7218685982546718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19747,59,0.93 [0.55-1.55],0.7673327060748334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,22619,68,1.48 [1.00-2.19],0.0492476370781035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20029,58,1.06 [0.83-1.35],0.6250040194459054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFX1,Transcriptional repressor NF-X1,19410,56,1.14 [0.79-1.65],0.4768093074098913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFYA,Nuclear transcription factor Y subunit alpha,19410,56,1.05 [0.56-1.96],0.873064343127066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGF,Beta-nerve growth factor,22963,70,0.52 [0.09-3.09],0.473623088618253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGFR,Tumor necrosis factor receptor superfamily member 16,20092,59,1.07 [0.46-2.45],0.8817370423222939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGRN,Neugrin,20044,58,0.83 [0.26-2.65],0.7557354763181403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,19178,59,2.07 [0.94-4.54],0.0707474498067709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,23203,70,1.80 [1.03-3.13],0.0375689245351037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID2,Nidogen-2,23180,69,1.25 [0.94-1.65],0.1189597172661527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NINJ1,Ninjurin-1,22619,68,0.81 [0.49-1.31],0.3863992807881908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT1,Deaminated glutathione amidase,19543,57,1.13 [0.63-2.03],0.6820158398279694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT2,Omega-amidase NIT2,20010,58,1.23 [0.87-1.74],0.2381563033750004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN1,Neuroligin-1,19557,56,1.22 [0.90-1.64],0.2011732200544733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN2,Neuroligin-2,19446,57,0.90 [0.49-1.65],0.7296975705249824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME1,Nucleoside diphosphate kinase A,19503,59,0.42 [0.12-1.46],0.1729703494147414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME3,Nucleoside diphosphate kinase 3,23165,71,0.64 [0.24-1.65],0.3525944705152456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMI,N-myc-interactor,19940,60,1.16 [0.83-1.61],0.3871130809750314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22963,70,0.97 [0.73-1.28],0.8154818822331734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMRK2,Nicotinamide riboside kinase 2,19396,57,1.09 [0.60-2.01],0.7725060804465294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20053,58,0.97 [0.66-1.43],0.8773342518809069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOMO1,Nodal modulator 1,23180,69,1.19 [0.48-2.97],0.709008592248023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOP56,Nucleolar protein 56,19410,56,1.07 [0.86-1.32],0.5379296918436852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS1,"Nitric oxide synthase, brain",22655,70,1.24 [0.88-1.76],0.2183598609459134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS2,"Nitric oxide synthase, inducible",19410,56,0.71 [0.36-1.43],0.3408056795579251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",22655,70,1.36 [0.99-1.87],0.0549808078943144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH1,Neurogenic locus notch homolog protein 1,23457,69,0.35 [0.09-1.33],0.1228207052760492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH2,Neurogenic locus notch homolog protein 2,20102,59,0.64 [0.23-1.73],0.3753350786406265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH3,Neurogenic locus notch homolog protein 3,23457,69,0.92 [0.49-1.74],0.8072295782230726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,19760,57,2.41 [1.47-3.94],0.00048535942066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPDC1,Neural proliferation differentiation and control protein 1,23166,69,1.64 [0.94-2.85],0.0786723791422512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS1,Nephrin,19503,59,1.18 [0.58-2.40],0.6540624399146733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS2,Podocin,19503,59,1.06 [0.84-1.33],0.6440772770703139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,20092,59,1.64 [1.00-2.69],0.0515515836454509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,22746,68,1.10 [0.94-1.28],0.2535329536043643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPC,C-type natriuretic peptide,23141,70,1.28 [0.88-1.86],0.2013061855837631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPR1,Atrial natriuretic peptide receptor 1,19410,56,0.91 [0.47-1.78],0.7888136560075917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTN,Neuroplastin,22619,68,0.98 [0.73-1.31],0.871033420576262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX1,Neuronal pentraxin-1,23180,69,1.32 [0.81-2.16],0.2709759554134185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX2,Neuronal pentraxin-2,20102,59,1.00 [0.48-2.08],0.99697864945721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTXR,Neuronal pentraxin receptor,23166,69,0.95 [0.51-1.77],0.8652454265946503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPY,Pro-neuropeptide Y,23366,71,0.99 [0.72-1.36],0.9461176124925288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRCAM,Neuronal cell adhesion molecule,23166,69,1.18 [0.57-2.44],0.6510125787075505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRGN,Neurogranin,20118,60,1.16 [0.88-1.51],0.2881518408065773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRN1,Neuritin,20053,58,0.92 [0.43-1.93],0.8159978801044206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP1,Neuropilin-1,23312,70,1.79 [0.83-3.84],0.1374054924338313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP2,Neuropilin-2,23180,69,1.15 [0.56-2.39],0.6999261762365312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,22757,70,1.26 [0.88-1.81],0.2099189041427676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,19557,56,0.70 [0.29-1.67],0.4191274245286611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NSFL1C,NSFL1 cofactor p47,23375,71,1.16 [0.84-1.60],0.3649981022785881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20092,59,0.98 [0.70-1.39],0.9281261571008816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,20044,58,1.65 [0.93-2.93],0.0882219969478391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C3A,Cytosolic 5'-nucleotidase 3A,23098,69,1.09 [0.85-1.40],0.5065559362190192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,23228,70,1.54 [1.09-2.16],0.0141504151674211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,23141,70,1.51 [0.87-2.63],0.1434963302424899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF4,Neurotrophin-4,22619,68,1.09 [0.64-1.85],0.7596489094008466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK2,BDNF/NT-3 growth factors receptor,23166,69,0.61 [0.26-1.42],0.2486050216288001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK3,NT-3 growth factor receptor,23375,71,0.66 [0.25-1.74],0.4024515650048924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,23166,69,1.17 [0.98-1.39],0.0831542288092306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUB1,NEDD8 ultimate buster 1,23141,70,1.08 [0.84-1.38],0.5538403617313259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20022,60,0.85 [0.64-1.14],0.2755264641746495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,23332,71,1.68 [0.99-2.84],0.0537692818561684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDC,Nuclear migration protein nudC,23437,70,1.25 [0.89-1.75],0.2014902056646407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19543,57,1.41 [0.62-3.21],0.4087097006194964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19410,56,0.98 [0.59-1.65],0.9478851622537512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT16,U8 snoRNA-decapping enzyme,19995,58,1.19 [0.90-1.57],0.2225261356632549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],23054,68,1.07 [0.74-1.56],0.71430785469461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT5,ADP-sugar pyrophosphatase,23180,69,1.38 [0.92-2.07],0.1194646420801337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUMB,Protein numb homolog,19503,59,1.09 [0.80-1.47],0.5933469817579393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUP50,Nuclear pore complex protein Nup50,19410,56,0.92 [0.40-2.12],0.853576994793994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPE4,NXPE family member 4,19410,56,1.35 [0.70-2.59],0.3723164972478364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH1,Neurexophilin-1,22655,70,1.45 [0.93-2.24],0.0982612518046689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH3,Neurexophilin-3,19503,59,0.79 [0.35-1.81],0.5826660105571033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OBP2B,Odorant-binding protein 2b,22884,70,0.76 [0.54-1.09],0.1330520842826461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,20053,58,1.65 [1.00-2.71],0.0493676650699423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ODAM,Odontogenic ameloblast-associated protein,22613,70,0.80 [0.52-1.24],0.3205204749259074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OFD1,Oral-facial-digital syndrome 1 protein,19747,59,1.06 [0.74-1.52],0.7444588521994049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGA,Protein O-GlcNAcase,20029,58,1.09 [0.77-1.56],0.6210669767587906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGFR,Opioid growth factor receptor,23054,68,1.19 [0.62-2.27],0.5982315827176268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGN,Mimecan,23180,69,1.36 [0.85-2.20],0.2027400322153229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19747,59,0.84 [0.53-1.32],0.4453525033456686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLFM4,Olfactomedin-4,18911,56,1.11 [0.90-1.38],0.3236504478583336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLR1,Oxidized low-density lipoprotein receptor 1,22941,68,1.06 [0.75-1.50],0.734726099490925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMD,Osteomodulin,23248,71,1.09 [0.66-1.81],0.7326362668314139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMG,Oligodendrocyte-myelin glycoprotein,23054,68,0.98 [0.72-1.34],0.9121088942325406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMP,Olfactory marker protein,19446,57,0.88 [0.49-1.56],0.6558892757056844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPHN1,Oligophrenin-1,20044,58,1.12 [0.89-1.41],0.3448809105595921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPLAH,5-oxoprolinase,19543,57,0.95 [0.65-1.38],0.7808528838344884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPTC,Opticin,23054,68,0.80 [0.48-1.33],0.3877119058991086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ORM1,Alpha-1-acid glycoprotein 1,20042,59,2.28 [0.70-7.43],0.170193337577611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSBPL2,Oxysterol-binding protein-related protein 2,20044,58,0.93 [0.45-1.91],0.8376574621906692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSCAR,Osteoclast-associated immunoglobulin-like receptor,23165,71,0.80 [0.44-1.45],0.4673673789594984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSM,Oncostatin-M,23029,70,1.15 [0.86-1.55],0.3431005790138854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSMR,Oncostatin-M-specific receptor subunit beta,23312,70,1.33 [0.45-3.94],0.6083704436502622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSTN,Osteocrin,19557,56,1.00 [0.54-1.87],0.9984275548548596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTOA,Otoancorin,19446,57,0.95 [0.58-1.58],0.8538256238404769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD6B,Deubiquitinase OTUD6B,20029,58,1.04 [0.68-1.61],0.8488246526145986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD7B,OTU domain-containing protein 7B,20053,58,1.11 [0.75-1.64],0.6141513892628024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19543,57,1.12 [0.79-1.60],0.5153540431663635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXT,Oxytocin-neurophysin 1,23375,71,1.07 [0.92-1.23],0.3801142358563855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,P4HB,Protein disulfide-isomerase,23041,70,1.21 [0.71-2.06],0.4934759151418227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PACS2,Phosphofurin acidic cluster sorting protein 2,19410,56,1.01 [0.67-1.54],0.9501665981272844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI2,Protein-arginine deiminase type-2,22757,70,0.80 [0.51-1.25],0.3252009581600404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI4,Protein-arginine deiminase type-4,22613,70,0.88 [0.65-1.20],0.4182694992704343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAEP,Glycodelin,22963,70,0.99 [0.81-1.22],0.9507653964790136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20053,58,0.69 [0.48-0.99],0.0457566072548587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19747,59,0.96 [0.57-1.61],0.8827527341374084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22746,68,1.12 [0.77-1.62],0.5443589940309275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAGR1,PAXIP1-associated glutamate-rich protein 1,19543,57,0.68 [0.35-1.32],0.2568905338082773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19362,57,0.90 [0.54-1.50],0.6853028230335301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAK4,Serine/threonine-protein kinase PAK 4,22655,70,1.08 [0.77-1.51],0.6432545756919064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALLD,Palladin,19503,59,0.57 [0.25-1.30],0.1844869940905578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM,Paralemmin-1,19916,58,1.12 [0.52-2.43],0.7701321671066356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,20044,58,1.68 [0.96-2.94],0.0680398449547393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM3,Paralemmin-3,19410,56,0.56 [0.30-1.03],0.0613355309191143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAM,Peptidyl-glycine alpha-amidating monooxygenase,23357,69,1.02 [0.48-2.19],0.9577346629296056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAMR1,Inactive serine protease PAMR1,23180,69,0.86 [0.39-1.91],0.7119346149046822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAPPA,Pappalysin-1,22757,70,0.71 [0.45-1.10],0.1261361221661777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARD3,Partitioning defective 3 homolog,19747,59,1.08 [0.79-1.48],0.6361203891380562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARK7,Parkinson disease protein 7,23180,69,1.10 [0.73-1.66],0.6581258723725306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,23141,70,1.28 [1.01-1.63],0.0424761729464348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAXX,Protein PAXX,19647,60,1.35 [0.81-2.23],0.2470083858028258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19396,57,0.88 [0.39-1.97],0.7510540345977607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBLD,Phenazine biosynthesis-like domain-containing protein,22655,70,0.98 [0.65-1.49],0.934939626671054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20029,58,0.73 [0.30-1.78],0.491413530499952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,19446,57,0.61 [0.37-0.99],0.0450981109382663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19608,60,1.70 [1.08-2.68],0.0230894083603602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBP2,Poly(rC)-binding protein 2,20053,58,1.03 [0.73-1.46],0.8465886911695739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH1,Protocadherin-1,23362,69,1.73 [0.73-4.10],0.2172113627646981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH12,Protocadherin-12,20053,58,0.51 [0.19-1.36],0.1778253464401999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH17,Protocadherin-17,23166,69,1.45 [0.84-2.53],0.1835548729256507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH7,Protocadherin-7,20029,58,1.02 [0.51-2.05],0.9618600192369752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,20029,58,1.55 [0.74-3.24],0.2407656744840052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDHB15,Protocadherin beta-15,20022,60,0.54 [0.29-1.02],0.0583338914283979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCNA,Proliferating cell nuclear antigen,19396,57,1.00 [0.68-1.48],0.9917569493099484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK7,Proprotein convertase subtilisin/kexin type 7,20022,60,1.27 [0.81-2.00],0.299145330466579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK9,Proprotein convertase subtilisin/kexin type 9,23457,69,1.18 [0.70-1.99],0.5441570117131531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCYT2,Ethanolamine-phosphate cytidylyltransferase,20029,58,1.14 [0.82-1.58],0.4406199854260829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDAP1,28 kDa heat- and acid-stable phosphoprotein,20092,59,1.04 [0.81-1.34],0.7536404848347277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1,Programmed cell death protein 1,23322,71,1.29 [0.81-2.08],0.2850080520052977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1LG2,Programmed cell death 1 ligand 2,23054,68,0.73 [0.37-1.44],0.3663187100270577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD5,Programmed cell death protein 5,23375,71,1.19 [0.83-1.69],0.3423928477063729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD6,Programmed cell death protein 6,23166,69,1.13 [0.81-1.59],0.4681926951402434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCL2,Phosducin-like protein 2,19396,57,0.81 [0.46-1.42],0.4614567068247136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19396,57,1.08 [0.69-1.69],0.7427604997471743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19410,56,1.09 [0.73-1.62],0.6720838407652574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19647,60,1.17 [0.91-1.49],0.214339545659361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFA,Platelet-derived growth factor subunit A,23457,69,1.18 [0.88-1.58],0.2761420138424884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFB,Platelet-derived growth factor subunit B,23248,71,1.17 [0.92-1.50],0.2037818180604452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFC,Platelet-derived growth factor C,22619,68,0.98 [0.45-2.15],0.9629700794767426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRA,Platelet-derived growth factor receptor alpha,23166,69,1.17 [0.56-2.46],0.6777278543203835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRB,Platelet-derived growth factor receptor beta,23457,69,0.67 [0.37-1.22],0.1925510172081786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA2,Protein disulfide-isomerase A2,19396,57,0.87 [0.44-1.72],0.6960347695300635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,19647,60,1.79 [0.79-4.03],0.1614806390013222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA4,Protein disulfide-isomerase A4,20102,59,1.03 [0.68-1.54],0.8992511111551434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA5,Protein disulfide-isomerase A5,19396,57,1.12 [0.77-1.63],0.5578491772958234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM5,PDZ and LIM domain protein 5,20053,58,1.03 [0.83-1.28],0.7714854726306986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM7,PDZ and LIM domain protein 7,23248,71,1.02 [0.87-1.21],0.7944559954111146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22619,68,1.27 [0.89-1.82],0.1940765329105014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDRG1,p53 and DNA damage-regulated protein 1,19557,56,0.78 [0.43-1.40],0.4036825885156628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19396,57,0.95 [0.59-1.53],0.8268498700135496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,19410,56,1.42 [1.01-2.01],0.0460706547887362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19503,59,1.47 [0.90-2.39],0.1223040168162597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEAR1,Platelet endothelial aggregation receptor 1,23457,69,0.81 [0.32-2.06],0.6578458071784902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEBP1,Phosphatidylethanolamine-binding protein 1,23180,69,1.27 [0.88-1.82],0.1967090444822517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECAM1,Platelet endothelial cell adhesion molecule,23180,69,1.07 [0.53-2.14],0.8561096215270874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19543,57,0.76 [0.28-2.04],0.5857899430470068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PENK,Proenkephalin-A,19647,60,1.66 [0.96-2.88],0.0693959833800817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEPD,Xaa-Pro dipeptidase,20118,60,0.76 [0.30-1.93],0.5655565787703858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PER3,Period circadian protein homolog 3,19503,59,1.15 [0.94-1.40],0.1711860367114996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,19966,60,1.31 [1.03-1.66],0.0276744908008664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN2,Prefoldin subunit 2,22655,70,1.21 [0.83-1.76],0.3194006837983912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,19396,57,0.63 [0.35-1.13],0.1183281975303844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN6,Prefoldin subunit 6,19557,56,1.04 [0.71-1.53],0.8246703122865804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23018,67,1.06 [0.81-1.41],0.6613861978833488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGA4,Pepsin A-4,20118,60,0.99 [0.72-1.36],0.964286372332236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20092,59,1.22 [0.77-1.93],0.3904999268257683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGF,Placenta growth factor,23437,70,1.96 [0.98-3.90],0.0567120593014876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,23346,69,1.61 [1.05-2.48],0.0299578884385716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19866,60,1.43 [0.60-3.39],0.414648439987626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP4,Peptidoglycan recognition protein 4,19410,56,1.02 [0.66-1.58],0.9338619696840604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGM2,Phosphoglucomutase-2,19557,56,1.03 [0.68-1.58],0.8776097166857098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGR,Progesterone receptor,19503,59,0.70 [0.46-1.07],0.1026402506346634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHACTR2,Phosphatase and actin regulator 2,20053,58,1.04 [0.84-1.30],0.7236060807373043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB1,Pleckstrin homology-like domain family B member 1,20029,58,1.11 [0.69-1.78],0.6566796647540589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB2,Pleckstrin homology-like domain family B member 2,19396,57,1.18 [0.94-1.48],0.1541138394514053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22963,70,1.47 [0.71-3.03],0.2953640092814737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19647,60,1.63 [0.91-2.91],0.097787049784454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI16,Peptidase inhibitor 16,20118,60,0.87 [0.32-2.37],0.7857873598914037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI3,Elafin,22871,68,0.93 [0.62-1.38],0.7138857835046464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20053,58,1.07 [0.78-1.47],0.6762802742076441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,22878,69,1.65 [0.97-2.80],0.0638905595499316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,23141,70,1.08 [0.78-1.51],0.6338783354120967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23180,69,1.42 [0.71-2.84],0.319775539350649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19503,59,0.89 [0.55-1.45],0.6380911325001675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,23180,69,1.71 [1.03-2.82],0.0363236152317503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,23166,69,1.60 [1.07-2.38],0.0211838126969674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19647,60,1.12 [0.78-1.60],0.5475396261117224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PITHD1,PITH domain-containing protein 1,19362,57,0.82 [0.55-1.23],0.3445499297033781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,20092,59,1.28 [0.50-3.27],0.6119682677020319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD2,Polycystin-2,19410,56,1.06 [0.69-1.64],0.7828071374385295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKLR,Pyruvate kinase PKLR,23167,71,1.05 [0.77-1.44],0.7639149738058681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKN3,Serine/threonine-protein kinase N3,19747,59,0.92 [0.65-1.30],0.6374932460997103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G10,Group 10 secretory phospholipase A2,22963,70,1.31 [0.91-1.89],0.1415396114977226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,23228,70,2.32 [1.15-4.68],0.0189388196358615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G1B,Phospholipase A2,23424,69,1.07 [0.67-1.72],0.7729569749415146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",23155,68,1.08 [0.74-1.59],0.6807804307794574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G4A,Cytosolic phospholipase A2,23248,71,1.16 [0.92-1.46],0.2223808859350119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G7,Platelet-activating factor acetylhydrolase,23180,69,0.90 [0.48-1.69],0.7407756576928801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAT,Tissue-type plasminogen activator,23381,69,1.09 [0.72-1.65],0.6774104898656419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAU,Urokinase-type plasminogen activator,23180,69,0.81 [0.38-1.73],0.5797171988099039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAUR,Urokinase plasminogen activator surface receptor,22975,71,1.89 [0.96-3.71],0.0640932185255793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLB1,"Phospholipase B1, membrane-associated",20044,58,0.94 [0.62-1.42],0.7547813293739901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19503,59,0.80 [0.40-1.58],0.5120746523989723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20044,58,1.00 [0.77-1.29],0.9905384600124616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLEKHO1,Pleckstrin homology domain-containing family O member 1,20044,58,1.11 [0.78-1.58],0.5663623382843925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLG,Plasminogen,19620,60,2.28 [0.84-6.22],0.1077720566046702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN1,Perilipin-1,22655,70,1.08 [0.59-1.99],0.7953724107759456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN3,Perilipin-3,23166,69,1.23 [0.76-1.98],0.403049356848342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLPBP,Pyridoxal phosphate homeostasis protein,23166,69,1.18 [0.86-1.61],0.2968021825141574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLSCR3,Phospholipid scramblase 3,20001,58,1.07 [0.69-1.65],0.752981421464627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLTP,Phospholipid transfer protein,23389,69,0.71 [0.41-1.22],0.2161691905269612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC1,Plexin domain-containing protein 1,22619,68,1.10 [0.59-2.07],0.7608624951895354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC2,Plexin domain-containing protein 2,20044,58,0.48 [0.18-1.28],0.1440666147456226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNA4,Plexin-A4,23141,70,1.16 [0.89-1.50],0.27232342862233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,23343,69,2.68 [1.22-5.88],0.0140468289830032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB3,Plexin-B3,23090,69,1.26 [0.82-1.94],0.2968990463224101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,23064,69,1.11 [0.98-1.26],0.0868111444381193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMCH,Pro-MCH,19410,56,0.96 [0.68-1.35],0.8145336500076352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMM2,Phosphomannomutase 2,19410,56,1.07 [0.70-1.64],0.7557689955681681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMS1,PMS1 protein homolog 1,19557,56,1.04 [0.64-1.70],0.8594026198846152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMVK,Phosphomevalonate kinase,22619,70,1.05 [0.86-1.28],0.6220605754963666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIP,Pancreatic triacylglycerol lipase,20118,60,1.09 [0.77-1.56],0.6262589580210685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP1,Inactive pancreatic lipase-related protein 1,20044,58,1.23 [0.92-1.65],0.1605697974329402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP2,Pancreatic lipase-related protein 2,23129,71,1.02 [0.95-1.09],0.6394300776846489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA1,Paraneoplastic antigen Ma1,19543,57,0.95 [0.60-1.49],0.807688219710934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA2,Paraneoplastic antigen Ma2,19446,57,1.27 [0.77-2.11],0.3484740248723302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22757,70,1.07 [0.90-1.27],0.4442901940003781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL,Podocalyxin,23054,68,0.65 [0.16-2.63],0.5438738269075043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,23228,70,1.36 [0.65-2.82],0.4109892149378927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POF1B,Protein POF1B,19503,59,1.41 [0.90-2.22],0.1353417861831807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19503,59,0.85 [0.35-2.07],0.7267082979813331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23054,68,1.50 [0.98-2.30],0.0596080113827385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POMC,Pro-opiomelanocortin,19543,57,1.11 [0.79-1.58],0.5467569510987039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON1,Serum paraoxonase/arylesterase 1,20118,60,0.89 [0.38-2.08],0.7947883424055499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON2,Serum paraoxonase/arylesterase 2,22746,68,1.27 [0.70-2.32],0.4290800531103703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,23248,71,0.69 [0.46-1.05],0.0816194927595376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,20102,59,0.44 [0.23-0.86],0.0169531821148416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPBP,Platelet basic protein,19966,60,1.30 [0.98-1.73],0.0688694192856615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPCDC,Phosphopantothenoylcysteine decarboxylase,23375,71,1.33 [0.87-2.05],0.1905888280344253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIB,Peptidyl-prolyl cis-trans isomerase B,23195,69,1.07 [0.86-1.34],0.5313570182675755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIE,Peptidyl-prolyl cis-trans isomerase E,19747,59,1.16 [0.82-1.64],0.4151073759153905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20102,59,0.92 [0.61-1.38],0.6742047489051164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPL,Periplakin,19503,59,1.28 [0.62-2.65],0.5085613914257763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1A,Protein phosphatase 1A,22619,68,0.64 [0.30-1.38],0.2573873195636634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1B,Protein phosphatase 1B,19503,59,0.55 [0.29-1.05],0.0721084615789548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1F,Protein phosphatase 1F,20092,59,1.09 [0.69-1.74],0.7010253867313316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPME1,Protein phosphatase methylesterase 1,23054,68,1.13 [0.79-1.62],0.4956944091958688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20022,60,0.97 [0.72-1.31],0.8468904134888113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23228,70,1.14 [0.91-1.41],0.2484046954437726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19747,59,0.84 [0.56-1.27],0.4154741752909062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20053,58,1.03 [0.75-1.41],0.8713350199521415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20053,58,0.96 [0.50-1.84],0.8907976592107227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R2,Protein phosphatase inhibitor 2,23166,69,1.13 [0.87-1.47],0.3472403522150042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R9B,Neurabin-2,23437,70,1.07 [0.86-1.34],0.5327312507917479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20029,58,0.97 [0.79-1.20],0.7766260675129222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP3R1,Calcineurin subunit B type 1,22963,70,1.10 [0.66-1.85],0.7187526541723146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPT1,Palmitoyl-protein thioesterase 1,19557,56,1.13 [0.85-1.51],0.392542529212827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,23102,70,1.31 [1.08-1.59],0.0069271907101882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PQBP1,Polyglutamine-binding protein 1,22619,68,1.04 [0.72-1.49],0.8435150106073588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAME,Melanoma antigen preferentially expressed in tumors,19396,57,1.20 [0.47-3.04],0.704426169840292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAP1,Proline-rich acidic protein 1,20102,59,1.18 [0.62-2.23],0.6172453014253279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRC1,Protein regulator of cytokinesis 1,20022,60,0.59 [0.25-1.40],0.2299293645438461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRCP,Lysosomal Pro-X carboxypeptidase,23309,69,1.08 [0.55-2.10],0.8255385860805453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX1,Peroxiredoxin-1,22473,67,0.85 [0.66-1.10],0.2099538957184952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX2,Peroxiredoxin-2,19776,58,0.91 [0.61-1.37],0.6666067400897648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22757,70,1.21 [0.91-1.60],0.1982017865470266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX5,"Peroxiredoxin-5, mitochondrial",23437,70,1.07 [0.77-1.47],0.69355436029399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX6,Peroxiredoxin-6,23366,71,0.88 [0.62-1.25],0.4730175874220329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,22757,70,1.39 [0.74-2.63],0.3055060940969489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRELP,Prolargin,23129,71,1.72 [0.67-4.42],0.2562586723124623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG2,Bone marrow proteoglycan,20102,59,0.99 [0.62-1.59],0.9713228090848172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG3,Proteoglycan 3,20102,59,0.80 [0.50-1.28],0.35846722416695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22757,70,1.02 [0.69-1.51],0.9194385402716876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19557,56,0.59 [0.23-1.50],0.2697255280682081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,23166,69,0.99 [0.77-1.28],0.9490940029617564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20000,58,0.96 [0.70-1.32],0.7928476429403476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,22757,70,0.47 [0.26-0.87],0.0161543202917495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKD2,Serine/threonine-protein kinase D2,19410,56,0.61 [0.28-1.33],0.2126828778001356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKG1,cGMP-dependent protein kinase 1,19647,60,1.06 [0.87-1.29],0.5848962672164378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22619,68,1.06 [0.77-1.45],0.7352976816874888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRL,Prolactin,23375,71,1.08 [0.82-1.43],0.5741567822340891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRND,Prion-like protein doppel,20044,58,0.81 [0.48-1.38],0.4371966077943936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROC,Vitamin K-dependent protein C,23240,70,1.43 [0.63-3.24],0.3981773394509627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROCR,Endothelial protein C receptor,19410,56,0.91 [0.41-2.05],0.8252186191288913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROK1,Prokineticin-1,23141,70,1.03 [0.69-1.55],0.8803008743830715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROS1,Vitamin K-dependent protein S,20117,60,1.15 [0.43-3.09],0.7774119174022727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR4,Proline-rich protein 4,19496,60,0.98 [0.69-1.39],0.9069556273980702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR5,Proline-rich protein 5,19503,59,0.82 [0.45-1.49],0.5081222739379021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRRT3,Proline-rich transmembrane protein 3,19543,57,0.76 [0.40-1.47],0.4222858421106387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,23274,70,1.56 [1.15-2.12],0.0039798212423831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS22,Brain-specific serine protease 4,19503,59,1.27 [0.69-2.33],0.4355069702849935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS27,Serine protease 27,23091,69,1.21 [0.72-2.02],0.4741253687691417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS53,Serine protease 53,20044,58,0.61 [0.33-1.12],0.1130972947793929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,23055,71,1.61 [1.00-2.59],0.0489741596354759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22655,70,1.12 [0.92-1.37],0.2424775742737223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTG,Protogenin,23366,71,0.89 [0.38-2.08],0.7824725176883831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTN3,Myeloblastin,22616,69,0.68 [0.42-1.10],0.1134203875254766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRUNE2,Protein prune homolog 2,19747,59,1.17 [0.51-2.67],0.7145294192373873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,19915,58,2.60 [1.54-4.38],0.0003316884047621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAPL1,Proactivator polypeptide-like 1,20029,58,0.75 [0.46-1.24],0.2680496135911723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSCA,Prostate stem cell antigen,20029,58,1.00 [0.91-1.10],0.9857549765295288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22963,70,1.08 [0.88-1.32],0.4417156549398993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSIP1,PC4 and SFRS1-interacting protein,23141,70,1.15 [0.88-1.52],0.3120849641455269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,22619,68,0.54 [0.31-0.93],0.0270929986891742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMC3,26S proteasome regulatory subunit 6A,19396,57,1.44 [0.67-3.13],0.3525268698134514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD1,26S proteasome non-ATPase regulatory subunit 1,20053,58,0.66 [0.38-1.14],0.1320383109667519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19557,56,1.19 [0.79-1.80],0.392147299124309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD9,26S proteasome non-ATPase regulatory subunit 9,23054,68,1.11 [0.77-1.61],0.5760976521204673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME1,Proteasome activator complex subunit 1,22919,70,1.27 [0.72-2.24],0.4040350300873172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME2,Proteasome activator complex subunit 2,22860,70,1.32 [0.74-2.36],0.3418421187711037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG3,Proteasome assembly chaperone 3,23141,70,1.21 [0.81-1.81],0.3551790605540641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG4,Proteasome assembly chaperone 4,19503,59,0.92 [0.59-1.43],0.7040179589827993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSPN,Persephin,23141,70,1.18 [0.92-1.50],0.1886790527635875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSRC1,Proline/serine-rich coiled-coil protein 1,22619,68,1.13 [0.80-1.59],0.4856925491666836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18960,58,1.14 [0.89-1.46],0.2969094584378069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22655,70,0.94 [0.46-1.89],0.8548560500169878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGDS,Prostaglandin-H2 D-isomerase,23012,70,1.60 [0.88-2.92],0.1248085882960787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGES2,Prostaglandin E synthase 2,19368,59,1.19 [0.76-1.87],0.452525921481559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGR1,Prostaglandin reductase 1,20092,59,1.15 [0.86-1.54],0.3343126867996426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH,Parathyroid hormone,19557,56,1.00 [0.74-1.36],0.996349077624084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23141,70,1.21 [0.75-1.95],0.4437453838186672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTK7,Inactive tyrosine-protein kinase 7,22655,70,0.73 [0.42-1.27],0.2728175582105819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTN,Pleiotrophin,22746,68,1.21 [0.79-1.85],0.3876344364277286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTP4A3,Protein tyrosine phosphatase type IVA 3,19503,59,1.35 [0.91-1.99],0.1349517832126953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22963,70,1.10 [0.84-1.43],0.5031763291454888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,23212,71,1.16 [0.91-1.49],0.2220925666909801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19471,59,0.57 [0.27-1.23],0.1531764029330334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,20092,59,2.84 [1.29-6.27],0.0095424898115618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,20102,59,1.79 [0.67-4.77],0.2412615517239622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRF,Receptor-type tyrosine-protein phosphatase F,23457,69,0.62 [0.29-1.30],0.2076352810550792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRH,Receptor-type tyrosine-protein phosphatase H,20029,58,0.81 [0.48-1.37],0.4261258500802346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20029,58,0.73 [0.21-2.57],0.6259920209880994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRM,Receptor-type tyrosine-protein phosphatase mu,23104,70,0.65 [0.27-1.52],0.318888788267627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22889,70,1.33 [0.72-2.47],0.3624303144483123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRR,Receptor-type tyrosine-protein phosphatase R,20044,58,0.92 [0.48-1.78],0.8035679248741965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRS,Receptor-type tyrosine-protein phosphatase S,23457,69,0.92 [0.40-2.14],0.8455514874601967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20092,59,0.79 [0.35-1.78],0.5633762558009388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19647,60,1.07 [0.70-1.63],0.7430039481303197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22539,69,1.46 [1.03-2.08],0.0336958159301139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTTG1,Securin,19747,59,0.91 [0.49-1.72],0.7801676656992232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,23141,70,1.22 [0.78-1.91],0.3877063124419131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVALB,Parvalbumin alpha,23267,70,1.04 [0.86-1.26],0.6695099758616169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVR,Poliovirus receptor,23375,71,1.08 [0.62-1.87],0.7885630653707232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXDNL,Peroxidasin-like protein,20022,60,0.59 [0.32-1.09],0.0934764981441283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXN,Paxillin,22655,70,0.78 [0.50-1.22],0.2739230170474759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYDC1,Pyrin domain-containing protein 1,19543,57,1.08 [0.58-1.99],0.8082099654325525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYY,Peptide YY,19410,56,1.15 [0.91-1.47],0.2458358461343217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PZP,Pregnancy zone protein,20117,60,1.58 [0.83-2.99],0.1633832901906736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QDPR,Dihydropteridine reductase,23050,69,1.24 [0.75-2.03],0.4017164191982901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,23189,69,2.71 [1.33-5.54],0.0060303213381009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,19712,59,1.49 [1.06-2.10],0.0234390107335631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB10,Ras-related protein Rab-10,20092,59,1.12 [0.71-1.78],0.627675703483431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB11FIP3,Rab11 family-interacting protein 3,20092,59,1.06 [0.84-1.33],0.6289877128407816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB27B,Ras-related protein Rab-27B,20092,59,1.13 [0.83-1.55],0.4342694705129539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB2B,Ras-related protein Rab-2B,20022,60,0.92 [0.61-1.38],0.6832246650208345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB33A,Ras-related protein Rab-33A,19410,56,0.96 [0.65-1.41],0.8229810012211154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB37,Ras-related protein Rab-37,22757,70,1.10 [0.86-1.40],0.4560733277121319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB39B,Ras-related protein Rab-39B,19410,56,1.09 [0.85-1.40],0.5128744051535387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19446,57,1.50 [1.20-1.88],0.0003331631768093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB44,Ras-related protein Rab-44,20022,60,0.93 [0.53-1.64],0.8140436701675271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6A,Ras-related protein Rab-6A,23141,70,1.02 [0.64-1.64],0.9244135694717814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6B,Ras-related protein Rab-6B,22655,70,1.05 [0.67-1.64],0.8368565998847505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEP1,Rab GTPase-binding effector protein 1,19647,60,1.07 [0.77-1.48],0.6738590030099754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,22619,68,1.30 [0.96-1.76],0.0939292069184833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABGAP1L,Rab GTPase-activating protein 1-like,22757,70,1.17 [0.84-1.65],0.3548604967593411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAC3,Ras-related C3 botulinum toxin substrate 3,19557,56,1.19 [0.88-1.62],0.2647474848477797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD23B,UV excision repair protein RAD23 homolog B,22619,68,0.90 [0.56-1.45],0.666020045902888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD51,DNA repair protein RAD51 homolog 1,19747,59,1.09 [0.71-1.67],0.6905215954439279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALB,Ras-related protein Ral-B,19503,59,0.79 [0.34-1.84],0.5831038952092359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,20022,60,1.38 [0.96-1.99],0.0852777431265299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP1,Ran-specific GTPase-activating protein,19543,57,0.70 [0.42-1.15],0.1568947283964909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP2,E3 SUMO-protein ligase RanBP2,19446,57,0.88 [0.39-1.98],0.7648666704824122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,22619,68,0.64 [0.37-1.10],0.1057234911405883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAP1A,Ras-related protein Rap-1A,19503,59,0.82 [0.52-1.28],0.3736822883740048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAPGEF2,Rap guanine nucleotide exchange factor 2,19747,59,0.86 [0.52-1.41],0.5485075314520936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,22619,68,1.67 [1.12-2.47],0.0108907655721733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,23312,70,1.50 [1.05-2.14],0.0261278063355645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,22655,70,0.47 [0.24-0.91],0.0251933876275134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19396,57,1.14 [0.64-2.02],0.656764866271465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASSF2,Ras association domain-containing protein 2,22619,68,1.11 [0.80-1.54],0.5404631084207876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,20053,58,1.34 [0.76-2.34],0.3096800913097511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBKS,Ribokinase,22622,70,0.91 [0.60-1.37],0.6401610947836516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM17,Splicing factor 45,20053,58,1.32 [0.97-1.80],0.0756858631966935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM19,Probable RNA-binding protein 19,19410,56,0.84 [0.45-1.59],0.5965731310937126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM25,RNA-binding protein 25,19396,57,1.27 [0.76-2.14],0.3604972053705221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP1,Retinol-binding protein 1,19557,56,0.75 [0.45-1.24],0.2555298243220182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP2,Retinol-binding protein 2,23054,68,0.94 [0.71-1.24],0.6569907000419148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,23054,68,1.44 [1.00-2.06],0.047642089198694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP7,Retinoid-binding protein 7,20029,58,0.95 [0.63-1.42],0.7926843110931863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS,RNA-binding protein with multiple splicing,19503,59,0.70 [0.41-1.19],0.1883839129374815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS2,RNA-binding protein with multiple splicing 2,19543,57,1.00 [0.78-1.28],0.9791693399505194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,20022,60,1.31 [0.89-1.94],0.174853718621387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCOR1,REST corepressor 1,22746,68,0.91 [0.53-1.57],0.7403660826549074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19543,57,1.81 [0.55-5.98],0.3324461111532187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REEP4,Receptor expression-enhancing protein 4,20053,58,0.82 [0.53-1.27],0.3682707589211331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1A,Lithostathine-1-alpha,23048,70,1.42 [0.98-2.06],0.0658143248463707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1B,Lithostathine-1-beta,23457,69,1.31 [0.94-1.82],0.115302472645522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,23457,69,1.48 [1.11-1.97],0.00698455074365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3G,Regenerating islet-derived protein 3-gamma,20022,60,1.31 [0.75-2.31],0.3410980837787427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG4,Regenerating islet-derived protein 4,23165,71,1.15 [0.77-1.71],0.5003391139618782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELB,Transcription factor RelB,19503,59,1.04 [0.61-1.75],0.8904909815767607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELT,Tumor necrosis factor receptor superfamily member 19L,23180,69,1.74 [0.90-3.36],0.0992408334838659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REN,Renin,23166,69,1.03 [0.79-1.33],0.8438507439150552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REPS1,RalBP1-associated Eps domain-containing protein 1,19503,59,0.64 [0.31-1.33],0.2304637213281567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,19396,57,1.52 [0.80-2.89],0.198122990080532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23054,68,0.82 [0.46-1.45],0.4891569154590647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RETN,Resistin,23122,69,1.27 [0.80-2.00],0.308535883808658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REXO2,"Oligoribonuclease, mitochondrial",19410,56,0.76 [0.40-1.45],0.3975831807112339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RFC4,Replication factor C subunit 4,20022,60,1.29 [0.44-3.81],0.6406119386509731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGCC,Regulator of cell cycle RGCC,20053,58,0.97 [0.70-1.36],0.879841989619803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19747,59,0.91 [0.60-1.40],0.6759358392832817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMA,Repulsive guidance molecule A,23375,71,0.99 [0.52-1.90],0.9769549926506048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMB,RGM domain family member B,23375,71,0.65 [0.30-1.41],0.2769749745933415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS10,Regulator of G-protein signaling 10,20053,58,0.94 [0.61-1.44],0.7699102537385482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS8,Regulator of G-protein signaling 8,22757,70,0.75 [0.49-1.13],0.1703778942896304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RHOC,Rho-related GTP-binding protein RhoC,22844,70,1.12 [0.93-1.35],0.2384501860867274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RICTOR,Rapamycin-insensitive companion of mTOR,19503,59,0.84 [0.46-1.55],0.5786731649595002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19647,60,1.44 [0.91-2.27],0.1190349428343395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,23304,70,1.23 [0.87-1.74],0.2462006611758106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILPL2,RILP-like protein 2,20092,59,1.10 [0.85-1.42],0.4666245968017121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19410,56,0.95 [0.64-1.43],0.8193930112515917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN1,Prorelaxin H1,20053,58,1.30 [0.87-1.94],0.2089409813762353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN2,Prorelaxin H2,19612,60,0.93 [0.57-1.52],0.7852591027790725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,20118,60,2.29 [1.20-4.34],0.0115076676852022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE10,Inactive ribonuclease-like protein 10,19543,57,0.92 [0.53-1.59],0.76462039813987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE3,Eosinophil cationic protein,23055,69,0.95 [0.79-1.15],0.6124163271747279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE4,Ribonuclease 4,19463,58,1.59 [0.73-3.46],0.2383231029161219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,19983,60,2.06 [1.39-3.04],0.0002863442357768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASEH2A,Ribonuclease H2 subunit A,20053,58,0.69 [0.37-1.28],0.2411969455206128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,23347,69,1.83 [0.88-3.81],0.107076943336672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF149,E3 ubiquitin-protein ligase RNF149,19543,57,1.82 [0.89-3.73],0.0999384581985276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,19503,59,0.37 [0.17-0.81],0.0126904407430163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF31,E3 ubiquitin-protein ligase RNF31,19503,59,1.08 [0.56-2.10],0.8176128742791784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF4,E3 ubiquitin-protein ligase RNF4,19747,59,1.03 [0.71-1.51],0.8662471383627146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF41,E3 ubiquitin-protein ligase NRDP1,22619,68,1.05 [0.76-1.45],0.7794868556827456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF43,E3 ubiquitin-protein ligase RNF43,19747,59,0.96 [0.61-1.53],0.8768741380617071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF5,E3 ubiquitin-protein ligase RNF5,19543,57,1.14 [0.80-1.64],0.4629985457133247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO1,Roundabout homolog 1,23165,71,1.02 [0.42-2.51],0.9572774308247952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO2,Roundabout homolog 2,23375,71,0.50 [0.20-1.29],0.1519994416239736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO4,Roundabout homolog 4,19543,57,0.73 [0.18-3.03],0.6632852885389379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23166,69,0.89 [0.46-1.71],0.7192184110600217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RP2,Protein XRP2,23054,68,1.13 [0.70-1.84],0.6202478541967311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPA2,Replication protein A 32 kDa subunit,19503,59,0.86 [0.37-2.01],0.7283771027933306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPE,Ribulose-phosphate 3-epimerase,19747,59,0.92 [0.64-1.34],0.6803425520251337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPGR,X-linked retinitis pigmentosa GTPase regulator,19557,56,1.08 [0.58-2.02],0.8005937001933721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPL14,60S ribosomal protein L14,19543,57,0.61 [0.29-1.28],0.1944213129091329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPS10,40S ribosomal protein S10,19410,56,0.71 [0.34-1.47],0.3514580931236839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRAS,Ras-related protein R-Ras,19557,56,1.03 [0.85-1.26],0.7556263626790236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22619,68,1.28 [0.92-1.79],0.140481548604219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22619,68,1.10 [0.80-1.52],0.5415267348387219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRP15,RRP15-like protein,19446,57,1.10 [0.84-1.44],0.5004538521369621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO1,R-spondin-1,22963,70,1.66 [0.91-3.00],0.0961674298515519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO3,R-spondin-3,23366,71,1.55 [0.76-3.16],0.2280481750750458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTBDN,Retbindin,23054,68,1.01 [0.50-2.03],0.9869633481329048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,19410,56,1.09 [0.67-1.76],0.7318712484241245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20053,58,1.00 [0.76-1.32],0.9812990062228136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4R,Reticulon-4 receptor,23366,71,1.72 [1.00-2.96],0.0517953470044816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RUVBL1,RuvB-like 1,22619,68,1.11 [0.91-1.34],0.3095685426413264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RWDD1,RWD domain-containing protein 1,23375,71,1.19 [0.85-1.66],0.314459847720125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RYR1,Ryanodine receptor 1,19410,56,0.46 [0.18-1.19],0.1079845161643358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A11,Protein S100-A11,22991,69,1.20 [0.82-1.76],0.3557424441992771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A12,Protein S100-A12,22819,67,1.04 [0.78-1.38],0.8041454553694838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A13,Protein S100-A13,19503,59,0.79 [0.38-1.64],0.5289432748124492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A14,Protein S100-A14,20053,58,0.97 [0.59-1.58],0.8876390412947202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,22613,70,0.61 [0.42-0.88],0.0092129741361085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,20022,60,0.41 [0.16-1.04],0.0595231217469126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A4,Protein S100-A4,23228,70,1.32 [0.90-1.94],0.1531045169008226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100G,Protein S100-G,20053,58,0.77 [0.45-1.32],0.3463489485402858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100P,Protein S100-P,22746,68,1.01 [0.69-1.47],0.9793669187760784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,20117,60,1.73 [1.21-2.47],0.0025471052185861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAFB2,Scaffold attachment factor B2,20053,58,0.78 [0.29-2.09],0.6221978507633938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAG,S-arrestin,19446,57,1.24 [0.80-1.91],0.3332641575991349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAMD9L,Sterile alpha motif domain-containing protein 9-like,23141,70,1.15 [0.87-1.53],0.3227542620538556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,19747,59,0.81 [0.56-1.16],0.2432784823251671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SARG,Specifically androgen-regulated gene protein,20019,59,1.18 [0.94-1.48],0.1596486532324024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19410,56,1.26 [0.74-2.13],0.3979139665988246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT1,Diamine acetyltransferase 1,19410,56,0.87 [0.48-1.56],0.6360351576727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,19747,59,0.85 [0.56-1.28],0.4381413114068345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SATB1,DNA-binding protein SATB1,20053,58,0.94 [0.38-2.30],0.8862235502653437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SBSN,Suprabasin,20066,59,0.58 [0.29-1.19],0.1385559239092723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCAMP3,Secretory carrier-associated membrane protein 3,23054,68,1.21 [0.95-1.56],0.1236332505118775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARA5,Scavenger receptor class A member 5,23375,71,1.19 [0.59-2.39],0.6296427045833145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB1,Scavenger receptor class B member 1,22655,70,1.16 [0.84-1.62],0.3665440737932794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,22503,68,2.24 [1.34-3.76],0.0021503598137585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF1,Scavenger receptor class F member 1,23457,69,1.51 [0.93-2.43],0.0938223319253877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF2,Scavenger receptor class F member 2,23375,71,0.81 [0.38-1.71],0.5732908687275199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG2,Secretogranin-2,23270,70,1.48 [0.79-2.75],0.2185931982741762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG3,Secretogranin-3,23165,71,0.94 [0.50-1.76],0.8443939328355161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB1A1,Uteroglobin,23169,70,0.93 [0.64-1.35],0.7006510549085918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB2A2,Mammaglobin-A,19410,56,1.16 [0.52-2.59],0.7159226062563572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A1,Secretoglobin family 3A member 1,19647,60,0.60 [0.23-1.54],0.2886782064364795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A2,Secretoglobin family 3A member 2,23212,71,1.04 [0.81-1.35],0.741278536003751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGN,Secretagogin,22757,70,1.14 [0.72-1.82],0.5689264808203689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCIN,Adseverin,19446,57,0.95 [0.66-1.35],0.7593430440747211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,23304,70,1.73 [1.15-2.59],0.0083156859509189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,19446,57,1.16 [0.73-1.87],0.5258351817053417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2B,Sodium channel subunit beta-2,19557,56,1.16 [0.46-2.90],0.7529567895720629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3A,Sodium channel protein type 3 subunit alpha,19557,56,0.93 [0.45-1.96],0.8558732442761124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3B,Sodium channel subunit beta-3,19446,57,0.76 [0.41-1.44],0.4034965605105066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN4B,Sodium channel subunit beta-4,19543,57,0.94 [0.52-1.69],0.8450422029462714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCP2,Non-specific lipid-transfer protein,22619,68,1.14 [0.89-1.47],0.3007153824425835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCPEP1,Retinoid-inducible serine carboxypeptidase,19478,57,1.09 [0.66-1.80],0.7414530091129541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRG1,Scrapie-responsive protein 1,20092,59,1.07 [0.44-2.56],0.8877516154852905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRIB,Protein scribble homolog,19543,57,1.08 [0.83-1.42],0.5674383799371387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRN1,Secernin-1,23141,70,1.17 [0.82-1.67],0.3820151613457657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCT,Secretin,19557,56,0.62 [0.35-1.10],0.1007046341973846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,23166,69,1.65 [1.02-2.66],0.0419045965951245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC4,Syndecan-4,23166,69,1.37 [0.86-2.17],0.1809417726065445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDCCAG8,Serologically defined colon cancer antigen 8,20022,60,1.05 [0.85-1.31],0.6533974562980049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDHB,Succinate dehydrogenase,20029,58,0.98 [0.65-1.48],0.9386852196638064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDK2,Protein sidekick-2,19647,60,0.72 [0.36-1.43],0.3414496076993355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEC31A,Protein transport protein Sec31A,19543,57,1.10 [0.79-1.54],0.5609665116769046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEL1L,Protein sel-1 homolog 1,19543,57,1.55 [0.95-2.53],0.0787915020757168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELE,E-selectin,23457,69,1.22 [0.80-1.86],0.3641760920500557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELENOP,Selenoprotein P,20117,60,0.51 [0.17-1.52],0.2233278092648839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELL,L-selectin,20117,60,1.25 [0.43-3.62],0.6831436367811718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELP,P-selectin,23274,70,1.10 [0.76-1.60],0.6017435289176476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELPLG,P-selectin glycoprotein ligand 1,23141,70,0.70 [0.40-1.21],0.2015054276155185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3F,Semaphorin-3F,23166,69,1.33 [0.61-2.91],0.479681943215372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,19647,60,1.98 [1.30-3.03],0.0015756466481671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4C,Semaphorin-4C,23054,68,0.94 [0.43-2.06],0.8731418229893806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4D,Semaphorin-4D,23375,71,1.47 [0.73-2.95],0.2776317622419149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA6C,Semaphorin-6C,19503,59,0.34 [0.10-1.08],0.0666569006082553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,23381,69,1.80 [1.01-3.23],0.0476584385701037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN3,Neuronal-specific septin-3,20053,58,1.07 [0.78-1.46],0.6914176987356788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN7,Septin-7,19747,59,0.78 [0.44-1.39],0.3939781732774143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN8,Septin-8,20007,58,1.39 [0.71-2.72],0.3420196271172562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN9,Septin-9,23054,68,0.78 [0.35-1.71],0.5314175182027016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA1,Alpha-1-antitrypsin,19748,59,2.34 [0.16-35.31],0.5392390408121107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,23457,69,0.97 [0.58-1.62],0.8988862703072616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA12,Serpin A12,22506,68,1.02 [0.86-1.22],0.8007089121766606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA3,Alpha-1-antichymotrypsin,20054,60,1.43 [0.32-6.52],0.6403966565743462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA4,Kallistatin,19758,60,1.66 [0.60-4.61],0.3311912892417672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA5,Plasma serine protease inhibitor,19827,60,0.74 [0.31-1.77],0.4935928683346621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA6,Corticosteroid-binding globulin,20117,60,2.73 [0.59-12.73],0.2010870637360297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA7,Thyroxine-binding globulin,20117,60,1.98 [0.54-7.21],0.301126887098841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA9,Serpin A9,22959,68,1.22 [0.92-1.62],0.1688896721463324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB1,Leukocyte elastase inhibitor,23099,69,1.14 [0.90-1.43],0.275766868678367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB5,Serpin B5,22746,68,1.13 [0.72-1.77],0.5942766058817343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB6,Serpin B6,23296,71,1.22 [0.85-1.73],0.275607214502279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB8,Serpin B8,23437,70,1.08 [0.78-1.49],0.6340091443022806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,22963,70,2.02 [1.08-3.77],0.0275543155583096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINC1,Antithrombin-III,20085,60,1.71 [0.32-9.18],0.5341849182537755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPIND1,Heparin cofactor 2,20085,60,1.81 [0.78-4.22],0.1701158951153651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE1,Plasminogen activator inhibitor 1,23457,69,1.08 [0.79-1.49],0.6173493832884775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE2,Glia-derived nexin,20092,59,1.34 [0.93-1.94],0.1187946113145797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF1,Pigment epithelium-derived factor,19810,58,1.14 [0.44-2.95],0.7937949093021857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF2,Alpha-2-antiplasmin,19743,58,2.15 [0.34-13.43],0.4140649513209528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPING1,Plasma protease C1 inhibitor,20085,60,1.25 [0.33-4.71],0.7442047565205039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINH1,Serpin H1,19747,59,1.07 [0.89-1.30],0.4626295182725692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI1,Neuroserpin,19615,60,0.80 [0.33-1.95],0.6217987918414934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI2,Serpin I2,20029,58,1.14 [0.76-1.72],0.5297902457641415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22655,70,1.16 [0.84-1.60],0.360985231809608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,22880,70,1.51 [0.80-2.83],0.203552725408223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6,Seizure protein 6 homolog,19557,56,0.83 [0.35-1.96],0.6741380442598381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L,Seizure 6-like protein,23228,70,1.50 [0.72-3.15],0.2810319705907314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,23054,68,1.07 [0.43-2.62],0.8881896108540561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SF3B4,Splicing factor 3B subunit 4,23054,68,0.91 [0.68-1.22],0.5315324309297884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP1,Secreted frizzled-related protein 1,22882,70,1.37 [0.87-2.18],0.173822982571725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP4,Secreted frizzled-related protein 4,19647,60,1.06 [0.56-1.98],0.8597763722760392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA1,Pulmonary surfactant-associated protein A1,22619,68,1.04 [0.71-1.51],0.8447007821447043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA2,Pulmonary surfactant-associated protein A2,22619,68,1.18 [0.80-1.73],0.4073029640726145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPD,Pulmonary surfactant-associated protein D,23166,69,0.96 [0.70-1.31],0.7864007716724835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SGSH,N-sulphoglucosamine sulphohydrolase,19769,59,1.25 [0.82-1.90],0.2952351471553406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2B3,SH2B adapter protein 3,22619,68,1.17 [0.93-1.46],0.1722499138991806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2D1A,SH2 domain-containing protein 1A,23141,70,1.12 [0.82-1.55],0.4699251042879276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19446,57,0.97 [0.63-1.49],0.8945086484309125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BP1,SH3 domain-binding protein 1,20029,58,0.92 [0.54-1.57],0.7616564587491517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GL3,Endophilin-A3,19629,59,0.82 [0.63-1.07],0.1471297379670047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GLB2,Endophilin-B2,20044,58,0.88 [0.60-1.28],0.5014910286113164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHBG,Sex hormone-binding globulin,20118,60,0.63 [0.38-1.04],0.0733741480648257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHC1,SHC-transforming protein 1,19396,57,1.04 [0.84-1.30],0.6972102426275706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHD,SH2 domain-containing adapter protein D,19378,56,1.04 [0.77-1.39],0.8096996296456299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHH,Sonic hedgehog protein,19503,59,0.93 [0.51-1.69],0.8069645310223315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,20102,59,1.79 [0.91-3.52],0.0909104684467193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",23212,71,1.28 [1.00-1.64],0.0488823710395603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHPK,Sedoheptulokinase,19747,59,1.04 [0.56-1.93],0.9075994665258368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,23187,70,1.43 [0.92-2.22],0.1089577834549771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,23248,71,1.29 [0.79-2.10],0.3147181511014956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,23141,70,1.77 [1.07-2.95],0.0275425783467185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22655,70,0.94 [0.70-1.27],0.7014935560343599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC5,Sialic acid-binding Ig-like lectin 5,23180,69,1.04 [0.87-1.25],0.6611915207642917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23366,71,1.75 [0.98-3.13],0.0578591209138035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC7,Sialic acid-binding Ig-like lectin 7,23166,69,1.34 [0.63-2.83],0.4464580729026307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19543,57,1.32 [0.77-2.25],0.3179761758613338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23330,70,0.80 [0.41-1.55],0.5026332195000233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIL1,Nucleotide exchange factor SIL1,19543,57,1.25 [0.64-2.44],0.515419671074913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23231,69,0.87 [0.61-1.25],0.455067360504136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPB1,Signal-regulatory protein beta-1,23084,71,1.10 [0.71-1.70],0.6626669338777749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19503,59,0.56 [0.32-0.96],0.0352263370123304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT2,NAD-dependent protein deacetylase sirtuin-2,23054,68,1.10 [0.86-1.41],0.442729290044632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22655,70,1.00 [0.67-1.49],0.9973033397142396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIT1,Signaling threshold-regulating transmembrane adapter 1,22757,70,1.16 [0.80-1.69],0.4366267404728348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP1,Src kinase-associated phosphoprotein 1,22930,70,0.96 [0.72-1.29],0.806380654166702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP2,Src kinase-associated phosphoprotein 2,23248,71,1.05 [0.86-1.28],0.63386705256291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKIV2L,Helicase SKI2W,19410,56,1.22 [0.67-2.24],0.5156316474573884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLA2,Src-like-adapter 2,20053,58,1.04 [0.82-1.31],0.7649003960976088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,22757,70,1.19 [0.83-1.70],0.3444466306481809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,22619,68,1.73 [1.11-2.70],0.0163024858814185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,23141,70,1.55 [1.12-2.15],0.0077334416214451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF8,SLAM family member 8,22619,68,1.11 [0.74-1.67],0.6238240147479743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC12A2,Solute carrier family 12 member 2,19410,56,0.90 [0.33-2.47],0.8422260344117773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC13A1,Solute carrier family 13 member 1,20022,60,1.11 [0.76-1.60],0.5956175733732888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,22655,70,1.36 [1.01-1.84],0.0435021471933407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC1A4,Neutral amino acid transporter A,19557,56,1.11 [0.69-1.79],0.6637194753780908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC27A4,Long-chain fatty acid transport protein 4,22655,70,0.83 [0.58-1.19],0.3079731632387602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC28A1,Sodium/nucleoside cotransporter 1,19396,57,1.25 [0.89-1.77],0.1952562624782487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC34A3,Sodium-dependent phosphate transport protein 2C,19396,57,0.91 [0.51-1.62],0.7405740631394764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A14,Zinc transporter ZIP14,22655,70,0.95 [0.51-1.78],0.8821968118422739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A5,Zinc transporter ZIP5,23141,70,0.81 [0.55-1.22],0.3158867521731894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC44A4,Choline transporter-like protein 4,19557,56,0.99 [0.67-1.46],0.9499545565989566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC4A1,Band 3 anion transport protein,20102,59,0.89 [0.53-1.49],0.6491483009662639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC51B,Organic solute transporter subunit beta,19410,56,1.11 [0.80-1.56],0.5288840462917281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19647,60,1.13 [0.85-1.51],0.3867419076710261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20029,58,0.81 [0.45-1.45],0.4701551639890904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19396,57,0.93 [0.58-1.50],0.7648580992819285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIT2,Slit homolog 2 protein,22655,70,0.91 [0.59-1.39],0.6619342956506408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK1,SLIT and NTRK-like protein 1,19503,59,0.47 [0.22-1.02],0.0565975308883289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK2,SLIT and NTRK-like protein 2,23366,71,1.11 [0.67-1.84],0.6788871166500393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,22746,68,0.59 [0.31-1.11],0.1013535149806735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLK,STE20-like serine/threonine-protein kinase,19747,59,1.06 [0.79-1.44],0.6817797808496492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLMAP,Sarcolemmal membrane-associated protein,20029,58,1.07 [0.80-1.44],0.6485188311948336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLURP1,Secreted Ly-6/uPAR-related protein 1,19963,59,1.40 [0.79-2.46],0.2484439595704091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD1,Mothers against decapentaplegic homolog 1,22619,68,1.13 [0.88-1.46],0.3254675065170628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD2,Mothers against decapentaplegic homolog 2,20022,60,1.07 [0.75-1.51],0.7093794697264217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD3,Mothers against decapentaplegic homolog 3,20022,60,0.82 [0.50-1.34],0.4194473748006533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD5,Mothers against decapentaplegic homolog 5,23054,68,0.88 [0.30-2.60],0.8115009370884574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMARCA2,Probable global transcription activator SNF2L2,22655,70,1.11 [0.84-1.48],0.4595688357373704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMC3,Structural maintenance of chromosomes protein 3,19396,57,1.02 [0.63-1.65],0.9450474692860468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMNDC1,Survival of motor neuron-related-splicing factor 30,20029,58,1.07 [0.74-1.54],0.7168051225649106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC1,SPARC-related modular calcium-binding protein 1,23366,71,1.12 [0.60-2.10],0.7141316423942221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC2,SPARC-related modular calcium-binding protein 2,23248,71,1.47 [0.87-2.49],0.1547477293385289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD1,Sphingomyelin phosphodiesterase,23260,71,0.80 [0.53-1.21],0.2865305165342144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD3,Sphingomyelin phosphodiesterase 3,19503,59,0.59 [0.29-1.17],0.1307496695010235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,23203,71,0.86 [0.64-1.17],0.3378274666311056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20022,60,1.03 [0.75-1.40],0.8656829482795327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMS,Spermine synthase,19446,57,0.99 [0.66-1.49],0.9555910351315628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMTN,Smoothelin,20002,58,0.93 [0.70-1.23],0.6047863769657819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP23,Synaptosomal-associated protein 23,23166,69,1.22 [0.94-1.58],0.1287805272976116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP25,Synaptosomal-associated protein 25,19446,57,1.43 [0.86-2.37],0.1642869402058679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP29,Synaptosomal-associated protein 29,23228,70,1.16 [0.92-1.46],0.2014469236485819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAPIN,SNARE-associated protein Snapin,20053,58,0.79 [0.51-1.24],0.3109419947746656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCA,Alpha-synuclein,19647,60,1.00 [0.81-1.24],0.9637131362111142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCG,Gamma-synuclein,22963,70,1.12 [0.81-1.56],0.4789575920141125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19543,57,1.41 [0.67-2.96],0.3667796188722972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNRPB2,U2 small nuclear ribonucleoprotein B'',20044,58,0.94 [0.53-1.66],0.8186522424855811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,19410,56,0.63 [0.36-1.12],0.1183456285818336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX15,Sorting nexin-15,19647,60,1.09 [0.69-1.71],0.7189367067776407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX18,Sorting nexin-18,20029,58,0.85 [0.46-1.58],0.6044185822119639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX2,Sorting nexin-2,20022,60,0.77 [0.56-1.08],0.1295909105139471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,19543,57,0.39 [0.14-1.08],0.0694875620876073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX9,Sorting nexin-9,23166,69,1.26 [0.93-1.70],0.1385967531029968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD1,Superoxide dismutase [Cu-Zn],22723,68,1.18 [0.76-1.82],0.461863763240103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",23180,69,1.44 [0.86-2.40],0.163024945388292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD3,Extracellular superoxide dismutase,20118,60,0.69 [0.38-1.25],0.2223775933966834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORBS1,Sorbin and SH3 domain-containing protein 1,20053,58,1.13 [0.63-2.02],0.6892431810708144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORCS2,VPS10 domain-containing receptor SorCS2,22619,68,1.49 [0.83-2.67],0.1772799040556216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORD,Sorbitol dehydrogenase,23266,70,1.21 [0.88-1.66],0.231447203773506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORT1,Sortilin,23136,69,1.41 [0.82-2.45],0.2144101609916155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOST,Sclerostin,23136,69,1.33 [0.77-2.29],0.3031441793783203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19557,56,0.56 [0.27-1.14],0.1110566644272517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX2,Transcription factor SOX-2,20013,58,0.77 [0.26-2.29],0.6318383882691163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX9,Transcription factor SOX-9,19557,56,1.37 [0.53-3.51],0.5184483690321853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20053,58,1.58 [0.84-3.00],0.1593475313459089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPAG1,Sperm-associated antigen 1,20053,58,1.07 [0.72-1.59],0.7279589273910558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARC,SPARC,23228,70,1.31 [0.96-1.80],0.0930628203788867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARCL1,SPARC-like protein 1,23192,70,1.20 [0.59-2.47],0.6133312218630944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPART,Spartin,19647,60,1.08 [0.78-1.48],0.6527270831165649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPESP1,Sperm equatorial segment protein 1,20092,59,1.32 [0.65-2.67],0.4428919687289554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,23180,69,1.68 [1.08-2.63],0.0226072475995175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK2,Serine protease inhibitor Kazal-type 2,19647,60,1.54 [0.87-2.72],0.1396998712837695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,23141,70,1.58 [1.19-2.08],0.0013320640148583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK5,Serine protease inhibitor Kazal-type 5,23180,69,0.96 [0.53-1.76],0.8999902652322692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,23366,71,1.79 [1.20-2.67],0.0044227460422977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK8,Serine protease inhibitor Kazal-type 8,19410,56,1.04 [0.52-2.11],0.9037632054318324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT1,Kunitz-type protease inhibitor 1,23092,69,1.11 [0.49-2.50],0.8094288159590564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,23248,71,1.87 [1.11-3.14],0.0176910262594661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT3,Kunitz-type protease inhibitor 3,20029,58,0.92 [0.80-1.07],0.2882215843757317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPOCK1,Testican-1,22963,70,0.87 [0.39-1.94],0.7273422485670717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,23165,71,1.69 [0.96-2.97],0.0702166127669664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON2,Spondin-2,23055,69,1.11 [0.59-2.06],0.7505680017275367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPP1,Osteopontin,23422,69,1.05 [0.65-1.69],0.8471119765735283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19503,59,0.65 [0.33-1.25],0.1917062787677105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRING1,SREBP regulating gene protein,19396,57,0.74 [0.42-1.29],0.2844923441874879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR1B,Cornifin-B,19747,59,0.87 [0.61-1.24],0.4366968823943604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR3,Small proline-rich protein 3,20044,58,1.15 [0.78-1.71],0.4782635876287421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRY2,Protein sprouty homolog 2,22757,70,1.09 [0.87-1.37],0.4317774432354968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19446,57,0.85 [0.36-2.02],0.718447584846406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTLC1,Serine palmitoyltransferase 1,20044,58,0.84 [0.41-1.75],0.6432577688141874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRC,Proto-oncogene tyrosine-protein kinase Src,23190,70,1.09 [0.92-1.31],0.3156799735952095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRP14,Signal recognition particle 14 kDa protein,23054,68,1.07 [0.76-1.50],0.7092961860801015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPK2,SRSF protein kinase 2,23141,70,1.13 [0.90-1.44],0.2970780680710217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPX,Sushi repeat-containing protein SRPX,20092,59,1.54 [0.80-2.94],0.1939800088538852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSB,Lupus La protein,22655,70,1.01 [0.72-1.42],0.9661932412831548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19503,59,1.10 [0.55-2.22],0.7867489051600576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23136,69,0.97 [0.82-1.16],0.7682662598734027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23274,70,1.61 [0.99-2.62],0.0570485026838973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSH3,Protein phosphatase Slingshot homolog 3,19396,57,1.39 [0.65-2.99],0.3990282437379167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSNA1,Sjoegren syndrome nuclear autoantigen 1,20029,58,0.98 [0.60-1.60],0.9377097030816944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST13,Hsc70-interacting protein,19647,60,0.99 [0.63-1.56],0.9575594457324244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",23054,68,0.99 [0.60-1.64],0.9681502287866782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23457,69,1.68 [0.96-2.96],0.0712745333292632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19503,59,0.67 [0.33-1.36],0.2639591100909223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAB2,Stabilin-2,20102,59,0.73 [0.31-1.73],0.4723417065263796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAM,Signal transducing adapter molecule 1,20022,60,0.87 [0.43-1.77],0.6938039429631401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAMBP,STAM-binding protein,22930,70,1.20 [0.86-1.67],0.29279724173941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT2,Signal transducer and activator of transcription 2,19503,59,1.20 [0.88-1.65],0.2445074208522918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT5B,Signal transducer and activator of transcription 5B,23054,68,1.12 [0.95-1.31],0.1686451025932644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19396,57,1.25 [0.90-1.75],0.1843403607927047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC1,Stanniocalcin-1,23375,71,1.24 [0.80-1.91],0.33277104700762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC2,Stanniocalcin-2,23150,69,0.97 [0.40-2.38],0.9526365355747368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STEAP4,Metalloreductase STEAP4,19446,57,0.95 [0.65-1.38],0.7871553465015395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STIP1,Stress-induced-phosphoprotein 1,23134,69,1.03 [0.74-1.44],0.8491868332517938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK11,Serine/threonine-protein kinase STK11,22746,68,1.16 [0.86-1.55],0.3281888147458323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK24,Serine/threonine-protein kinase 24,22655,70,0.99 [0.70-1.41],0.9767856980958513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK4,Serine/threonine-protein kinase 4,23166,69,1.08 [0.85-1.38],0.5378710465474115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STOML2,"Stomatin-like protein 2, mitochondrial",19396,57,0.95 [0.70-1.27],0.7120285171084203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX16,Syntaxin-16,22619,68,1.15 [0.81-1.64],0.4343229247826159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX1B,Syntaxin-1B,19557,56,0.82 [0.40-1.69],0.58868444667285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX3,Syntaxin-3,20044,58,1.46 [0.90-2.39],0.1280963674931883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX4,Syntaxin-4,23054,68,1.14 [0.82-1.58],0.4401363759359578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX5,Syntaxin-5,19503,59,1.23 [0.72-2.09],0.4427561283922874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX6,Syntaxin-6,22619,68,0.89 [0.62-1.28],0.5244298717563677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX7,Syntaxin-7,19503,59,0.82 [0.49-1.38],0.4505693852642207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX8,Syntaxin-8,23141,70,1.27 [0.84-1.91],0.2561383909040127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP1,Syntaxin-binding protein 1,20053,58,1.09 [0.79-1.51],0.5952960077772855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP3,Syntaxin-binding protein 3,22619,68,0.81 [0.48-1.38],0.4429736561751788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGP1,SURP and G-patch domain-containing protein 1,20029,58,1.07 [0.58-1.97],0.8276291501374881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGT1,Protein SGT1 homolog,22619,68,1.08 [0.82-1.41],0.5902176960723183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT1A1,Sulfotransferase 1A1,23375,71,1.09 [0.92-1.28],0.3228679445953256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,23141,70,1.30 [0.95-1.78],0.1058550691661357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF1,Formylglycine-generating enzyme,19503,59,1.22 [0.92-1.62],0.1593298307696189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23375,71,1.12 [0.75-1.67],0.586010589750315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUOX,"Sulfite oxidase, mitochondrial",20053,58,1.18 [0.81-1.74],0.3898985226830062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,22746,68,1.53 [1.02-2.31],0.0409983577855579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD2,Sushi domain-containing protein 2,23180,69,0.92 [0.44-1.93],0.816193669444899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD4,Sushi domain-containing protein 4,20022,60,0.67 [0.34-1.32],0.2459818080276789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,19547,60,1.48 [0.73-3.00],0.2781794619047055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,19557,56,1.42 [1.03-1.95],0.0301392776413937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SWAP70,Switch-associated protein 70,20029,58,1.50 [0.86-2.61],0.1489790727268147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYAP1,Synapse-associated protein 1,19647,60,1.03 [0.67-1.58],0.8971684396534049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19446,57,1.27 [0.89-1.82],0.183374091552777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYT1,Synaptotagmin-1,20044,58,1.06 [0.59-1.93],0.8384557383972044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYTL4,Synaptotagmin-like protein 4,20092,59,0.94 [0.66-1.33],0.7203814406776468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19747,59,0.99 [0.78-1.26],0.9501614119972916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACC3,Transforming acidic coiled-coil-containing protein 3,23054,68,1.06 [0.89-1.28],0.504017909538572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACSTD2,Tumor-associated calcium signal transducer 2,20514,65,0.73 [0.34-1.57],0.4149162598532061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TADA3,Transcriptional adapter 3,20022,60,1.38 [0.77-2.48],0.2767677422314986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAFA5,Chemokine-like protein TAFA-5,23054,68,1.62 [0.94-2.78],0.0838083454109912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,19396,57,0.63 [0.41-0.95],0.0276291686177829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TALDO1,Transaldolase,20033,59,1.04 [0.59-1.83],0.8865379982260687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TANK,TRAF family member-associated NF-kappa-B activator,22757,70,1.02 [0.76-1.39],0.8754700181496601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAP1,Antigen peptide transporter 1,19747,59,1.23 [0.88-1.70],0.221933858266467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARBP2,RISC-loading complex subunit TARBP2,22655,70,1.14 [0.87-1.48],0.3514388222487372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19557,56,0.94 [0.66-1.35],0.7476370476600909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20022,60,1.02 [0.53-1.99],0.9418306418669266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAX1BP1,Tax1-binding protein 1,20044,58,0.88 [0.58-1.35],0.5695074200902592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D17,TBC1 domain family member 17,22655,70,1.07 [0.68-1.70],0.7657414184053585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D23,TBC1 domain family member 23,23054,68,1.08 [0.85-1.36],0.5402583883202208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D5,TBC1 domain family member 5,23141,70,1.03 [0.79-1.34],0.8380547441843801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCA,Tubulin-specific chaperone A,19647,60,1.06 [0.79-1.42],0.6945087455904766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCB,Tubulin-folding cofactor B,22963,70,1.10 [0.89-1.37],0.373687802994141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCC,Tubulin-specific chaperone C,22963,70,1.18 [0.91-1.53],0.2218743527026443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22619,68,1.22 [0.95-1.58],0.1212366587262748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBR1,T-box brain protein 1,19557,56,1.38 [0.95-2.00],0.0916203017702721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1A,T-cell leukemia/lymphoma protein 1A,22934,70,0.98 [0.80-1.19],0.8113516460410841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1B,T-cell leukemia/lymphoma protein 1B,22746,68,1.05 [0.81-1.36],0.6880795272614675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN1,Transcobalamin-1,19723,59,1.50 [0.87-2.60],0.1482049893338748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN2,Transcobalamin-2,23422,69,1.37 [0.71-2.66],0.3478073497002009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCOF1,Treacle protein,20092,59,1.27 [0.63-2.56],0.5033457103307415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCP11,T-complex protein 11 homolog,19747,59,0.92 [0.56-1.51],0.7484922842588558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCTN3,Tectonic-3,20092,59,0.85 [0.37-1.94],0.6999360286250084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDGF1,Teratocarcinoma-derived growth factor 1,22655,70,0.94 [0.81-1.09],0.4047003100940258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDO2,"Tryptophan 2,3-dioxygenase",19557,56,1.24 [0.69-2.24],0.4688717629623862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDP1,Tyrosyl-DNA phosphodiesterase 1,20022,60,0.89 [0.61-1.31],0.5566154077826058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDRKH,Tudor and KH domain-containing protein,22655,70,1.14 [0.89-1.45],0.2912017214295489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEF,Thyrotroph embryonic factor,19410,56,0.66 [0.33-1.30],0.2295327529381003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,23228,70,1.30 [0.50-3.39],0.5899393539661957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TERF1,Telomeric repeat-binding factor 1,19503,59,0.89 [0.36-2.21],0.8043007242295056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TET2,Methylcytosine dioxygenase TET2,19711,59,1.18 [0.97-1.43],0.0898146162527197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX101,Testis-expressed protein 101,19557,56,1.29 [0.87-1.93],0.2101274338573393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,19747,59,1.74 [1.31-2.29],0.0001034626558325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TF,Serotransferrin,20117,60,1.43 [0.46-4.39],0.5364924307321849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFAP2A,Transcription factor AP-2-alpha,19446,57,0.98 [0.63-1.51],0.9164042942276316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,23069,69,1.37 [1.10-1.71],0.0053395443588547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,23212,71,1.46 [1.06-2.01],0.0221779048321106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF3,Trefoil factor 3,23159,70,1.37 [0.87-2.15],0.168931032568024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI,Tissue factor pathway inhibitor,23127,70,0.92 [0.46-1.84],0.8193004243223394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,23166,70,1.34 [0.92-1.94],0.1275701586841475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,23268,70,1.30 [0.76-2.22],0.3291496031887931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TG,Thyroglobulin,20022,60,1.08 [0.86-1.35],0.4957184008317644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFA,Protransforming growth factor alpha,23141,70,1.30 [0.84-1.99],0.2346808714601924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB1,Transforming growth factor beta-1 proprotein,23399,69,1.58 [0.96-2.60],0.0716203340446502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB2,Transforming growth factor beta-2 proprotein,20022,60,1.31 [0.85-2.01],0.2194771429059577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBI,Transforming growth factor-beta-induced protein ig-h3,23053,70,1.46 [0.67-3.18],0.3463260341080414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR1,TGF-beta receptor type-1,19503,59,1.06 [0.35-3.20],0.9188407202653864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR2,TGF-beta receptor type-2,23228,70,1.40 [0.79-2.49],0.2480290378835727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR3,Transforming growth factor beta receptor type 3,23457,69,0.97 [0.48-1.96],0.9377851082409792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGM2,Protein-glutamine gamma-glutamyltransferase 2,23126,69,1.10 [0.83-1.46],0.5041647148333137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGOLN2,Trans-Golgi network integral membrane protein 2,20118,60,0.99 [0.39-2.51],0.984933398511501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19362,57,1.02 [0.75-1.38],0.901673629849356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBD,Thrombomodulin,23166,69,1.11 [0.54-2.29],0.770850149243541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,23180,69,1.48 [0.88-2.50],0.142370908511072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,23203,70,1.18 [0.74-1.87],0.4908654445456308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THOP1,Thimet oligopeptidase,23056,69,1.55 [0.84-2.88],0.1620392231763268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THPO,Thrombopoietin,22746,68,0.87 [0.50-1.50],0.6072581091673892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,19410,56,1.21 [1.01-1.45],0.0378684500333665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THSD1,Thrombospondin type-1 domain-containing protein 1,19366,59,1.06 [0.51-2.21],0.8774067325397673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THTPA,Thiamine-triphosphatase,19975,60,1.11 [0.84-1.47],0.4685517861818957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THY1,Thy-1 membrane glycoprotein,23375,71,1.11 [0.54-2.30],0.769508646154855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIA1,Nucleolysin TIA-1 isoform p40,22495,68,1.05 [0.88-1.25],0.6070605566047587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,23457,69,1.15 [0.67-1.97],0.606975264366415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22622,70,1.16 [0.75-1.79],0.5009878604951117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19747,59,1.37 [0.79-2.35],0.2599840089170293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23274,70,0.90 [0.55-1.47],0.6754486661365013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20092,59,1.09 [0.59-2.02],0.7816371436566203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20044,58,0.99 [0.74-1.33],0.9686482289109002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,22938,70,2.34 [1.27-4.30],0.0062277503529285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP2,Metalloproteinase inhibitor 2,20092,59,0.97 [0.38-2.52],0.955049648177307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP3,Metalloproteinase inhibitor 3,23248,71,1.14 [0.97-1.33],0.1015963033307612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP4,Metalloproteinase inhibitor 4,23180,69,0.83 [0.48-1.43],0.4955260766991166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,23100,69,1.65 [0.64-4.28],0.3023325370610592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJAP1,Tight junction-associated protein 1,23228,70,1.14 [0.89-1.47],0.2948673552966729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,19446,57,1.15 [0.64-2.05],0.645186967417553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",19747,59,0.98 [0.56-1.70],0.9346769689720668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR1,Toll-like receptor 1,19503,59,0.70 [0.26-1.88],0.478088951586409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR2,Toll-like receptor 2,19747,59,1.06 [0.36-3.13],0.917962361502553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR3,Toll-like receptor 3,23437,70,1.02 [0.72-1.45],0.8995893777630836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR4,Toll-like receptor 4,19503,59,0.93 [0.38-2.27],0.8800014781291097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19557,56,1.12 [0.71-1.77],0.6135840860129183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED1,Transmembrane emp24 domain-containing protein 1,19747,59,0.87 [0.53-1.42],0.5713533393567698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED10,Transmembrane emp24 domain-containing protein 10,19410,56,0.66 [0.29-1.52],0.3286115661434664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED4,Transmembrane emp24 domain-containing protein 4,19410,56,0.74 [0.42-1.31],0.3023047445217324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED8,Protein TMED8,20029,58,1.08 [0.84-1.37],0.5560270891029611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM106A,Transmembrane protein 106A,20022,60,1.12 [0.80-1.56],0.5222421737790535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM132A,Transmembrane protein 132A,19543,57,0.78 [0.51-1.17],0.2276711159065665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM25,Transmembrane protein 25,20053,58,0.74 [0.40-1.38],0.3398718298721473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMOD4,Tropomodulin-4,19396,57,0.86 [0.44-1.67],0.6487600523436291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11B,Transmembrane protease serine 11B,19446,57,0.97 [0.68-1.37],0.8458871820906054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11D,Transmembrane protease serine 11D,20007,58,1.47 [0.83-2.59],0.1876255314983173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS15,Enteropeptidase,23054,68,1.15 [0.91-1.46],0.2540200115548658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS5,Transmembrane protease serine 5,22852,70,1.29 [0.74-2.26],0.3714080873999607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMSB10,Thymosin beta-10,23180,69,1.31 [0.99-1.72],0.0550716992269637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,23274,70,1.21 [0.78-1.87],0.3912242993648019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,22715,68,1.40 [0.86-2.26],0.1718760718031673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20029,58,1.45 [0.96-2.19],0.0781458396509173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22757,70,1.02 [0.57-1.81],0.9589165509843848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19647,60,1.08 [0.73-1.59],0.6966463524552395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22963,70,2.02 [1.21-3.37],0.0068852175145502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22963,70,1.30 [0.96-1.76],0.0938429406575226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23239,69,0.87 [0.57-1.34],0.5314648984562564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23437,70,1.67 [1.02-2.73],0.0407150360436154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23129,71,1.37 [0.69-2.73],0.3734766824133467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23228,70,1.67 [0.97-2.85],0.0623678473996773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23165,71,2.03 [1.48-2.78],1.089851943031208e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22757,70,1.37 [0.87-2.15],0.1684566258472441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23165,71,2.04 [1.12-3.72],0.0201525327911463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19647,60,1.94 [1.13-3.34],0.0168855721931821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23366,71,1.70 [0.97-2.95],0.0616505030586036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23180,69,1.41 [0.73-2.72],0.3049483963904434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23180,69,1.40 [0.87-2.26],0.166575956038352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23375,71,0.83 [0.39-1.78],0.6356692310858847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23399,69,1.32 [0.77-2.25],0.3112096448585634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22963,70,1.19 [0.84-1.68],0.3351869082097545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23375,71,1.37 [0.89-2.09],0.1485725886273617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22963,70,1.21 [0.76-1.92],0.4318277655463147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23437,70,0.55 [0.24-1.25],0.1561501032721177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF11,Tumor necrosis factor ligand superfamily member 11,23141,70,0.84 [0.60-1.18],0.3106383952069988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23437,70,1.87 [0.90-3.92],0.0951833695109408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23248,71,1.83 [0.88-3.83],0.1073567965139937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23422,69,1.06 [0.50-2.27],0.8723954139761279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22963,70,1.37 [0.97-1.93],0.0751446842189672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF8,Tumor necrosis factor ligand superfamily member 8,20102,59,0.70 [0.34-1.41],0.3116196948479346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNIP1,TNFAIP3-interacting protein 1,20044,58,0.96 [0.72-1.28],0.7865405370154498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNN,Tenascin-N,20102,59,1.14 [0.64-2.02],0.658182044547468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNNI3,"Troponin I, cardiac muscle",22746,68,1.18 [0.90-1.53],0.2283910682555031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNPO1,Transportin-1,19747,59,0.53 [0.25-1.09],0.0855028072977499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNR,Tenascin-R,22963,70,1.10 [0.67-1.82],0.7045201228794875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNXB,Tenascin-X,23180,69,0.86 [0.38-1.96],0.7200240192491676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20092,59,1.11 [0.81-1.52],0.5291975053698106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1,DNA topoisomerase 1,20029,58,1.23 [1.00-1.52],0.051228281195237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1MT,"DNA topoisomerase I, mitochondrial",19396,57,1.35 [0.89-2.04],0.1574651784139628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP2B,DNA topoisomerase 2-beta,19503,59,1.09 [0.80-1.48],0.5996532687121148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOR1AIP1,Torsin-1A-interacting protein 1,19543,57,0.94 [0.58-1.52],0.7902467423403439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53,Cellular tumor antigen p53,22619,68,0.88 [0.53-1.45],0.6129744854941777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53BP1,TP53-binding protein 1,19503,59,1.01 [0.75-1.37],0.9337086971695752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53I3,Quinone oxidoreductase PIG3,19219,59,1.26 [0.80-2.00],0.3225752193898937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22746,68,1.02 [0.50-2.09],0.960686809334787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP73,Tumor protein p73,19557,56,1.35 [0.63-2.89],0.4431468894404955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPBGL,Trophoblast glycoprotein-like,19557,56,1.07 [0.58-1.98],0.8267891350847445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPD52L2,Tumor protein D54,19647,60,1.13 [0.89-1.43],0.3065520974921955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPK1,Thiamin pyrophosphokinase 1,20092,59,1.16 [0.48-2.79],0.7373372825052948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPM3,Tropomyosin alpha-3 chain,19410,56,0.66 [0.35-1.24],0.1975614529056091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,22619,68,1.01 [0.75-1.37],0.9374544548067018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,22974,70,1.22 [0.81-1.85],0.3446483508802449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP2,Tubulin polymerization-promoting protein family member 2,19747,59,1.21 [0.94-1.57],0.141366445869912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP3,Tubulin polymerization-promoting protein family member 3,22655,70,1.23 [0.77-1.98],0.3833794688662647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPR,Nucleoprotein TPR,19410,56,0.84 [0.47-1.51],0.5641294679990516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPRKB,EKC/KEOPS complex subunit TPRKB,19396,57,1.18 [0.86-1.62],0.3148010602975673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSAB1,Tryptase alpha/beta-1,23399,70,1.08 [0.72-1.63],0.7029198756341439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSD1,Tryptase delta,20053,58,0.85 [0.41-1.77],0.6609785575694846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSG1,Tryptase gamma,19503,59,0.82 [0.31-2.21],0.696514801344279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPT1,Translationally-controlled tumor protein,22757,70,0.74 [0.49-1.13],0.158438229343138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF2,TNF receptor-associated factor 2,23141,70,1.09 [0.81-1.47],0.5748623199367999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19503,59,0.96 [0.49-1.88],0.9111403185561148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19410,56,1.37 [0.95-1.98],0.0898219659549264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19747,59,1.07 [0.81-1.42],0.614053608445209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,20102,59,1.44 [1.02-2.06],0.0408727948671383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREM2,Triggering receptor expressed on myeloid cells 2,23129,71,1.14 [0.78-1.66],0.4942596095559524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML1,Trem-like transcript 1 protein,20118,60,1.36 [0.87-2.13],0.1796548611590632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML2,Trem-like transcript 2 protein,23180,69,1.54 [0.86-2.76],0.1458575597423888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIAP1,TP53-regulated inhibitor of apoptosis 1,23366,71,1.27 [0.92-1.75],0.1527558590508064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,23141,70,0.97 [0.73-1.29],0.8263458968075631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,19712,59,1.44 [1.03-2.00],0.0312035976831072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20029,58,1.12 [0.88-1.41],0.3577598968037293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM26,Tripartite motif-containing protein 26,19396,57,1.17 [0.79-1.73],0.4363504461970081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM40,E3 ubiquitin ligase TRIM40,19557,56,1.14 [0.81-1.60],0.4647829432731867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM5,Tripartite motif-containing protein 5,23141,70,1.19 [0.93-1.51],0.1707230894006969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM58,E3 ubiquitin-protein ligase TRIM58,20022,60,0.87 [0.65-1.16],0.3360437436945686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRPV3,Transient receptor potential cation channel subfamily V member 3,19410,56,0.92 [0.53-1.61],0.7745758906912914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC1,Hamartin,19503,59,0.60 [0.35-1.03],0.063858580652891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC22D1,TSC22 domain family protein 1,20053,58,1.20 [0.83-1.74],0.3228249923750361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSHB,Thyrotropin subunit beta,23166,69,0.99 [0.73-1.35],0.974130948740722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,22746,68,0.60 [0.37-0.96],0.0329928796064265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSNAX,Translin-associated protein X,19410,56,0.54 [0.27-1.08],0.0804479660684484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN1,Tetraspanin-1,22746,68,0.99 [0.76-1.30],0.970112997467396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN15,Tetraspanin-15,19410,56,0.73 [0.40-1.34],0.3081632984093436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN7,Tetraspanin-7,19446,57,0.99 [0.75-1.30],0.9173513471679338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN8,Tetraspanin-8,20029,58,1.05 [0.81-1.36],0.7282837927639272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPYL1,Testis-specific Y-encoded-like protein 1,19503,59,0.86 [0.45-1.65],0.6516339204384164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TST,Thiosulfate sulfurtransferase,22619,70,0.94 [0.71-1.25],0.6912840706012611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTF2,Transcription termination factor 2,19557,56,0.88 [0.52-1.51],0.6504191433862846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTN,Titin,19410,56,0.66 [0.40-1.09],0.1046864273676135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTR,Transthyretin,19903,60,0.84 [0.32-2.21],0.7185091062702644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TUBB3,Tubulin beta-3 chain,19446,57,1.17 [0.49-2.80],0.7168717964967379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TWF2,Twinfilin-2,20102,59,1.02 [0.76-1.37],0.8792165388062474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,19747,59,0.50 [0.28-0.89],0.0186095730687717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXLNA,Alpha-taxilin,22963,70,1.25 [0.98-1.59],0.0730001878110688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXN,Thioredoxin,19796,59,1.17 [0.70-1.97],0.5423525969612395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC15,Thioredoxin domain-containing protein 15,23228,70,1.28 [0.60-2.70],0.5225834630004527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC5,Thioredoxin domain-containing protein 5,23375,71,1.18 [0.87-1.59],0.2818102528808354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC9,Thioredoxin domain-containing protein 9,20044,58,1.08 [0.68-1.72],0.7501079097139103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNL1,Thioredoxin-like protein 1,19412,57,0.75 [0.52-1.07],0.1168037635999066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23180,69,1.56 [1.01-2.41],0.0441801668736292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYMP,Thymidine phosphorylase,23019,69,1.30 [0.95-1.78],0.1048853786064252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRO3,Tyrosine-protein kinase receptor TYRO3,23166,69,0.74 [0.35-1.57],0.4292187808194468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19503,59,0.82 [0.56-1.22],0.3329776126995727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBAC1,Ubiquitin-associated domain-containing protein 1,23054,68,1.26 [0.67-2.36],0.4657946638305843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2B,Ubiquitin-conjugating enzyme E2 B,20022,60,0.54 [0.21-1.38],0.2009569818882642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20092,59,1.37 [0.93-2.02],0.1124326819969306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19503,59,0.75 [0.45-1.25],0.2692311190089403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,19410,56,1.40 [1.00-1.96],0.0499076627937567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBXN1,UBX domain-containing protein 1,19647,60,1.04 [0.73-1.50],0.8230757708113337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20029,58,1.03 [0.87-1.24],0.7076147218004103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UGDH,UDP-glucose 6-dehydrogenase,19410,56,0.91 [0.68-1.23],0.5436034554443813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UHRF2,E3 ubiquitin-protein ligase UHRF2,19410,56,0.95 [0.43-2.06],0.8895177730251288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ULBP2,UL16-binding protein 2,22963,70,1.01 [0.60-1.71],0.9676630698385068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,23376,69,0.62 [0.43-0.88],0.0082244306379517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC5D,Netrin receptor UNC5D,19503,59,0.61 [0.22-1.68],0.3408470204010665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC79,Protein unc-79 homolog,19396,57,0.68 [0.41-1.14],0.1411798262990328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNG,Uracil-DNA glycosylase,20022,60,1.61 [0.98-2.64],0.0625259099699832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,20092,59,1.29 [1.00-1.67],0.0464432734940071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3A,Uroplakin-3a,19446,57,0.95 [0.56-1.61],0.8417975313161685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3BL1,Uroplakin-3b-like protein 1,19707,59,1.09 [0.71-1.67],0.6819596806385975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROD,Uroporphyrinogen decarboxylase,19647,60,1.01 [0.70-1.47],0.9413985757398036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROS,Uroporphyrinogen-III synthase,19557,56,0.90 [0.60-1.35],0.6007095161255168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USO1,General vesicular transport factor p115,23054,68,1.09 [0.86-1.39],0.4886645625616617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP25,Ubiquitin carboxyl-terminal hydrolase 25,20022,60,1.05 [0.74-1.48],0.7765676877596946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP28,Ubiquitin carboxyl-terminal hydrolase 28,20044,58,1.37 [0.77-2.42],0.2819755406020999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19410,56,0.91 [0.66-1.25],0.5591859624161672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22746,68,1.12 [0.90-1.39],0.3245370244462303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UXS1,UDP-glucuronic acid decarboxylase 1,22619,68,0.85 [0.54-1.32],0.4639941013761828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,22746,68,1.27 [0.91-1.77],0.1646272021611143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP8,Vesicle-associated membrane protein 8,19503,59,1.03 [0.77-1.37],0.8554772375547404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASH1,Tubulinyl-Tyr carboxypeptidase 1,23141,70,1.08 [0.84-1.39],0.5476461475540062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASN,Vasorin,22819,67,1.07 [0.49-2.35],0.8707983121346314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASP,Vasodilator-stimulated phosphoprotein,20118,60,1.08 [0.77-1.51],0.6545324625757406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,23054,68,0.42 [0.14-1.30],0.1313905960937224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAV3,Guanine nucleotide exchange factor VAV3,19446,57,0.97 [0.75-1.26],0.8228524053142983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,23240,70,1.61 [0.77-3.38],0.2051480205842764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,23375,71,1.66 [0.86-3.19],0.127899564991525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCPKMT,Protein-lysine methyltransferase METTL21D,19396,57,0.95 [0.69-1.30],0.7329453619531399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,23363,70,1.61 [1.16-2.23],0.0042239905691738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFB,Vascular endothelial growth factor B,19503,59,1.76 [0.78-3.99],0.1756460294721993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,23228,70,1.45 [1.00-2.12],0.050940119311648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFD,Vascular endothelial growth factor D,23403,70,0.84 [0.50-1.42],0.5200856333885304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VGF,Neurosecretory protein VGF,20053,58,1.08 [0.48-2.44],0.8477667112338624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,22746,68,1.12 [0.92-1.36],0.2746800220867764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIPR1,Vasoactive intestinal polypeptide receptor 1,19543,57,1.12 [0.40-3.17],0.831531237593426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIT,Vitrin,20092,59,1.46 [0.77-2.77],0.2498359428052755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VMO1,Vitelline membrane outer layer protein 1 homolog,23054,68,1.30 [0.93-1.82],0.1290023406764767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN1,Pantetheinase,20118,60,0.88 [0.63-1.22],0.4287826138583069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,23054,68,1.67 [1.03-2.71],0.0361529485918781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19747,59,1.06 [0.73-1.54],0.7700938564857236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS37A,Vacuolar protein sorting-associated protein 37A,23054,68,1.07 [0.82-1.39],0.632851633137377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS4B,Vacuolar protein sorting-associated protein 4B,20022,60,1.07 [0.83-1.39],0.6048582636461332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS53,Vacuolar protein sorting-associated protein 53 homolog,23054,68,1.15 [0.88-1.50],0.3216643695461629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10,V-set and immunoglobulin domain-containing protein 10,20022,60,1.01 [0.50-2.06],0.9783740202121388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19410,56,0.65 [0.28-1.52],0.3183204234039452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG2,V-set and immunoglobulin domain-containing protein 2,20022,60,1.36 [0.97-1.91],0.0720197842190201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG4,V-set and immunoglobulin domain-containing protein 4,23150,69,1.51 [0.93-2.44],0.0944684580692412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,23130,69,1.29 [0.93-1.77],0.1267280747033709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,20044,58,1.66 [1.04-2.65],0.0336011157972798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM1,V-set and transmembrane domain-containing protein 1,22655,70,0.85 [0.55-1.31],0.4578774578119126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2B,V-set and transmembrane domain-containing protein 2B,19747,59,0.70 [0.33-1.51],0.3640604545598159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22746,68,1.29 [0.96-1.73],0.0963552639912238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23375,71,1.20 [0.90-1.61],0.2149918674825002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22619,68,1.00 [0.51-1.96],0.9896904270913678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19647,60,1.04 [0.67-1.60],0.8620969221459156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA1,von Willebrand factor A domain-containing protein 1,23340,71,0.92 [0.56-1.52],0.752359967591971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA5A,von Willebrand factor A domain-containing protein 5A,19396,57,0.88 [0.60-1.30],0.5247879919579614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2,Brorin,22890,70,1.39 [0.83-2.32],0.2077945081380948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2L,von Willebrand factor C domain-containing protein 2-like,20053,58,0.72 [0.36-1.46],0.3643956308571268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,23457,69,1.18 [0.89-1.57],0.2400438148254399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",23180,69,1.56 [0.90-2.71],0.1145886271180945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WAS,Wiskott-Aldrich syndrome protein,22757,70,0.96 [0.69-1.33],0.801219919355944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF1,Wiskott-Aldrich syndrome protein family member 1,22746,68,1.01 [0.80-1.27],0.9385776061968912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF3,Wiskott-Aldrich syndrome protein family member 3,22655,70,0.91 [0.71-1.15],0.4236673152480649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASHC3,WASH complex subunit 3,20044,58,0.93 [0.66-1.30],0.6598343369116062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASL,Neural Wiskott-Aldrich syndrome protein,19503,59,0.85 [0.53-1.37],0.5040780422250619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WDR46,WD repeat-containing protein 46,20022,60,1.27 [0.72-2.24],0.4060913293890957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC1,WAP four-disulfide core domain protein 1,19603,56,0.97 [0.60-1.59],0.9184333311676656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC12,WAP four-disulfide core domain protein 12,23319,71,1.07 [0.77-1.49],0.6691269474987129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,22005,69,1.77 [1.15-2.73],0.0092898751366263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22880,70,0.79 [0.47-1.32],0.3740769576247781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23165,71,0.88 [0.47-1.66],0.6929102665761979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WIF1,Wnt inhibitory factor 1,23366,71,1.04 [0.56-1.90],0.9107647827232884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WNT9A,Protein Wnt-9a,22757,70,1.79 [0.96-3.33],0.0655994490812211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22963,70,1.20 [0.81-1.78],0.3613203921932868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XCL1,Lymphotactin,23366,71,1.07 [0.73-1.56],0.7421569448178936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XG,Glycoprotein Xg,23352,68,1.66 [0.92-2.98],0.0905774190556631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XIAP,E3 ubiquitin-protein ligase XIAP,19503,59,1.01 [0.65-1.56],0.978305903119487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XPNPEP2,Xaa-Pro aminopeptidase 2,23228,70,0.96 [0.80-1.16],0.665527359503953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XRCC4,DNA repair protein XRCC4,22655,70,0.88 [0.49-1.60],0.6788199891450842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YAP1,Transcriptional coactivator YAP1,20044,58,1.59 [0.72-3.54],0.2525844328946309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20029,58,1.09 [0.91-1.30],0.3386052531206586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YES1,Tyrosine-protein kinase Yes,23054,68,1.11 [0.92-1.34],0.2599995689161068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YJU2,Splicing factor YJU2,20022,60,1.12 [0.53-2.35],0.7602809637333875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YOD1,Ubiquitin thioesterase OTU1,19410,56,0.88 [0.58-1.33],0.5336328002526474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YTHDF3,YTH domain-containing family protein 3,22757,70,1.21 [0.95-1.55],0.118608987378699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YWHAQ,14-3-3 protein theta,19647,60,1.11 [0.79-1.55],0.5436935175455346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YY1,Transcriptional repressor protein YY1,19503,59,0.87 [0.35-2.17],0.7682052402833353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBP1,Z-DNA-binding protein 1,19503,59,0.99 [0.53-1.84],0.9726708822453056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB16,Zinc finger and BTB domain-containing protein 16,22619,68,0.96 [0.71-1.30],0.7805646570235144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,22746,68,1.42 [0.98-2.06],0.0658771377238453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19410,56,0.86 [0.53-1.39],0.5438530377961552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZFYVE19,Abscission/NoCut checkpoint regulator,20029,58,1.02 [0.77-1.35],0.9065426691366604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZHX2,Zinc fingers and homeoboxes protein 2,20044,58,0.71 [0.28-1.75],0.4516160843080613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF174,Zinc finger protein 174,19503,59,0.74 [0.32-1.68],0.4681839135608339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF75D,Zinc finger protein 75D,19747,59,1.15 [0.80-1.63],0.4541924630402658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF830,Zinc finger protein 830,20022,60,1.12 [0.83-1.49],0.4580637656194554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRD2,Protein ZNRD2,20029,58,1.05 [0.74-1.51],0.7771333034091756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20022,60,1.54 [1.07-2.21],0.0191285501721632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP3,Zona pellucida sperm-binding protein 3,19543,57,1.04 [0.94-1.15],0.4578596067019622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP4,Zona pellucida sperm-binding protein 4,19396,57,0.97 [0.42-2.22],0.9404739551104644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,19446,57,1.24 [1.02-1.51],0.0335699376959012
